2012-2017 NPPA decisions
1 March 2012 to 31 August 2017
This is a list of decisions on NPPA applications – both approvals and declines. We’ve withheld some decisions to maintain patient confidentiality.
Approximately 1/3 of all submitted applications didn’t met the underlying principles of NPPA (or the pre-requisites under the previous NPPA Policy). Applications that don’t meet the principles (or pre-requisites) aren’t assessed any further. They therefore don’t reach the point where we’d make funding decisions about them. Those applications don’t appear in this list, because no funding decision was made.
Drug | Indication | Outcome |
---|---|---|
0.45% saline | fluid replacement, Chronic Idiopathic Intestinal Pseudo-obstruction | Approved |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome | Approved |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome | Approved |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome | Approved |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome | Approved renewal |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome | Approved renewal |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome | Approved renewal |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome | Approved renewal |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome, hypertension | Approved |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome, Malnutrition | Approved |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome, Malnutrition | Approved |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome, Malnutrition | Approved renewal |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome, Malnutrition | Approved renewal |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome, metastatic adenocarcinoma prostate, Metastatic Bone Disease | Approved |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome, metastatic adenocarcinoma prostate, Metastatic Bone Disease | Approved renewal |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome, Small Cell lung Cancer | Approved |
3,4 diaminopyridine | Lambert-Eaton myasthenic syndrome, Small Cell lung Cancer | Approved |
4 - aminosalicylic acid | MDR tuberculosis | Approved |
4-aminopyridine | downbeat nystagmus, opsoclonus myoclonus ataxia, Upbeat nystagmus | Approved |
4-aminopyridine | episodic ataxia, migraine, CACNA 1 (calcium channel) gene abnormality | Approved |
4-aminopyridine | relapsing remitting Multiple Sclerosis, hyperlipidaemia, hypertension | Declined |
8-methoxypsoralen | cutaneous t cell lymphoma, mycosis fungoides, Early CD 30 transformation, Post transplant lymphoproliferative disorder (PTLD), Renal transplant 1987 for reflux nephropathy | Approved |
abatacept | polyarticular juvenile idiopathic arthritis, refractory to other treatments | Approved |
abatacept | polyarticular juvenile idiopathic arthritis, refractory to other treatments | Approved renewal |
abiraterone | castrate resistant, metastatic cancer of prostate, bronchiectasis, GI bleed, leg oedema, ongoing DVT, previous CVA, tophaceous gout | Declined |
aciclovir | viral encephalitis | Approved |
acitretin oral suspension | pustular psoriasis | Approved |
adalimumab | Behcet's disease, allergy to infliximab | Approved |
adalimumab | Behcet's disease, allergy to infliximab | Approved renewal |
adalimumab | Behcet's disease, allergy to infliximab | Approved renewal |
adalimumab | Behcet's disease, allergy to infliximab | Approved renewal |
adalimumab | Behcet's disease, autonomic neuropathy, GORD, hypertension, multiple pulmonary nodules, optic neuritis, Vertigo | Approved |
adalimumab | Behcet's disease, autonomic neuropathy, GORD, hypertension, multiple pulmonary nodules, optic neuritis, Vertigo | Approved renewal |
adalimumab | Behcet's disease, infusion reaction to infliximab, occlusive retinal vasculitis | Approved |
adalimumab | Behcet's disease, occlusive retinal vasculitis, allergy to infliximab | Approved |
adalimumab | Behcet's disease, occlusive retinal vasculitis, allergy to infliximab | Approved renewal |
adalimumab | Behcet's disease, occlusive retinal vasculitis, retinitis, allergy to infliximab | Approved |
adalimumab | Behcet's disease, occlusive retinal vasculitis, retinitis, allergy to infliximab | Approved renewal |
adalimumab | Behcet's disease, occlusive retinal vasculitis, retinitis, allergy to infliximab | Approved renewal |
adalimumab | Behcet's disease, uveitis, Mouth ulcers, oesophageal ulcers, polyarthralgia, vasculitis | Approved |
adalimumab | Behcet's disease, uveitis, Mouth ulcers, oesophageal ulcers, polyarthralgia, vasculitis | Approved renewal |
adalimumab | bilateral chronic uveitis, cataract, keratopathy, learning difficulties, progressive blindness, splenomegaly, unilateral blindness | Approved |
adalimumab | bilateral chronic uveitis, cataract, keratopathy, learning difficulties, progressive blindness, splenomegaly, unilateral blindness | Approved renewal |
adalimumab | bilateral chronic uveitis, cataract, keratopathy, learning difficulties, progressive blindness, splenomegaly, unilateral blindness | Approved renewal |
adalimumab | bilateral chronic uveitis, cataract, keratopathy, learning difficulties, progressive blindness, splenomegaly, unilateral blindness | Approved renewal |
adalimumab | bilateral chronic uveitis, panuveitis | Approved |
adalimumab | chronic pityriasis rubra pilaris | Approved |
adalimumab | cutaneous Crohns disease | Approved |
adalimumab | cutaneous Crohns disease | Approved renewal |
adalimumab | cystoid macular oedema, severe uveitis, cataract, uveitic sarcoidosis | Approved |
adalimumab | cystoid macular oedema, severe uveitis, cataract, uveitic sarcoidosis | Approved renewal |
adalimumab | funded alternative unsuitable, rheumatoid arthritis, liver fibrosis | Approved |
adalimumab | hidradenitis suppurativa, unresponsive to alternatives | Approved |
adalimumab | HLA B27 associated spondyloarthropathy, iritis, oligoarthritis | Approved |
adalimumab | HLA B27 associated spondyloarthropathy, iritis, oligoarthritis | Approved renewal |
adalimumab | infusion reaction to infliximab, severe uveitis, bilateral | Approved |
adalimumab | juvenile idiopathic arthritis, uveitis | Approved renewal |
adalimumab | juvenile idiopathic uveitis, cataract, cystoid macular oedema, keratopathy | Approved |
adalimumab | occlusive retinal vasculitis, intolerance of infliximab | Approved |
adalimumab | occlusive retinal vasculitis, intolerance of infliximab | Approved renewal |
adalimumab | paradoxical inflammatory reaction to cerebral tuberculosis, allergy to infliximab, cerebral tuberculosis | Approved |
adalimumab | paradoxical inflammatory reaction to cerebral tuberculosis, allergy to infliximab, cerebral tuberculosis | Approved renewal |
adalimumab | punctate inner choroidopathy, uveitis, allergy to infliximab | Approved |
adalimumab | severe idiopathic uveitis, obesity, social issues | Approved |
adalimumab | severe idiopathic uveitis, obesity, social issues | Approved renewal |
adalimumab | severe idiopathic uveitis, obesity, social issues | Approved renewal |
aflibercept | age related macular degeneration, choroidal neovascularisation | Declined |
aflibercept | choroidal neovascularisation | Approved |
aflibercept | diabetic macular oedema, Addison's disease, refractory to other treatments, small cell lymphoma | Declined |
aflibercept | diabetic macular oedema, diabetes type 2 | Declined |
aflibercept | diabetic macular oedema, macular oedema, diabetes | Approved renewal |
aflibercept | macular oedema, choroidal neovascularisation | Approved renewal |
aflibercept | macular oedema, choroidal neovascularisation | Approved renewal |
aflibercept | macular oedema, retinal vein occlusion, diabetes type 2, open angle glaucoma | Declined |
aflibercept | neovascular membranes | Approved renewal |
albendazole | hydatid disease | Approved |
albendazole | microsporidia keratosis | Approved |
albendazole | Ruptured hydatid cyst of the liver | Approved |
alemtuzumab | chronic lymphocytic leukaemia, fludarabine refractory | Approved |
alemtuzumab | relapsing remitting Multiple Sclerosis | Declined |
alpha tocopheryl acetate | Alagille's syndrome | Approved |
alpha tocopheryl acetate | Alagille's syndrome, cholestasis, Liver disease | Approved |
alpha tocopheryl acetate | alpha-1 antitrypsin deficiency, cholestatic jaundice | Approved |
alpha tocopheryl acetate | anaemia, iron deficiency, seizures, Vitamin E deficiency | Approved |
alpha tocopheryl acetate | autism, Cystic fibrosis | Approved |
alpha tocopheryl acetate | biliary atresia | Approved |
alpha tocopheryl acetate | biliary atresia | Approved |
alpha tocopheryl acetate | biliary atresia | Approved |
alpha tocopheryl acetate | biliary atresia | Approved |
alpha tocopheryl acetate | biliary atresia | Approved |
alpha tocopheryl acetate | biliary atresia | Approved |
alpha tocopheryl acetate | biliary atresia, choledhocal cyst | Approved |
alpha tocopheryl acetate | biliary atresia, cholestasis | Approved |
alpha tocopheryl acetate | biliary atresia, cholestasis, malabsorption | Approved |
alpha tocopheryl acetate | biliary atresia, cholestatic liver disease | Approved |
alpha tocopheryl acetate | biliary atresia, neonate | Approved |
alpha tocopheryl acetate | biliary atresia, Short Gut Syndrome | Approved |
alpha tocopheryl acetate | biliary cirrhosis | Approved |
alpha tocopheryl acetate | carnitine palmitoyl transferase II deficiency, Vitamin E deficiency | Approved |
alpha tocopheryl acetate | cholestasis | Approved |
alpha tocopheryl acetate | cholestasis | Approved |
alpha tocopheryl acetate | cholestasis | Approved |
alpha tocopheryl acetate | cholestasis, Cystic fibrosis, Liver disease | Approved |
alpha tocopheryl acetate | cholestatic jaundice | Approved |
alpha tocopheryl acetate | cholestatic jaundice | Approved |
alpha tocopheryl acetate | cholestatic jaundice, Chronic lung disease, decreased gastrointestinal function, fat soluable vitamins deficiency, Liver disease, Premature birth, previous metabolic bone disease, pulmonary hypertension | Approved |
alpha tocopheryl acetate | cholestatic liver disease | Approved |
alpha tocopheryl acetate | cholestatic liver disease | Approved |
alpha tocopheryl acetate | cholestatic liver disease | Approved |
alpha tocopheryl acetate | cholestatic liver disease | Approved |
alpha tocopheryl acetate | cholestatic liver disease | Approved |
alpha tocopheryl acetate | cholestatic liver disease | Approved |
alpha tocopheryl acetate | cholestatic liver disease | Approved |
alpha tocopheryl acetate | cholestatic liver disease | Approved |
alpha tocopheryl acetate | cholestatic liver disease | Approved |
alpha tocopheryl acetate | cholestatic liver disease | Approved |
alpha tocopheryl acetate | cholestatic liver disease, biliary atresia | Approved |
alpha tocopheryl acetate | cholestatic liver disease, biliary atresia | Approved renewal |
alpha tocopheryl acetate | cirrhosis, Juvenile Xanthogranulomatosis, Liver disease | Approved |
alpha tocopheryl acetate | cmt 1 disease | Approved |
alpha tocopheryl acetate | congenital nephrotic syndrome | Approved |
alpha tocopheryl acetate | conjugated hyperbilirubinemia | Approved |
alpha tocopheryl acetate | conjugated hyperbilirubinemia | Approved |
alpha tocopheryl acetate | conjugated hyperbilirubinemia | Approved |
alpha tocopheryl acetate | conjugated hyperbilirubinemia | Approved |
alpha tocopheryl acetate | conjugated hyperbilirubinemia | Approved |
alpha tocopheryl acetate | conjugated hyperbilirubinemia | Approved |
alpha tocopheryl acetate | conjugated hyperbilirubinemia | Approved |
alpha tocopheryl acetate | conjugated hyperbilirubinemia | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic Fibrosis | Approved |
alpha tocopheryl acetate | Cystic Fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Cystic fibrosis, liver disease or short gut syndrome | Approved |
alpha tocopheryl acetate | Cystic fibrosis, pancreatic insufficiency | Approved |
alpha tocopheryl acetate | Cystic fibrosis, Vitamin E deficiency | Approved |
alpha tocopheryl acetate | Cystic fibrosis, Vitamin E deficiency | Approved renewal |
alpha tocopheryl acetate | deranged liver enzymes, jaundice, myocarditis | Approved |
alpha tocopheryl acetate | fat intolerance, low vit E, malabsorbtion syndrome, cervical cancer, Hepatitis C, hysterectomy, post irradiation bowel disease, recent bacterial endocarditis, recto-vaginal fistulae, urinary incontinence | Approved |
alpha tocopheryl acetate | fat soluable vitamins deficiency, cholestatic jaundice | Approved |
alpha tocopheryl acetate | infantile Refsum phenotype | Approved |
alpha tocopheryl acetate | infantile Refsum phenotype | Approved renewal |
alpha tocopheryl acetate | infantile Refsum phenotype, intellectual disability | Approved renewal |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | Liver disease | Approved |
alpha tocopheryl acetate | liver disease or short gut syndrome | Approved |
alpha tocopheryl acetate | liver disease or short gut syndrome | Approved |
alpha tocopheryl acetate | liver disease or short gut syndrome | Approved |
alpha tocopheryl acetate | liver disease or short gut syndrome, Alagille's syndrome, cholestasis | Approved |
alpha tocopheryl acetate | liver disease or short gut syndrome, Vitamin E deficiency | Approved renewal |
alpha tocopheryl acetate | Liver disease, Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Liver disease, Short Gut Syndrome | Approved |
alpha tocopheryl acetate | liver dysfunction | Approved |
alpha tocopheryl acetate | multiple vitamin deficiency | Approved |
alpha tocopheryl acetate | multisystem langerhans cell histiocytosis, cholestasis, cirrhosis, Portal Hypertension | Approved |
alpha tocopheryl acetate | neonatal cholestasis | Approved |
alpha tocopheryl acetate | neonatal hepatitis | Approved |
alpha tocopheryl acetate | neutropaenia | Approved |
alpha tocopheryl acetate | progressive familial intrahepatic cholestasis | Approved |
alpha tocopheryl acetate | severe cholestasis | Approved |
alpha tocopheryl acetate | severe necrotising entercolitis, cholestatic, IVN related Liver disease, jaundice | Approved |
alpha tocopheryl acetate | short gut syndrome | Approved |
alpha tocopheryl acetate | short gut syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | short gut syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Short Gut Syndrome | Approved renewal |
alpha tocopheryl acetate | Short Gut Syndrome | Approved renewal |
alpha tocopheryl acetate | short gut syndrome, biliary atresia | Approved |
alpha tocopheryl acetate | TPN cholestasis | Approved |
alpha tocopheryl acetate | Vitamin E deficiency | Approved |
alpha tocopheryl acetate | Vitamin E deficiency | Approved |
alpha tocopheryl acetate | Vitamin E deficiency | Approved |
alpha tocopheryl acetate | Vitamin E deficiency, Cystic fibrosis | Approved |
alpha tocopheryl acetate | Vitamin E deficiency, Cystic fibrosis | Approved |
alpha tocopheryl acetate | Vitamin E deficiency, Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Vitamin E deficiency, Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Vitamin E deficiency, Cystic fibrosis | Approved renewal |
alpha tocopheryl acetate | Vitamin E deficiency, liver disease or short gut syndrome | Approved |
alpha tocopheryl acetate | Vitamin E deficiency, liver disease or short gut syndrome | Approved |
alpha tocopheryl acetate | Vitamin E deficiency, liver disease or short gut syndrome | Approved |
alpha tocopheryl acetate | Vitamin E deficiency, Liver disease, Short Gut Syndrome | Approved |
alpha tocopheryl acetate | Approved | |
amikacin | MAIC infection, mycobacterium abscessus pulmonary infection, chronic renal impairment | Approved |
amikacin | MDR tuberculosis | Approved |
amikacin | multidrug-resistant TB | Approved |
amikacin | multidrug-resistant tuberculosis | Approved |
amiloride | chronic kidney disease, multiple drug intolerances, Renal Artery Stenosis, resistant hypertension | Approved |
amiloride | hypercalciuria, recurrent nephrolithiasis | Approved |
amiloride | hypertension | Approved |
amiloride | hypertension, primary hyperaldosteronism | Approved |
amiloride | primary hyperaldosteronism, intolerance to spironolactone | Approved |
amiloride | refractory to treatment hypertension, diabetes type 2, intolerance to alternatives, Renal Artery Stenosis | Approved |
amino acid formula | aminoadipic semialdehyde (AASA) dehydrogenase deficiency, pyridoxine dependant epilepsy, developmental delay | Approved |
amino acid formula | glutaric aciduria type 1 | Approved |
amino acid formula | Maple syrup urine disease | Approved |
amino acid formula | tyrosinaemia type I | Approved |
amiodarone hydrochloride | Shone's syndrome, atrial ectopic beats, norwood procedure performed | Approved |
amiodarone hydrochloride | supraventricular tachycardia | Approved |
amphotericin | Allergic bronchopulmonary aspergillosis, Cystic fibrosis | Approved |
amphotericin | persitent candida vulvovaginitis | Approved |
anakinra | autoinflammatory syndrome | Approved renewal |
anakinra | Bilateral chronic bronchiectasis, Hypertension, Reaction to tocilizumab, systemic onset juvenile idiopathic arthritis | Approved |
anakinra | cryopyrin-associated periodic syndrome (CAPS) | Approved |
anakinra | cryopyrin-associated periodic syndrome (CAPS) | Approved renewal |
anakinra | PAPA syndrome | Approved |
anakinra | periodic fever syndrome | Approved |
anakinra | periodic fever syndrome, failure to thrive | Approved |
anakinra | persistent idiopathic pericarditis | Approved |
anakinra | Schnitzler syndrome | Approved |
anamix | methylmalonic acidemia | Approved renewal |
androstanolone | microphallus, Partial Androgen Insensitivity Syndrome | Approved |
androstanolone | microphallus, Partial Androgen Insensitivity Syndrome | Approved |
androstanolone | microphallus, Partial Androgen Insensitivity Syndrome | Approved renewal |
arginine | Citrullinaemia type 1 | Approved renewal |
arginine | MELAS, epilepsy, fatigue, muscular weakness, Weight Loss | Approved |
arginine | OTC Deficiency, learing impairment, recurrent encephalopathy | Approved |
arginine | OTC Deficiency, urea cycle disorder | Approved |
aripiprazole | aggression, agitation, Autistic Spectrum Disorder, intellectual disability, obesity | Approved |
aripiprazole | Autistic Spectrum Disorder, intellectual disability, anxiety, severe obesity | Approved |
aripiprazole | PTSD, eating disorder, multiple suicide attempts, severe affect dysregulation | Approved |
atenolol | supraventricular tachycardia | Approved |
atenolol | ectopic atrial tachycardia | Approved |
atenolol | junctional tachycardia, hypoplastic right ventricle, tricuspid atresia | Approved |
atenolol | supraventricular tachycardia | Approved |
atenolol | SVT, flecainide toxicity, Wolff-Parkinson-White syndrome | Approved |
atenolol | Wolff-Parkinson-White syndrome | Approved |
atomoxetine | severe postural hypotension, severe vasovagal syncope | Approved |
atomoxetine | severe postural hypotension, severe vasovagal syncope | Approved renewal |
atropine | excessive salivation, cognitive impairment, distal arthrogryposis syndrome, epilepsy, Excessive drooling | Approved renewal |
azacitidine | acute myeloblastic leukaemia, myelodysplasia, scheduled MUD transplant delayed | Approved |
azacitidine | myelodysplastic syndrome, Refractory Cytopenai with Multilineage Dysplasia (RCMD), multiple skin tumours, xeroderma pigmentosum | Approved |
azithromycin | bronchiolitis obliterans syndrome, Graft Versus Host Disease | Approved |
azithromycin | bronchiolitis obliterans, domiciliary oxygen, possibly secondary to adenovirus, Premature birth | Declined |
azithromycin | bronchiolitis obliterans, Hodgkin's lymphoma, post bone marrow transplant | Approved |
azithromycin | cryptosporidium, bronchiectasis, Cholecystitis, cirrhosis, Congenital Immune Deficiency, malabsorption, Malnutrition, osteoporosis | Approved |
azithromycin | diffuse panbronchiolitis | Approved |
azithromycin | Graft versus host disease of lungs, history of acute lymphoblastic leukemia, history of allogeneic bone marrow transplant | Approved |
azithromycin | MAIC infection, diverticular disease, hypertension | Approved |
azithromycin | Mycobacterium Avium Intracellulare infection | Approved |
azithromycin | mycobacterium chelonae osteomyelitis | Approved |
azithromycin | mycobacterium xenopi infection | Approved |
azithromycin | prophylaxis to prevent infection, acquired gamma-interferon autoantibodies, recurrent atypical mycobacterial infections | Approved |
azithromycin | Radiation Pneumonitis, High Risk Neuroblastoma | Approved |
azithromycin | Severe bronchiectasis, asthma | Approved |
azithromycin | Severe bronchiectasis, asthma | Approved renewal |
baclofen | dystonia, Dopamine-2-receptor antibody encephalitis, spasticity | Approved |
bedaquiline | MDR tuberculosis, pulmonary tuberculosis | Approved |
bendamustine | mantle cell lymphoma | Approved |
benzathine penicillin | prophylaxis, Rheumatic Heart Disease, anaphylaxis to funded alternatives | Approved |
benzathine penicillin | secondary prevention of rheumatic fever | Approved |
benzathine penicillin | secondary prevention of rheumatic fever | Approved renewal |
benzbromarone | allopurinol hypersensitivity, chronic kidney disease, severe tophaceous gout | Approved |
benzbromarone | Chronic Severe Tophaceous Gout, Chronic Renal Failure, heart failure | Approved |
benzbromarone | chronic tophaceous gout | Approved |
benzbromarone | chronic tophaceous gout | Approved |
benzbromarone | chronic tophaceous gout, chronic renal impairment, hypertension, ischaemic heart disease | Approved |
benzbromarone | chronic tophaceous gout, Giant Cell Myocarditis, impaired left ventricle dysfunction, ventricular tachycardia | Approved |
benzbromarone | gout, heart transplant | Approved |
benzbromarone | severe tophaceous gout, CCF, chronic kidney disease, polycythaemia rubra vera | Approved |
benzbromarone | severe tophaceous gout, renal transplant | Approved |
betaine | Homocysteinuria, ataxia, dizziness, Ulcerative Colitis, vitamin B6 responsiveness, vitamin D deficiency | Approved |
betamethasone | encephalopathy, severe intellectual disability, spasticity, status epilepticus | Approved |
betamethasone sodium phosphate | oral graft vs host disease post stem cell transplant, Chronic Myeloid Leukaemia | Approved |
bevacizumab | cerebral radionecrosis | Approved |
bevacizumab | Colorectal Cancer, kras wild type | Approved |
bevacizumab | Hereditary hemorrhagic telangiectasia | Approved renewal |
bevacizumab | Laryngeal and Subglottic Papillomatosis, Scleroderma | Approved |
bevacizumab | Laryngeal and Subglottic Papillomatosis, Scleroderma | Approved renewal |
bevacizumab | Laryngeal and Subglottic Papillomatosis, Scleroderma | Approved renewal |
bevacizumab | neurofibromatosis type 2 | Approved |
bevacizumab | recurrent glioblastoma multiforme | Declined |
bevacizumab | recurrent gondal stromal mixed ovarian tumour | Declined |
bevacizumab | recurrent respiratory papillomatosis | Approved |
bevacizumab | recurrent respiratory papillomatosis | Approved |
bevacizumab | recurrent respiratory papillomatosis | Approved |
bevacizumab | recurrent respiratory papillomatosis | Approved |
bevacizumab | recurrent respiratory papillomatosis | Approved |
bevacizumab | recurrent respiratory papillomatosis | Approved |
bevacizumab | recurrent respiratory papillomatosis | Approved |
bevacizumab | recurrent respiratory papillomatosis | Approved |
bevacizumab | recurrent respiratory papillomatosis | Approved |
bevacizumab | recurrent respiratory papillomatosis | Approved renewal |
bevacizumab | recurrent respiratory papillomatosis | Approved renewal |
bevacizumab | recurrent respiratory papillomatosis, atrial fibrillation, Right Heart Failure | Approved |
bevacizumab | recurrent respiratory papillomatosis, severe dysphonia | Approved |
bicalutamide | testotoxicosis (Male limited gonadotropin-independent precocious puberty), growth advancement, high testosterone levels, severe virilisation | Approved |
bimatoprost | glaucoma, Unable to tolerate funded medicaton | Approved |
biotin | basal ganglia disease, Biotin Deficiency, Metabolic disorder, autism, brain damage, global development delay, NG Feeding | Approved renewal |
biotin | basal ganglia disease, Biotin Deficiency, Metabolic disorder, autism, brain damage, global development delay, NG Feeding | Approved renewal |
biotin | Biotin Deficiency, Metabolic disorder, autism, brain damage, global development delay, NG Feeding | Approved |
biotin | biotinidase deficiency | Approved |
biotin | epileptic encephalopathy, infantile spasms | Approved |
biotin | holocarboxylase synthetase deficiency | Approved |
biotin | holocarboxylase synthetase deficiency | Approved |
biotin | holocarboxylase synthetase deficiency | Approved |
biotin | holocarboxylase synthetase deficiency | Approved |
biotin | holocarboxylase synthetase deficiency | Approved renewal |
biotin | holocarboxylase synthetase deficiency | Approved renewal |
biotin | holocarboxylase synthetase deficiency | Approved renewal |
biotin | holocarboxylase synthetase deficiency | Approved renewal |
biotin | holocarboxylase synthetase deficiency, antenatal therapy | Approved |
biotin | multiple carboxylase deficiency, Hypertrophic cardiomyopathy, possible mitochondrial disorder | Approved |
boric acid | metronidazole resistant trichomoniasis | Approved |
bosentan | pulmonary arterial hypertension | Approved |
bosentan | pulmonary arterial hypertension | Approved renewal |
bosentan | raynaud's syndrome, recurrent ulceration, ulceration of digits, risk of amputation | Approved |
bosutinib | Chronic Myeloid Leukaemia, paroxysmal af, Peripheral Vascular disease, Pleural Effusion | Declined |
brentuximab | bridge to transplant, relapsed Hodgkin's lymphoma | Approved |
brentuximab vedotin | anaplastic large cell lymphoma relapse, bridge to transplant | Approved |
brentuximab vedotin | bridge to transplant, relapsed Hodgkin's lymphoma | Approved |
brentuximab vedotin | Hodgkin's lymphoma, post autologous bone marrow transplant | Approved |
brentuximab vedotin | Hodgkin's lymphoma, relapsed/refractory | Approved |
brentuximab vedotin | mycosis fungoides, nodular phase, multiple relapses, refractory to chemotherapy | Declined |
brentuximab vedotin | primary refractory Hodgkin lymphoma, bridge to transplant, planned allogeneic SCT post autograft | Approved |
brentuximab vedotin | relapsed Hodgkin's lymphoma | Approved |
brentuximab vedotin | relapsed Hodgkin's lymphoma, conditioning for stem cell transplant | Approved |
brimonidine | allergy to preservative, glaucoma | Approved |
brimonidine | glaucoma, intolerance to funded alternative | Approved |
brimonidine | glaucoma, intolerance to funded alternative | Approved renewal |
budesonide | autoimmune hepatitis, Dermatitis herpetiformis, obesity | Approved |
budesonide | autoimmune hepatitis, diabetes type 2, Necrotic Lesions | Approved |
budesonide | autoimmune hepatitis, diabetes, severe osteoporosis | Approved |
budesonide | autoimmune hepatitis, sclerosing cholangitis, unacceptable side effects of prednisone | Approved |
budesonide | autoimmune hepatitis, sclerosing cholangitis, unacceptable side effects of prednisone | Approved renewal |
budesonide | common variable immunodeficiency | Approved |
budesonide | common variable immunodeficiency | Approved renewal |
budesonide | common variable immunodeficiency | Approved renewal |
budesonide | common variable immunodeficiency, protein losing enteropathy | Approved renewal |
budesonide | Immunosuppressive Therapy, unacceptable side effects of prednisone, Chronic Idiopathic Intestinal Pseudo-obstruction, Intestinal transplant | Approved |
budesonide | Immunosuppressive Therapy, unacceptable side effects of prednisone, Chronic Idiopathic Intestinal Pseudo-obstruction, Intestinal transplant | Approved renewal |
budesonide | protein losing enteropathy | Approved |
budesonide | protein losing enteropathy | Approved |
budesonide | protein losing enteropathy, complex congenital heart disease, hypoalbuminaemia, oedema, Post Fontan procedure | Approved |
budesonide | protein losing enteropathy, Post Fontan procedure | Approved |
budesonide cr | protein losing enteropathy, hypoalbuminaemia, Post Fontan procedure | Approved |
bumetanide | complex congenital cardiac disease, Post Fontan procedure | Approved |
bumetanide | complex congenital heart disease, Post Fontan procedure | Approved |
bumetanide | complex congenital heart disease, post surgical chylothorax | Approved |
bumetanide | Post Fontan procedure, complex congenital cardiac disease | Approved |
bumetanide oral suspension | post surgical chylothorax, congenital cardiac condition, Post Fontan procedure | Approved |
bupivacaine hydrochloride | uncontrolled cancer pain, metastatic lung cancer | Approved |
bupivacaine/fentanyl | severe pain, metastatic carcinoma, parietal subdural haemorrhage | Approved |
bupivacaine/morphine/clonidine | pain, Myeloma, pathological fracture | Approved |
buprenorphine | progressive familial myopathy, gastrointestinal failure, Growth Failure, severe pain, TPN dependent pseudo-obstruction, vitamin D deficiency | Approved |
buprenorphine (Subutex) | opioid dependence, opiod substitution programme, pregnant | Approved |
cabergoline | Cushing's Disease, hypercorticolism | Approved |
cabergoline | non-functioning pituitary adenoma, not surgically resectable, visual impairment | Approved |
calcitriol | autosomal recessive polycystic kidney disease, End stage renal failure, gastrointestinal malabsorbtion, osteitis fibrosa cystica | Approved |
calcium hydroxyapatite | dysphonia, hypophonia, vascular disease | Approved |
calcium hydroxyapatite | Glottal insufficiency | Approved |
calcium hydroxyapatite | Glottal insufficiency | Approved |
calcium hydroxyapatite | Glottal insufficiency | Approved |
calcium hydroxyapatite | Glottal insufficiency | Approved |
calcium phosphate | diabetes type 2, mucositus, supraglottic tumour | Approved |
calcium phosphate | infection, carcinoma of the tonsil | Approved |
calcium phosphate | mucositis | Approved |
calcium phosphate | mucositis | Approved |
calcium phosphate | mucositis | Approved |
calcium phosphate | mucositis | Approved |
calcium phosphate | mucositis, squamous cell carcinoma | Approved |
calcium phosphate | oral mucositis | Approved |
calcium phosphate | oral mucositis | Approved |
calcium phosphate | oral mucositis | Approved |
calcium phosphate | oral mucositis | Approved |
calcium phosphate | oral mucositis | Approved |
calcium phosphate | oral mucositis | Approved |
calcium phosphate | oral mucositis, carcinoma of the tonsil | Approved |
calcium phosphate | oral mucositis, carcinoma of tongue, radiation treatment | Approved |
calcium phosphate | oral mucositis, chemotherapy, Radiotherapy | Approved |
calcium phosphate | oral mucositis, Radiotherapy | Approved |
calcium phosphate | oral mucositis, radiotherapy, squamous cell carcinoma of subglottic space | Approved |
calcium phosphate | oral mucositis, squamous cell carcinoma left tonsil, undergoing chemotherapy and radiotherapy | Approved |
calcium phosphate | oral mucositis, squamous cell carcinoma of subglottic space | Approved |
calcium phosphate | oral mucositis, squamous cell carcinoma of subglottic space | Approved |
calcium phosphate | radiation induced oral mucositis | Approved |
calcium phosphate | radiation induced oral mucositis | Approved |
calcium phosphate | radiation induced oral mucositis, squamous cell carcinoma | Approved |
calcium phosphate | squamous cell carcinoma, Mucosal radiation toxicity, Oral Chemotherapy, oral mucositis | Approved |
captopril | cystine stones, nephrolithiasis | Approved |
captopril | mitral regurgitation, mitral stenosis, Autistic Spectrum Disorder, elevated pulmonary arterial pressures, pulmonary hypertension | Approved renewal |
carbohydrate free mixture | congenital glucose galactose malabsorption | Approved |
carbohydrate free mixture | congenital glucose galactose malabsorption | Approved renewal |
carbohydrate free mixture | enteropathy, intestinal failure, carbohydrate intolerance, failure to thrive, fructose intolerance, glucose intolerance, secretory diarrhoea, TPN dependent | Approved |
carbomer | sicca syndrome, rheumatoid arthritis | Approved |
carmellose sodium | dry eyes, graft vs host disease | Approved |
carmellose sodium eye drops | bilateral corneal transplant, atopy, keratoconus, stem cell deficiency | Approved |
carmustine wafer | astrocytoma | Approved |
carmustine wafer | relapsed oligodendroglioma | Approved |
carnitine | carnitine deficiency | Approved |
carnitine | carnitine deficiency | Approved |
carnitine | carnitine deficiency | Approved renewal |
carnitine | carnitine deficiency | Approved renewal |
carnitine | carnitine deficiency, low L-carnitine levels post sodium valproate, Congenital Ponto-Cerebellar Hypolasia, nasogastric tube | Approved |
carnitine | carnitine deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency | Approved |
carnitine | carnitine palmitoyl transferase II deficiency | Approved |
carnitine | holocarboxylase synthetase deficiency | Approved |
caspofungin | candida lusitaniae infection, Glycogen Storage Disease type 1b, immunosuppressed, infected portacath, neutropaenia | Approved |
caspofungin | disseminated aspergillosis, Acute Lymphoblastic Leukaemia | Approved |
cefuroxime | microbial keratitis | Approved |
celecoxib | previous resection, pulmonary inflammatory myofibroblastic tumour, nasogastric tube | Approved renewal |
celecoxib | Rheumatoid Arthritis | Declined |
cetuximab | liver metastases, lung metastases, lymph node spread, metastatic squamous cell carcinoma, primary skin cancer, diabetes type 2, hyperlipidaemia, hypertension | Declined |
chloral hydrate | lissencephaly, cerebal palsy, epilepsy, severe sleep disorder, spastic quadriplegia | Approved |
chloral hydrate | seizure disorder, cerebral palsy, Incontinence, intellectual handicap, scoliosis, spastic quadriplegia | Approved |
chloral hydrate | severe sleep disorder, Complex Mitochondrial Disorder, gastrotomy fed, global development delay | Approved |
chloral hydrate | severe sleep disorder, FOX G1 Syndrome, gastrotomy fed, global development delay | Approved renewal |
chloral hydrate | severe sleep disorder, FOX G1 Syndrome, gastrotomy fed, global development delay | Approved renewal |
chloramphenicol | allergic eye disease, corneal ulcers, Herpes Simplex Keratitis | Approved |
cholic acid | infantile Refsum phenotype, peroxisomal biogenesis defect, Zellweger spectrum disorder | Approved |
cinacalcet | autonomous hyperparathyroidism, Cardiomyopathy, diabetes type 2, haemodialysis | Approved |
cinacalcet | autonomous hyperparathyroidism, end stage renal disease | Approved |
cinacalcet | autonomous hyperparathyroidism, end-stage renal failure on dialysis, Peripheral Vascular disease | Approved |
cinacalcet | autosomal recessive polycystic kidney disease, bone marrow fibrosis, congenital hepatic fibrosis, End stage renal failure, failure to thrive, hypersplenism, oesophageal varicies, Portal Hypertension, Severe hyperthyroidism | Approved |
cinacalcet | Calciphylaxis, Coronary Artery Disease, diabetes type 2, diabetic nephropathy, end stage renal disease, hyperparathyroidism, Peripheral Vascular disease | Approved |
cinacalcet | Calciphylaxis, dialysis, end stage renal failure, hyperparathyroidism | Approved |
cinacalcet | Calciphylaxis, hypercalcaemia, hyperphosphataemia, Severe ulceration of both legs, Atrial fibrillation, end stage kidney disease, gout, Insulin-Dependent Diabetes Mellitus, necrotic skin ulceration, non ST elevation myocardial infarction, secondary hyperparathyroidism, smoker, VF cardiac arrest | Approved |
cinacalcet | Calciphylaxis, tertiary hyperparathyroidism, diabetic nephropathy, haemodialysis, severe peripheral vascular disease | Approved |
cinacalcet | Calciphylaxis, tertiary hyperparathyroidism, parathyroidectomy | Approved |
cinacalcet | Calciphylaxis, tertiary hyperparathyroidism, parathyroidectomy | Approved renewal |
cinacalcet | Dialysis, hyperparathyroidism, renal failure | Approved |
cinacalcet | Dialysis, hyperparathyroidism, renal failure | Approved renewal |
cinacalcet | Dialysis, hyperparathyroidism, renal failure | Approved renewal |
cinacalcet | ESRF, IgA nephropathy, parathyromatosis, transplant planned, hypertension, limited vascular access | Approved |
cinacalcet | hypercalcaemia | Approved |
cinacalcet | hypercalcaemia, metastatic pancreatic neuroendocrine tumour | Approved |
cinacalcet | hypercalcaemia, primary hyperparathyroidism | Approved |
cinacalcet | hypercalcaemia, primary hyperparathyroidism | Approved |
cinacalcet | hypercalcaemia, primary hyperparathyroidism | Approved |
cinacalcet | hypercalcaemia, primary hyperparathyroidism, atrial fibrillation, B cell lymphoma, cognitive impairment, gout, parkinson's disease, previous PE, Prostate cancer | Approved |
cinacalcet | hyperparathyroidism | Approved |
cinacalcet | hyperparathyroidism | Approved |
cinacalcet | hyperparathyroidism | Approved renewal |
cinacalcet | hyperparathyroidism | Approved renewal |
cinacalcet | hyperparathyroidism, autonomous hyperparathyroidism, end stage renal failure, surgery contraindicated | Approved |
cinacalcet | hyperparathyroidism, autonomous hyperparathyroidism, end stage renal failure, surgery contraindicated | Approved renewal |
cinacalcet | hyperparathyroidism, autonomous hyperparathyroidism, previous surgery, surgery contraindicated, unsuccessful parathyroid surgery | Approved |
cinacalcet | hyperparathyroidism, diabetes type 2, end stage renal failure, hypertension, pulmonary tuberculosis | Approved |
cinacalcet | hyperparathyroidism, diabetes type 2, end stage renal failure, hypertension, pulmonary tuberculosis | Approved renewal |
cinacalcet | hyperparathyroidism, ectopic tissue | Approved |
cinacalcet | hyperparathyroidism, ectopic tissue | Approved renewal |
cinacalcet | hyperparathyroidism, failed surgery, post renal transplant | Approved renewal |
cinacalcet | hyperparathyroidism, IgA nephropathy, post kidney transplant | Approved |
cinacalcet | hyperparathyroidism, infected SVC clot, SVC stenosis | Approved |
cinacalcet | Pancreatic neuroendocrine tumor | Approved |
cinacalcet | Pancreatic neuroendocrine tumor | Approved renewal |
cinacalcet | Pancreatic neuroendocrine tumor | Approved renewal |
cinacalcet | Pancreatic neuroendocrine tumor | Approved renewal |
cinacalcet | pancreatic neuroendocrine tumour, severe treatment resistant hypercalcaemia | Approved renewal |
cinacalcet | parathyroid adenoma, primary hyperparathyroidism, severe treatment resistant hypercalcaemia, bridge to surgery, chronic renal impairment, heart failure | Approved |
cinacalcet | Parathyroid carcinoma with recurrence | Approved |
cinacalcet | primary hypercalcaemia, unfit for surgery | Approved |
cinacalcet | primary hyperparathyroidism | Approved renewal |
cinacalcet | primary hyperparathyroidism, atrial fibrillation, hypercalcaemia, previous CVAs, renal impairment | Approved |
cinacalcet | primary hyperparathyroidism, awaiting surgery, hypercalcaemia, metastatic melanoma | Approved |
cinacalcet | primary hyperparathyroidism, congestive heart failure, gout, hypercalcaemia, hypercholesterolaemia, hypertension, osteoporosis, renal failure | Approved |
cinacalcet | primary hyperparathyroidism, congestive heart failure, gout, hypercalcaemia, hypercholesterolaemia, hypertension, osteoporosis, renal failure | Approved renewal |
cinacalcet | primary hyperparathyroidism, dementia, surgery contraindicated | Approved |
cinacalcet | primary hyperparathyroidism, dementia, surgery contraindicated | Approved renewal |
cinacalcet | primary hyperparathyroidism, dementia, surgery contraindicated | Approved renewal |
cinacalcet | primary hyperparathyroidism, failed surgery | Approved |
cinacalcet | primary hyperparathyroidism, failed surgery | Approved renewal |
cinacalcet | primary hyperparathyroidism, heart disease, lung disease, parathyroid adenoma | Approved |
cinacalcet | primary hyperparathyroidism, heart disease, lung disease, parathyroid adenoma | Approved renewal |
cinacalcet | primary hyperparathyroidism, hypercalcaemia | Approved |
cinacalcet | primary hyperparathyroidism, hypercalcaemia | Approved |
cinacalcet | primary hyperparathyroidism, hypercalcaemia | Approved renewal |
cinacalcet | primary hyperparathyroidism, hypercalcaemia | Approved renewal |
cinacalcet | primary hyperparathyroidism, hyperlipidaemia, hypertension, impaired glucose tolerance, ischaemic heart disease | Approved |
cinacalcet | primary hyperparathyroidism, hyperlipidaemia, hypertension, impaired glucose tolerance, ischaemic heart disease | Approved renewal |
cinacalcet | primary hyperparathyroidism, IHD, Pancreatic neuroendocrine tumor, renal impairment | Approved |
cinacalcet | primary hyperparathyroidism, tertiary hyperparathyroidism, diabetes type 2, dilated cardiomyopathy, hypertension, obesity, Renal Impairment | Approved |
cinacalcet | primary hyperparathyroidism, unfit for surgery, bipolar disease, Diabetes Insipidus, diabetes type 2, ischaemic bowel | Approved |
cinacalcet | primary hyperparathyroidism, unsuccessful parathyroid surgery | Approved |
cinacalcet | secondary hyperparathyroidism, bone pain, ESRF on Dialysis, unfit for surgery | Approved |
cinacalcet | secondary hyperparathyroidism, bone pain, ESRF on Dialysis, unfit for surgery | Approved renewal |
cinacalcet | secondary hyperparathyroidism, bronchiectasis, CF related diabetes, Cystic fibrosis, end stage kidney disease, liver transplant, severe chronic lung disease, surgery contraindicated, tertiary hyperparathyroidism | Approved |
cinacalcet | secondary hyperparathyroidism, diabetes type 2, dilated cardiomyopathy, end stage renal failure, haemodialysis, long QT syndrome, obesity, Osteoarthritis | Approved |
cinacalcet | secondary hyperparathyroidism, diabetes type 2, dilated cardiomyopathy, end stage renal failure, haemodialysis, long QT syndrome, obesity, Osteoarthritis | Approved renewal |
cinacalcet | secondary hyperparathyroidism, dialysis dependent, ischaemic heart disease, kidney failure, Myasthenia gravis | Approved |
cinacalcet | secondary hyperparathyroidism, end stage renal failure, haemodialysis, tertiary hyperparathyroidism | Approved |
cinacalcet | secondary hyperparathyroidism, post renal transplant, unfit for surgery | Approved |
cinacalcet | secondary hyperparathyroidism, post renal transplant, unfit for surgery | Approved renewal |
cinacalcet | secondary hyperparathyroidism, unfit for surgery | Approved |
cinacalcet | secondary hyperparathyroidism, unfit for surgery | Approved renewal |
cinacalcet | severe hyperparathyroidism, aortic valve disease, cardiac disease, end stage renal failure, Endocarditis, ineligible for transplant, on warfarin, previous stroke, unfit for surgery | Approved |
cinacalcet | severe hyperparathyroidism, back pain, occlusion subclavian vein, renal failure, SLE | Approved |
cinacalcet | severe hyperparathyroidism, back pain, occlusion subclavian vein, renal failure, SLE | Approved renewal |
cinacalcet | severe hyperparathyroidism, back pain, occlusion subclavian vein, renal failure, SLE | Approved renewal |
cinacalcet | severe hyperparathyroidism, diabetes type 2, end stage renal failure, haemodialysis, ischaemic heart disease, obesity | Approved |
cinacalcet | severe hyperparathyroidism, diabetes type 2, end stage renal failure, haemodialysis, ischaemic heart disease, obesity | Approved renewal |
cinacalcet | severe hyperparathyroidism, end stage renal failure, ESRD, gout, obesity | Approved |
cinacalcet | severe hyperparathyroidism, end stage renal failure, haemodialysis, unfit for surgery | Approved |
cinacalcet | severe hyperparathyroidism, ESRD, haemodialysis, Peripheral Vascular disease, severe ischaemic heart disease | Approved |
cinacalcet | severe hyperparathyroidism, ESRD, haemodialysis, Peripheral Vascular disease, severe ischaemic heart disease | Approved renewal |
cinacalcet | severe hyperparathyroidism, surgery contraindicated | Approved |
cinacalcet | severe hyperparathyroidism, surgery contraindicated | Approved renewal |
cinacalcet | severe hyperparathyroidism, surgery contraindicated | Approved renewal |
cinacalcet | Severe hyperthyroidism, Calciphylaxis, diabetes type 2, ESRF on Dialysis, gout, IHD, no venous access, obesity, Peripheral Vascular disease, probable uterine fibroid mass, renal calculus | Approved |
cinacalcet | Severe hyperthyroidism, Calciphylaxis, diabetes type 2, ESRF on Dialysis, gout, IHD, no venous access, obesity, Peripheral Vascular disease, probable uterine fibroid mass, renal calculus | Approved renewal |
cinacalcet | Severe hyperthyroidism, Coronary Artery Disease, end stage renal failure, polycystic kidney disease | Approved |
cinacalcet | severe secondary hyperparathyroidism, aortic stenosis, end stage renal failure | Approved |
cinacalcet | severe secondary hyperparathyroidism, aortic stenosis, end stage renal failure | Approved renewal |
cinacalcet | severe secondary hyperparathyroidism, diabetes mellitus, end stage renal failure, ischaemic cardiomyopathy, Peripheral Vascular disease | Approved |
cinacalcet | severe secondary hyperparathyroidism, diabetes mellitus, end stage renal failure, ischaemic cardiomyopathy, Peripheral Vascular disease | Approved renewal |
cinacalcet | severe secondary hyperparathyroidism, diabetes mellitus, end stage renal failure, ischaemic cardiomyopathy, Peripheral Vascular disease | Approved renewal |
cinacalcet | severe secondary hyperparathyroidism, diabetes, end stage renal failure, Severe Ischaemic Heart Disease | Approved |
cinacalcet | severe secondary hyperparathyroidism, diabetes, end stage renal failure, Severe Ischaemic Heart Disease | Approved renewal |
cinacalcet | severe secondary hyperparathyroidism, diabetes, end stage renal failure, severe ischaemic heart disease | Approved renewal |
cinacalcet | severe secondary hyperparathyroidism, end stage renal disease, surgery contraindicated | Approved |
cinacalcet | severe secondary hyperparathyroidism, end stage renal failure, unfit for surgery | Approved |
cinacalcet | severe secondary hyperparathyroidism, end stage renal failure, unfit for surgery | Approved renewal |
cinacalcet | severe secondary hyperparathyroidism, severe treatment resistant hypercalcaemia, end stage renal failure, Right Heart Failure | Approved |
cinacalcet | severe secondary hyperparathyroidism, surgery contraindicated, coronary disease, dialysis dependent, ESRF secondary to focal glomerulosclerosis, previous CABG, severe peripheral vascular disease | Approved |
cinacalcet | severe secondary hyperparathyroidism, surgery contraindicated, coronary disease, dialysis dependent, ESRF secondary to focal glomerulosclerosis, previous CABG, severe peripheral vascular disease | Approved renewal |
cinacalcet | severe treatment resistant hypercalcaemia, end stage renal failure due to hypertension, ischaemic heart disease, post renal transplant, recurrent bacteraemia, recurrent urinary tract infections, tertiary hyperparathyroidism | Approved |
cinacalcet | severe treatment resistant hypercalcaemia, pre-operative treatment, primary hyperparathyroidism | Approved |
cinacalcet | tertiary hyperparathyroidism | Approved |
cinacalcet | tertiary hyperparathyroidism | Approved |
cinacalcet | tertiary hyperparathyroidism | Approved renewal |
cinacalcet | tertiary hyperparathyroidism | Approved renewal |
cinacalcet | tertiary hyperparathyroidism | Approved renewal |
cinacalcet | tertiary hyperparathyroidism, atrial fibrillation, diabetic nephropathy, dialysis, ESRD, severe peripheral vascular disease | Approved |
cinacalcet | tertiary hyperparathyroidism, atrial fibrillation, diabetic nephropathy, dialysis, ESRD, severe peripheral vascular disease | Approved renewal |
cinacalcet | tertiary hyperparathyroidism, atrial fibrillation, diabetic nephropathy, dialysis, ESRD, severe peripheral vascular disease | Approved renewal |
cinacalcet | tertiary hyperparathyroidism, cardiac disease, ESRD, Peripheral Vascular disease | Approved |
cinacalcet | tertiary hyperparathyroidism, Cardiomyopathy, ESRF, hypertension, musculoskeletal pain, severe emphysema, surgery contraindicated | Approved |
cinacalcet | tertiary hyperparathyroidism, Cardiomyopathy, ESRF, hypertension, musculoskeletal pain, severe emphysema, surgery contraindicated | Approved renewal |
cinacalcet | tertiary hyperparathyroidism, Coronary Artery Disease, diabetic nephropathy, ESRF, surgery contraindicated | Approved |
cinacalcet | tertiary hyperparathyroidism, coronary disease, diabetes type 2, ESRF secondary to FSGS, hypertension, myopathy | Approved |
cinacalcet | tertiary hyperparathyroidism, diabetes type 2, IHD, previous CVA | Approved |
cinacalcet | tertiary hyperparathyroidism, diabetes type 2, IHD, previous CVA | Approved renewal |
cinacalcet | tertiary hyperparathyroidism, diabetes type 2, IHD, previous CVA | Approved renewal |
cinacalcet | tertiary hyperparathyroidism, diabetes, ESRD | Approved |
cinacalcet | tertiary hyperparathyroidism, diabetic nephropathy, end stage renal failure, ischaemic heart disease | Approved |
cinacalcet | tertiary hyperparathyroidism, diabetic nephropathy, end stage renal failure, ischaemic heart disease | Approved renewal |
cinacalcet | tertiary hyperparathyroidism, end stage kidney failure, hypercalcaemia | Approved |
cinacalcet | tertiary hyperparathyroidism, end stage renal disease | Approved |
cinacalcet | tertiary hyperparathyroidism, ESRF on Dialysis, ischaemic heart disease, painful extra-skeletal calcium deposits | Approved |
cinacalcet | tertiary hyperparathyroidism, ESRF on Dialysis, ischaemic heart disease, painful extra-skeletal calcium deposits | Approved renewal |
cinacalcet | tertiary hyperparathyroidism, ESRF, surgery contraindicated | Approved |
cinacalcet | tertiary hyperparathyroidism, heart failure | Approved |
cinacalcet | tertiary hyperparathyroidism, heart failure | Approved renewal |
cinacalcet | tertiary hyperparathyroidism, hypercalcaemia, severe renal osteodystrophy | Approved |
cinacalcet | tertiary hyperparathyroidism, hypercalcaemia, severe renal osteodystrophy | Approved renewal |
cinacalcet | tertiary hyperparathyroidism, hypertension, polyarticular gout | Approved |
cinacalcet | tertiary hyperparathyroidism, hypertension, polyarticular gout | Approved renewal |
cinacalcet | tertiary hyperparathyroidism, infected SVC clot, SVC stenosis | Approved renewal |
cinacalcet | tertiary hyperparathyroidism, infected SVC clot, SVC stenosis | Approved renewal |
cincalcet | tertiary hyperparathyroidism, diabetes, ESRD, renal arterial disease | Approved |
cincalcet | tertiary hyperparathyroidism, diabetes, ESRD, renal arterial disease | Approved renewal |
ciprofloxacin | recurrent UTI, unable to swallow these pills | Approved |
cisapride | cerebral palsy, constipation, enteral feeds, pain | Approved |
cisapride | obstruction PU5, gut dysmotility, intolerance to feed, Renal Impairment, single dysplastic kidney, Vomiting | Approved |
cisapride | oesophageal dysmotility, dysphagia, GORD | Approved |
cisapride | oesophageal dysmotility, dysphagia, GORD | Approved renewal |
cisapride | poor antroduodenal motility, Hirschsprung's disease, intolerance to feed, jejunal obstruction | Approved |
citric acid 12 g + magnesium oxide 3.5 g + picosulfate sodium 10 mg oral liquid | Chronic severe constipation, constipation secondary to clozapine, Schizoaffective disorder | Approved |
citric acid with magnesium oxide and sodium picosulfate | abdominal pain, Encopresis, slow transit constipation | Approved |
citric acid with magnesium oxide and sodium picosulfate | Chronic severe constipation | Approved |
clarithromycin | Nocardiosis, prophylaxis, immunocompromised | Approved |
clindamycin | desquamative inflammatory vaginitis | Approved |
clindamycin clotrimazole | desquamative inflammatory vaginitis | Approved |
clindamycin clotrimazole | desquamative inflammatory vaginitis | Approved |
clindamycin clotrimazole | desquamative inflammatory vaginitis | Approved |
clindamycin clotrimazole | desquamative inflammatory vaginitis | Approved renewal |
clinigel lubricating jelly | persitent candida vulvovaginitis | Approved |
clofarabine | Langerhans cell histiocytosis | Approved |
clofazimine | Cystic fibrosis, mycobacterium abscessus pulmonary infection | Approved |
clofazimine | leprosy | Approved |
clofazimine | MDR tuberculosis | Approved |
clofazimine | multibacillary leprosy, peripheral neuropathy | Approved |
coagucheck testing strips | on warfarin, cerebral palsy, epilepsy, pericardial effusion, Pleural Effusion, Rheumatic Heart Disease, valve replacement | Approved |
co-enzyme q | autosomal recessive cerebellar atrophy | Approved |
co-enzyme q | autosomal recessive cerebellar atrophy | Approved renewal |
coenzyme q 10 | alpers' disease, mitochondrial disorder, gastrostomy feeding, Neuropathic pain, partial epilepsy | Approved renewal |
co-enzyme q10 | autosomal recessive cerebellar atrophy | Approved |
co-enzyme q10 | autosomal recessive cerebellar atrophy | Approved renewal |
co-enzyme q10 | heart failure, hyperkalaemia, MELAS, Pleural Effusion | Approved |
co-enzyme q10 | heart failure, hyperkalaemia, MELAS, Pleural Effusion | Approved renewal |
colesevelam | bile salt diarrhoea | Approved |
colesevelam | bile salt diarrhoea post cholecystectomy, Coeliac disease, multiple food intolerances | Approved |
colesevelam | bile salt diarrhoea post cholecystectomy, Coeliac disease, multiple food intolerances | Approved renewal |
colesevelam | bile salt diarrhoea post cholecystectomy, Coeliac disease, multiple food intolerances | Approved renewal |
colistin | Resistant Pseudomonas infection, Pseudomonas Chest Infection | Approved |
condoms | contraception, funded alternative unsuitable | Approved |
crisantaspase | NK/T cell lymphoma | Approved |
crizotinib | metastatic lung adenocarcinoma, ALK positive | Declined |
custodiol htk | aortic valve replacement | Approved |
custodiol htk | aortic valve replacement, cardiac surgery, coronary artery bypass grafting, mitral valve replacement | Approved |
custodiol htk | AVR, CABG | Approved |
custodiol htk | cardiac surgery | Approved |
custodiol htk | cardiac surgery | Approved |
custodiol htk | cardiac surgery | Approved |
custodiol htk | cardiac surgery | Approved |
custodiol htk | cardiac surgery | Approved |
custodiol htk | cardiac surgery | Approved |
custodiol htk | cardiac surgery | Approved |
custodiol htk | cardiac surgery, aortic arch repair, transluminal repair of aorta | Approved |
custodiol htk | cardiac surgery, aortic regurgitation, mitral regurgitation, Valve Replacement | Approved |
custodiol htk | cardiac surgery, aortic valve replacement, Congestive Heart Failure, mitral stenosis, Rheumatic Heart Disease | Approved |
custodiol htk | cardiac surgery, aortic valve replacement, mitral valve replacement, tricuspid valve replacement | Approved |
custodiol htk | cardiac surgery, Bentall's procedure | Approved |
custodiol htk | cardiac surgery, Congestive Heart Failure | Approved |
custodiol htk | cardiac surgery, coronary artery bypass grafting | Approved |
custodiol htk | cardiac surgery, PAH | Approved |
custodiol htk | coronary artery bypass graft, mitral valve replacement | Approved |
custodiol htk | triple valve replacement | Approved |
custodiol htk | triple valve replacement | Approved |
custodiol htk | upcoming aortic valve replacement surgery | Approved |
cyanocobalamin | transcobalamin deficiency | Approved |
cyanocobalamin | transcobalamin deficiency | Approved |
cyanocobalamin | vitamin B 12 deficiency, on warfarin, Post Fontan procedure, protein losing enteropathy | Approved |
cycloserine | MDR tuberculosis | Approved |
cycloserine | MDR tuberculosis | Approved |
cycloserine | multidrug-resistant TB | Approved |
cycloserine | multidrug-resistant tuberculosis | Approved |
cycloserine | suspected MDR tuberculosis | Approved |
cyclosporin | atopic conjunctivitis, dry eye | Approved |
cyclosporin | atopic keratoconjunctivitis | Approved |
cyclosporin | atopic keratoconjunctivitis | Approved |
cyclosporin | atopic keratoconjunctivitis | Approved |
cyclosporin | bilateral corneal ulcers, severe acute graft versus host disease, bone marrow transplant | Approved |
cyclosporin | Blepharitis, terrien's marginal deterioration, corneal neovascularisation | Approved |
cyclosporin | breakdown of corneal transplant, keratoconus, peripheral corneal vascularisation | Approved |
cyclosporin | Chronic hyposecretory dry eyes, juvenile rheumatoid arthritis | Approved |
cyclosporin | Chronic hyposecretory dry eyes, juvenile rheumatoid arthritis | Approved renewal |
cyclosporin | conjunctivitis sicca, severe dry eye syndrome | Approved renewal |
cyclosporin | conjunctivitis sicca, severe dry eye syndrome | Approved renewal |
cyclosporin | corneal graft rejection | Approved |
cyclosporin | corneal graft rejection, keratoconus | Approved |
cyclosporin | corneal graft rejection, keratoconus | Approved renewal |
cyclosporin | dry eyes | Approved |
cyclosporin | dry eyes | Approved |
cyclosporin | dry eyes | Approved renewal |
cyclosporin | dry eyes | Approved renewal |
cyclosporin | graft versus host disease, severe dry eyes, corneal transplant, intolerance to ocular steroids | Approved |
cyclosporin | Graft vs Host Disease, Blepharitis | Approved |
cyclosporin | Graft vs Host Disease, bone marrow transplant, conjunctivitis, leukaemia | Approved |
cyclosporin | keratoconjunctivitis | Approved |
cyclosporin | keratoconjunctivitis sicca | Approved |
cyclosporin | keratoconjunctivitis sicca | Approved |
cyclosporin | keratoconjunctivitis sicca | Approved |
cyclosporin | keratoconjunctivitis sicca | Approved |
cyclosporin | keratoconjunctivitis sicca | Approved renewal |
cyclosporin | keratoconjunctivitis sicca | Approved renewal |
cyclosporin | keratoconjunctivitis sicca | Approved renewal |
cyclosporin | keratoconjunctivitis sicca | Approved renewal |
cyclosporin | keratoconjunctivitis sicca | Approved renewal |
cyclosporin | keratoconjunctivitis sicca | Approved renewal |
cyclosporin | keratoconjunctivitis sicca | Approved renewal |
cyclosporin | keratoconjunctivitis sicca | Approved renewal |
cyclosporin | keratoconjunctivitis sicca | Approved renewal |
cyclosporin | keratoconjunctivitis sicca, glaucoma | Approved |
cyclosporin | keratoconjunctivitis sicca, glaucoma | Approved renewal |
cyclosporin | keratoconjunctivitis sicca, meibomian gland dysfunction, rheumatoid arthritis | Approved |
cyclosporin | keratoconjunctivitis sicca, meibomian gland dysfunction, rheumatoid arthritis | Approved renewal |
cyclosporin | keratoconjunctivitis sicca, meibomian gland dysfunction, rheumatoid arthritis | Approved renewal |
cyclosporin | keratoconjunctivitis sicca, meibomian gland dysfunction, rheumatoid arthritis | Approved renewal |
cyclosporin | keratoconjunctivitis sicca, severe dry eye syndrome | Approved |
cyclosporin | keratoconjunctivitis sicca, severe dry eyes | Approved |
cyclosporin | keratoconjunctivitis sicca, severe dry eyes | Approved renewal |
cyclosporin | keratoconus, corneal graft rejection, prophylaxis, recurrent corneal graft | Approved renewal |
cyclosporin | keratoconus, corneal graft rejection, prophylaxis, recurrent corneal graft | Approved renewal |
cyclosporin | keratoconus, recurrent corneal graft | Approved renewal |
cyclosporin | ocular inflammation, photophobia, thyroid eye disease | Approved |
cyclosporin | ocular rosacea, corneal neovascularisation, limbal stem cell deficiency | Approved |
cyclosporin | recurrent corneal graft, hsv recurrence, keratitis | Approved |
cyclosporin | severe allergic conjunctivitis, Vernal Keratoconjunctivitis | Approved |
cyclosporin | severe allergic eye disease, vernal catarrh, vernal conjunctivitis | Approved |
cyclosporin | severe atopic keratoconjunctivitis | Approved |
cyclosporin | severe atopic keratoconjunctivitis, glaucoma | Approved |
cyclosporin | severe dry eye syndrome | Approved |
cyclosporin | severe dry eye syndrome | Approved |
cyclosporin | severe dry eye syndrome, Blepharitis, meibomian gland dysfunction | Approved |
cyclosporin | severe dry eye syndrome, sjogrens syndrome | Approved |
cyclosporin | severe dry eye syndrome, sjogrens syndrome | Approved renewal |
cyclosporin | severe dry eye syndrome, sjogrens syndrome, Blepharitis, meibomian gland dysfunction | Approved |
cyclosporin | severe dry eye syndrome, Trichiasis | Approved |
cyclosporin | severe dry eyes, sjogrens syndrome | Approved |
cyclosporin | severe dry eyes, sjogrens syndrome | Approved renewal |
cyclosporin | severe dry eyes, sjogrens syndrome | Approved renewal |
cyclosporin | severe steroid dependant allergic eye disease | Approved |
cyclosporin | severe steroid dependant allergic eye disease | Approved renewal |
cyclosporin | severe vernal keratoconjunctivitis | Approved |
cyclosporin | severe vernal keratoconjunctivitis | Approved |
cyclosporin | sjogrens syndrome | Approved |
cyclosporin | sjogrens syndrome | Approved |
cyclosporin | sjogrens syndrome | Approved renewal |
cyclosporin | sjogrens syndrome | Approved renewal |
cyclosporin | sjogrens syndrome, corneal epithelial defect, keratoconjunctivitis sicca | Approved |
cyclosporin | sjogrens syndrome, corneal epithelial defect, keratoconjunctivitis sicca | Approved renewal |
cyclosporin | sjogrens syndrome, corneal epithelial defect, keratoconjunctivitis sicca | Approved renewal |
cyclosporin | sjogrens syndrome, Fibromyalgia, systemic lu | Approved renewal |
cyclosporin | Unable to produce tears, Blepharitis | Approved |
cyclosporin | vernal allergic eye disease | Approved |
cyclosporin | Vernal Keratoconjunctivitis | Approved |
cyclosporin | Vernal Keratoconjunctivitis | Approved |
cyclosporin | Vernal Keratoconjunctivitis | Approved |
cyclosporin | Vernal Keratoconjunctivitis | Approved renewal |
cyclosporin | Vernal Keratoconjunctivitis | Approved renewal |
cyclosporin | Vernal Keratoconjunctivitis | Approved renewal |
cyclosporin | Vernal Keratoconjunctivitis | Approved renewal |
cyclosporin | Vernal Keratoconjunctivitis | Approved renewal |
cyclosporin | Vernal Keratoconjunctivitis | Approved renewal |
cyclosporin | Vernal Keratoconjunctivitis | Approved renewal |
cyclosporin | Vernal Keratoconjunctivitis | Approved renewal |
cyclosporin | Vernal Keratoconjunctivitis | Approved renewal |
cyclosporin | Vernal Keratoconjunctivitis, asthma, eczema, hayfever, ocular hypertension | Approved |
cyclosporin | Vernal Keratoconjunctivitis, asthma, eczema, hayfever, ocular hypertension | Approved renewal |
cyclosporin | Vernal Keratoconjunctivitis, corneal ectasia | Approved |
cyclosporin 0.2% | Vernal Keratoconjunctivitis | Approved renewal |
cyclosporin eye | chronic dry eye, thyroid-related orbitopathy | Approved |
cyclosporin eye | severe dry eye syndrome | Approved |
cyclosporin eye | sjogrens syndrome, Fibromyalgia, systemic lu | Approved |
cyclosporin eye | sjogrens syndrome, Fibromyalgia, systemic lu | Approved renewal |
cyclosporin eye | Vernal Keratoconjunctivitis | Approved |
cyclosporin eye | Vernal Keratoconjunctivitis | Approved |
cyclosporin eye | Vernal Keratoconjunctivitis, allergic eye disease | Approved renewal |
cyclosporin eye drops | keratoconjunctivitis sicca | Approved |
cyclosporin eye drops | keratoconjunctivitis sicca | Approved |
cyclosporin eye drops | keratoconjunctivitis sicca | Approved renewal |
cyclosporin eye drops | keratoconjunctivitis sicca, meibomian gland dysfunction | Approved |
cyclosporin eye drops | keratoconus, corneal graft rejection | Approved |
cyclosporin eye drops | keratoconus, recurrent corneal graft | Approved |
cyclosporin eye drops | severe vernal keratoconjunctivitis | Approved |
cyclosporin eye drops | severe vernal keratoconjunctivitis | Approved |
cyclosporin eye drops | severe vernal keratoconjunctivitis | Approved renewal |
cyclosporin eye drops | severe vernal keratoconjunctivitis | Approved renewal |
cyclosporin eye drops | Stevens-Johnson Syndrome, bilateral forniceal scarring, chronic ocular discomfort, cicatricial conjunctivitis, corneal grafting, Trichiasis | Approved |
cyclosporin eye drops | Vernal Keratoconjunctivitis | Approved |
cyclosporin eye drops | Vernal Keratoconjunctivitis | Approved |
cyclosporin eye drops | Vernal Keratoconjunctivitis | Approved |
cyclosporin eye ointment | atopic keratoconjunctivitis, meibomian gland dysfunction | Approved |
cyclosporin eye ointment | corneal epithelial defect, ocular inflammation, allergies, keratitis, photophobia | Approved |
cyclosporin eye ointment | filamentary keratitis, ocular dry eyes | Approved |
cyclosporin eye ointment | filamentary keratitis, ocular dry eyes | Approved renewal |
cyclosporin eye ointment | keratoconjunctivitis sicca, glaucoma, melbomium gland dysfunction | Approved |
cyclosporin eye ointment | ocular rosacea, corneal neovascularisation, limbal stem cell deficiency | Approved renewal |
cyclosporin eye ointment | refractory dry eye | Approved |
cyclosporin eye ointment | severe dry eye syndrome | Approved |
cyclosporin eye ointment | severe dry eye syndrome | Approved renewal |
cyclosporin eye ointment | severe dry eye syndrome | Approved renewal |
cyclosporin eye ointment | severe dry eyes, facial nerve palsy, neurotrophic cornea secondary to herpes zoster opthalmicus, Rheumatoid Arthritis, sjogrens syndrome | Approved |
cyclosporin eye ointment | severe steroid dependant vernal keratoconjunctivitis | Approved |
cyclosporin eye ointment | sjogrens syndrome, severe dry eyes | Approved |
cyclosporin eye ointment | Vernal Keratoconjunctivitis, asthma, eczema | Approved |
cyclosporin eye ointment | Vernal Keratoconjunctivitis, asthma, eczema | Approved renewal |
cyclosporin eye ointment | Vernal Keratoconjunctivitis, limbitis, shield ulcer | Approved |
cyclosporin ointment | conjunctivitis | Approved |
cyclosporin ointment | conjunctivitis sicca, severe dry eye syndrome | Approved |
cyclosporin ointment | dry eyes | Approved |
cyclosporin ointment | herpes zoster, keratouveitis, severe dry eye syndrome | Approved |
cyclosporin ointment | keratoconjunctivitis sicca | Approved |
cyclosporin ointment | severe allergic conjunctivitis | Approved |
cyclosporin ointment | sjogrens syndrome, keratoconjunctivitis sicca | Approved |
cyclosporin ointment | Vernal Keratoconjunctivitis, allergic eye disease | Approved |
cyclosporin ointment | Vernal Keratoconjunctivitis, limbitis, shield ulcer | Approved renewal |
cyclosporin ointment, 0.2% | atopic keratoconjunctivitis | Approved |
cyclosporin ointment, 0.2% | Vernal Keratoconjunctivitis | Approved |
cyclosporin ointment, 0.2% | Vernal Keratoconjunctivitis, steroid side effects | Approved |
cyclosporin ointment, 0.2% | Vernal Keratoconjunctivitis, steroid side effects | Approved renewal |
cyclosporin ointment, 0.2% | Vernal Keratoconjunctivitis, steroid side effects | Approved renewal |
cyclosporin ophthalmic emulsion | sjogrens syndrome, keratitis | Approved renewal |
cyclosporine ophthalmic emulsion | sjogrens syndrome, keratitis | Approved |
cyproheptadine | cyclical vomiting, Alagille's syndrome, complex congenital heart disease, tetralogy of fallot repair | Approved |
cyproheptadine | Cyclical vomiting, Hydrocephalus, VP shunt | Approved |
cysteamine | Cystinosis | Approved |
cysteamine | Cystinosis | Approved renewal |
cysteamine | Cystinosis, Chronic Renal Failure | Approved renewal |
cysteamine eye drops | Cystinosis, Chronic Renal Failure | Approved |
cysteamine hcl | Cystinosis, cystine corneal deposits, failure to thrive, renal fanconi syndrome | Approved |
dabigatran | deep vein thrombosis, pulmonary embolism, Immobile, Motor Neurone disease | Approved |
d-alpha tocopheryl acetate | cholestasis | Approved |
dantrolene | Motor Neurone disease, spasm, spasticity, spinal myelopathy | Approved |
dantrolene | spasticity | Approved |
dantrolene | spasticity, cerebral palsy | Approved |
dantrolene | spasticity, stroke | Approved |
daptomycin | allergy to antibiotics, septic arthritis right hip | Approved |
daptomycin | infected prosthetic knee joint, vancomycin resistant staphylococcus aureus | Approved |
daptomycin | infected thrombus, MRSA, Septicaemia | Approved |
dasatinib | Philadelphia positive acute lymphoblastic leukemia | Approved |
dasatinib | Philidelphia positive acute lymphoblastic leukemia, Hodgkin's B cell lymphoma in remission, ischaemic heart disease | Approved |
deferasirox | Blackfan-Diamond Syndrome, transfusion dependent iron overload | Approved |
deferasirox | Blackfan-Diamond Syndrome, transfusion dependent iron overload | Approved renewal |
deferasirox | Fanconi Anaemia, bone marrow aplasia | Approved |
deferasirox | transfusion iron overload, t cell LGL | Approved |
deferiprone | iron overload | Approved |
deferiprone | superficial siderosis | Approved |
deferiprone | superficial siderosis | Approved |
deferiprone | superficial siderosis of CNS, cerebellar ataxia, deafness, erectile dysfunction, myelopathy | Approved |
deferiprone | transfusion dependent iron overload, Severe Aplastic Anaemia | Approved |
deflazacort | Duchenne Muscular Dystrophy | Approved |
deflazacort | Duchenne Muscular Dystrophy | Approved renewal |
delta-9-tetrahydrocannabinol and cannabidiol | Intractable epilepsy, myoclonic seizures, tonic clonic seizures, Behaviour disorder, Chromosomal abnormality, intellectual disability | Declined |
delta-9-tetrahydrocannabinol and cannabidiol | Intractable epilepsy, myoclonic seizures, tonic clonic seizures, Behaviour disorder, Chromosomal abnormality, intellectual disability | Declined |
delta-9-tetrahydrocannabinol and cannabidiol | muscle spasm and pain | Declined |
delta-9-tetrahydrocannabinol and cannabidiol | Severe epilepsy | Declined |
demeclocycline | hyponatraemia secondary to SIADH | Approved |
demeclocycline | hyponatraemia, SIADH, Small Cell lung Cancer | Approved |
demeclocycline | hyponatraemmia, Small Cell lung Cancer | Approved |
denosumab | giant cell tumour of the bone | Approved |
denosumab | giant cell tumour of the bone | Approved |
denosumab | giant cell tumour of the bone | Approved |
denosumab | giant cell tumour of the bone | Approved |
denosumab | giant cell tumour of the bone | Approved renewal |
denosumab | giant cell tumour of the bone | Approved renewal |
denosumab | giant cell tumour of the bone | Approved renewal |
denosumab | multicentric carpotarsal osteolysis | Approved |
desmopressin | addictive behaviour, diabetes insipidus, Langerhans cell histiocytosis | Approved |
desmopressin | central diabetes insipidus | Approved |
desmopressin | central diabetes insipidus, central adrenal insufficiency, central hypothyroidism, Septo-optic dysplasia | Approved |
desmopressin | diabetes insipidus | Approved |
desmopressin | diabetes insipidus secondary to brain tumour | Approved |
desmopressin | diabetes insipidus, Hypopituitarism, Nasal obstruction, somnolence | Approved |
desmopressin | diabetes insipidus, nasal surgery, requires lower dose | Approved |
desmopressin | severe epistaxis, Hereditary hemorrhagic telangiectasia | Approved |
desmopressin tablet | addictive behaviour, diabetes insipidus, Langerhans cell histiocytosis | Approved |
desmopressin tablet | central diabetes insipidus, Langerhans cell histiocytosis | Approved |
desmopressin tablet | central diabetes insipidus, Wegener's Granulomatosis | Approved |
desmopressin tablet | diabetes insipidus, blindness, suprasellar tumour | Approved |
dexamethasone | bilateral multifocal choroiditis, panuveitis, cystoid macular oedema, secondary glaucoma, vasoproliferative tumors | Approved |
dexamethasone | cystoid macular oedema | Approved |
dexamethasone | cystoid macular oedema, uveitis, Psoriatic Arthritis | Approved |
dexamethasone | ocular inflammation, steroid resistance | Approved |
dexamethasone | ocular inflammation, steroid resistance | Approved renewal |
dexamethasone | retinal vein occlusion | Approved |
dexamethasone | retinal vein occlusion | Approved renewal |
dexrazoxane | cardioprotective agent, metastatic osteosarcoma | Approved |
dextromethorphan | non-ketotic hyperglycinaemia | Approved |
diazoxide | generalised seizures, cognitive impairment, convulsions, glucose transporter abnormality | Approved |
diazoxide | generalised seizures, cognitive impairment, convulsions, glucose transporter abnormality | Approved |
diazoxide | Genetic testing re undiagnosed syndrome, Recurrent hypoglycaemia secondary to hyperinsulinism | Approved |
diazoxide | hypoglycaemia due to insulinoma | Approved |
diazoxide | Hypoglycaemia in infant, impaired LV function | Approved |
diazoxide | hypoglycaemia, gastric bypass, Hyperinsulinaemia | Approved |
diazoxide | hypoglycaemia, Insulinoma | Approved |
diazoxide | Insulinoma | Approved |
diazoxide | Insulinoma | Approved |
diazoxide | Insulinoma, spontaneous hypoglycaemia | Approved |
diazoxide | metastatic insulinoma | Approved |
diazoxide (ECP) | hyperinsulinism, hypoglycaemia | Approved |
dienogest | invasive endometriosis, refractory to surgery | Approved |
diethylcarbamazine | Filariasis | Approved |
dihydrotestosterone | androgen insensitivity syndrome | Approved |
diloxanide | amoebic liver abscess | Approved |
diloxanide | intestinal amebiasis | Approved |
diloxanide | invasive amoebiasis, cellulitis, entamoeba histolytica intestinal colonisation | Approved |
diloxanide fuorate | amoebic liver abscess, entamoeba histolytica liver abscess | Approved |
dimercaptosuccinic acid | lead toxicity | Approved |
diphtheria, tetanus and pertussis vaccine | post allogeneic stem cell transplant | Approved |
diptheria, tetanus and pertussis | acute leukamia post bone marrow transplant, preventing infection of immunocompromised patient | Approved |
diptheria, tetanus and pertussis | pertussis infections, Dee pertussis transmission to infant | Approved |
dipyridamole | congenital nephrotic syndrome, VTE prophylaxis | Approved |
dornase alfa | chronic infection with burkholderia cepecia, Cystic fibrosis | Approved |
dornase alfa | chronic obstructive asthma, bronchiolitis | Approved |
dornase alfa | Cystic fibrosis | Approved |
dornase alfa | Cystic fibrosis | Approved |
dornase alfa | Cystic fibrosis, chronic pseudomonas | Approved |
dornase alfa | Cystic fibrosis, lung disease | Approved |
dornase alfa | Cystic fibrosis, pancreatic insufficiency | Approved |
dornase alfa | Cystic fibrosis, pancreatic insufficiency | Approved renewal |
droperidol | anxiety, G tube, J tube, progressive gut failure, severe abdominal pain, TPN dependent | Approved |
droxidopa | intractable postural hypotension, autonomic neuropathy, Familial Amyloid Polyneuropathy due to a mutation in TTR | Approved |
duloxetine | Depression, social anxiety, Chronic Idiopathic Intestinal Pseudo-obstruction | Approved |
duloxetine | Depression, social anxiety, Chronic Idiopathic Intestinal Pseudo-obstruction | Approved renewal |
duloxetine | Major Depressive disorder, psychotic symptoms, long QT syndrome | Approved renewal |
duloxetine | pain, erythromelalgia | Approved |
eculizumab | atypical haemolytic uraemic syndrome | Declined |
eculizumab | atypical haemolytic uraemic syndrome, chronic anaemia, intravascular haemolysis | Declined |
eltrombopag | amegakaryocytic thrombocytopaenia | Approved |
eltrombopag | angio immunoblastic T cell lymphoma, aplastic anaemia | Approved |
eltrombopag | angio immunoblastic T cell lymphoma, aplastic anaemia | Approved renewal |
eltrombopag | angio immunoblastic T cell lymphoma, aplastic anaemia | Approved renewal |
eltrombopag | aplastic anaemia | Approved |
eltrombopag | aplastic anaemia | Approved |
eltrombopag | Aplastic Anaemia | Declined |
eltrombopag | aplastic anaemia, Thrombocytopaenia | Approved |
eltrombopag | aplastic anaemia, Thrombocytopaenia | Declined renewal |
eltrombopag | aplastic anaemia, transfusion dependent, high dose cyclophosphamide, severe neutropaenia | Approved |
eltrombopag | bone marrow failure, Severe Aplastic Anaemia, refractory pseudomonal sepsis | Approved |
eltrombopag | chronic immune mediated thrombocytopaenia | Approved |
eltrombopag | chronic immune thrombocytopenia | Approved |
eltrombopag | chronic immune thrombocytopenia | Approved renewal |
eltrombopag | idiopathic thrombocytopaenic purpura | Approved |
eltrombopag | idiopathic thrombocytopaenic purpura, low platelet count, aortic valve replacement, B cell non-hodgkin's lymphoma, upcoming major surgery | Approved |
eltrombopag | immune thrombocytopaenia, Hepatitis B, hyptertension, Recurrent bladder tumours | Approved |
eltrombopag | immune thrombocytopaenia, Hepatitis B, hyptertension, Recurrent bladder tumours, surgery contraindicated | Approved renewal |
eltrombopag | immune thrombocytopaenia, severe steroid effect | Approved |
eltrombopag | immune thrombocytopaenia, severe steroid effect | Approved renewal |
eltrombopag | immune thrombocytopaenic purpura | Approved |
eltrombopag | immune thrombocytopaenic purpura | Approved |
eltrombopag | immune thrombocytopaenic purpura, SLE | Approved |
eltrombopag | immune thrombocytopaenic purpura, SLE | Approved renewal |
eltrombopag | leukaemia, immune thrombocytopaenia | Approved renewal |
eltrombopag | Refractory ITP | Approved |
eltrombopag | Refractory ITP | Approved |
eltrombopag | Refractory ITP, chronic renal impairment, ischaemic heart disease | Approved |
eltrombopag | Refractory ITP, nasal mucosal ulceration, SLE, splenectomy, Thrombocytopaenia | Approved |
eltrombopag | Refractory ITP, nasal mucosal ulceration, SLE, splenectomy, Thrombocytopaenia | Approved renewal |
eltrombopag | Refractory ITP, Underlying CLL | Approved |
eltrombopag | refractory thrombocytopaenia, Underlying CLL | Approved |
eltrombopag | Severe Aplastic Anaemia | Approved |
eltrombopag | Severe Aplastic Anaemia | Approved |
eltrombopag | Severe Aplastic Anaemia | Approved |
eltrombopag | Severe Aplastic Anaemia | Approved |
eltrombopag | Severe Aplastic Anaemia, bone marrow failure | Approved |
eltrombopag | Severe Aplastic Anaemia, bronchiectasis, hypogammaglobulinaemia, thymoma | Approved |
eltrombopag | Severe Aplastic Anaemia, rare platelet match, risk of iron overload | Approved |
emsogen | carnitine-acylcarnitine translocase deficiency, eosinophilic oesophagitis, hyperammonaemia, Autistic Spectrum Disorder, epilepsy, intellectual disability, multiple food allergies | Approved |
energivit | Citrullinaemia type 1 | Approved renewal |
energivit | methylmalonic acidemia | Approved |
energivit | methylmalonic acidemia, brain injury, hyperammonaemia | Approved |
energivit | OTC Deficiency, Ornithine transcarbamylase deficiency, urea cycle disorder | Approved |
energivit | Propionic Acidaemia | Approved |
enfuvirtide | resistant HIV | Approved |
enoxaparin | Adenocarcinoma of the stomach, aortic regurgitation, mitral valve replacement, Rheumatic Heart Disease, st jude's aortic valve replacement | Approved |
enoxaparin | antiphospholipid syndrome, Chest Pain, pulmonary hypertension, unstable INR | Approved |
enoxaparin | antiphospholipid syndrome, thromboses on warfarin, venous thrombosis | Approved |
enoxaparin | antiphospholipid syndrome, thromboses on warfarin, venous thrombosis | Approved renewal |
enoxaparin | antiphospholipid syndrome, thromboses on warfarin, venous thrombosis | Approved renewal |
enoxaparin | aortic valve disease, warfarin interaction, latent TB | Approved |
enoxaparin | artery thrombosis, atrial fibrillation, TPN dependent | Approved |
enoxaparin | Atrial fibrillation, hypertension, lower extremety DVT, previous asbestos exposure | Approved |
enoxaparin | basilar artery occlusion, No resolution on warfarin, recurrent stroke syndromes | Approved |
enoxaparin | bilateral dvt | Approved |
enoxaparin | bilateral pulmonary emboli, deep vein thrombosis, thrombus on dabigatran, warfarin resistance | Approved |
enoxaparin | bilateral pulmonary emboli, PEG tube with gastroparesis/malabsorption oral meds | Approved |
enoxaparin | Calciphylaxis, end stage renal failure, long term anticoagulation, mechanical aortic valve replacement | Approved |
enoxaparin | Calciphylaxis, long term anticoagulation, end stage renal disease, mitral valve replacement | Approved |
enoxaparin | cerebral haemorrhages, familial cavernoma syndrome, inferior vena cava filter, large bilateral pulmonary emboli, severe essential hypertension | Approved |
enoxaparin | chronic loculated left sided pleural effusion, Crohn's disease, primary sclerosing cholangitis, pulmonary embolism | Approved |
enoxaparin | Crohn's diease, Chronic Renal Failure, enterocutaneous fistulae, renal vein thrombosis | Approved |
enoxaparin | deep vein thrombosis | Approved |
enoxaparin | deep vein thrombosis, bilateral pulmonary emboli, factor VII deficiency | Approved |
enoxaparin | deep vein thrombosis, diverticulitis, Malnutrition, pneumonia | Approved |
enoxaparin | deep vein thrombosis, hip fracture, impaired mobility | Approved |
enoxaparin | deep vein thrombosis, hip fracture, impaired mobility | Approved renewal |
enoxaparin | deep vein thrombosis, Multiple Sclerosis | Approved |
enoxaparin | DVT prophylaxis, PEG feeding | Approved |
enoxaparin | hepatic vein thrombosis, Budd Chiari Syndrome, thromboses on warfarin | Approved |
enoxaparin | high risk of deep vein thrombosis, risk of PE, R humeral fracture, Right distal radius fracture | Approved |
enoxaparin | increased risk of DVT due to immobilisation, previous DVT and PE | Approved |
enoxaparin | inferior mesenteric artery thrombosis, chronic diarrhoea, short bowel syndome, small bowel infarction | Approved |
enoxaparin | intolerance to warfarin, DVTs, pulmonary embolism | Approved |
enoxaparin | IVC thrombosis, venous thrombus of inferior vena cava, spontaneous VTE extending into the heart | Approved |
enoxaparin | lower limb deep vein thrombosis, chronic abdominal pain, ileal conduit and ACE, poorly functioning poracath in situ, recurrent infection, recurrent rectal bleeding, Spina Bifida, very poor venous access | Approved |
enoxaparin | multiple pulmonary embolisms, risk of bleeding on warfarin, tetraplegia, unstable INR | Approved |
enoxaparin | multiple thrombi, thromboembolic disease, stroke | Approved |
enoxaparin | non compliance on warfarin, pregnant, Rheumatic Heart Disease, upcoming aortic valve replacement surgery | Approved |
enoxaparin | portal vein thrombosis, atrial fibrillation, previous stroke | Approved |
enoxaparin | post-operative PE, IVF Therapy, polycythaemia | Approved |
enoxaparin | post-operative PE, IVF Therapy, polycythaemia | Approved renewal |
enoxaparin | pulmonary embolism | Approved |
enoxaparin | pulmonary embolism | Approved |
enoxaparin | pulmonary embolism, COPD, epistaxis, LLL pneumonia, recurrent haemoptysis | Approved |
enoxaparin | pulmonary embolism, deep vein thrombosis, warfarin contraindicated (risk of overdose) | Approved |
enoxaparin | pulmonary embolism, diabetes type 2, HSV skin lesions, hypertension, tuberculosis | Approved |
enoxaparin | pulmonary embolism, Headache | Approved |
enoxaparin | pulmonary embolism, intolerance to warfarin | Approved |
enoxaparin | pulmonary embolism, Multiple previous haemorraghic CVA, shoulder replacement | Approved |
enoxaparin | pulmonary embolism, previous stroke | Approved |
enoxaparin | pulmonary embolism, pseudoseizures, recurrent DVTs, thalamic bleed | Approved |
enoxaparin | pulmonary embolism, pseudoseizures, recurrent DVTs, thalamic bleed | Approved |
enoxaparin | recurrent DVTs, intolerance to dabigatran, intolerance to warfarin | Approved |
enoxaparin | recurrent DVTs, intolerance to dabigatran, intolerance to warfarin | Approved renewal |
enoxaparin | recurrent PE, antiphospholipid antibody syndrome | Approved |
enoxaparin | recurrent PE, intolerance to warfarin | Approved |
enoxaparin | recurrent pulmonary emboli | Approved |
enoxaparin | recurrent pulmonary emboli | Approved renewal |
enoxaparin | recurrent venous thromboembolism | Approved |
enoxaparin | recurrent VTE, failed on warfarin | Approved |
enoxaparin | recurrent VTE, failed on warfarin | Approved renewal |
enoxaparin | recurrent VTE, failed on warfarin | Approved renewal |
enoxaparin | recurrent VTE, Immobile, Motor Neurone disease, unable to swallow | Approved |
enoxaparin | relapsed multiple myeloma | Approved |
enoxaparin | right basilic vein thrombosis, very poor venous access | Approved |
enoxaparin | risk of bleeding on warfarin, Atrial fibrillation, congestive heart failure, prosthetic heart valve, Rheumatic Heart Disease, unstable INR | Approved |
enoxaparin | risk of bleeding on warfarin, haematoma, Metastatic liver cancer, post aortic valve replacement | Approved |
enoxaparin | risk of thrombosis, chemotherapy, chronic atrial fibrillation, endometrial cancer, rheumatic valvular disease, unstable INR | Approved |
enoxaparin | Short Gut Syndrome, intestinal failure, sepsis, venous thrombosis | Approved |
enoxaparin | st jude's aortic valve replacement, Depression, fatigue | Approved |
enoxaparin | stroke prevention in atrial fibrillation, GI cancer | Approved |
enoxaparin | superior mesenteric artery occlusion, atrial fibrillation, TPN dependent | Approved |
enoxaparin | SVC Obstruction, bilateral lung transplant, Cystic fibrosis | Approved |
enoxaparin | systemic lupus erythematosus, haematoma, lupus nephritis, SLE | Approved |
enoxaparin | thromboembolic CVAs, Atrial fibrillation | Approved |
enoxaparin | thromboembolic disease | Approved |
enoxaparin | thromboembolic disease | Approved |
enoxaparin | thromboembolic disease | Approved renewal |
enoxaparin | thromboembolic disease | Approved renewal |
enoxaparin | Thrombus, infarct | Approved |
enoxaparin | venous thrombosis | Approved |
enoxaparin | venous thrombosis | Approved renewal |
entecavir | HBsAg chronic carriage, cytotoxic chemotherapy | Approved |
entecavir | Hepatitis B | Approved |
entecavir | Hepatitis B, chronic hepatitis B virus cirrhosis, lamivudine resitant hepatitis B, liver fibrosis | Approved |
eplerenone | Cardiac Failure, Left Ventricular Dysfunction | Approved |
eplerenone | Cardiac Failure, Left Ventricular Dysfunction | Approved renewal |
eplerenone | Cardiac Failure, Left Ventricular Dysfunction | Approved renewal |
eplerenone | cardiac resynchronisation therapy not suitable, intolerance to spironolactone, Severe dilated cardiomyopathy | Approved |
eplerenone | central serous chorioretinopathy, intolerance to funded alternative | Approved |
eplerenone | dilated cardiomyopathy, gynaecomastia, intolerance to funded alternative | Approved |
eplerenone | dilated cardiomyopathy, gynaecomastia, intolerance to funded alternative | Approved renewal |
eplerenone | end stage heart failure, intolerance to funded alternative, prior cerebrovascular accidents | Approved |
eplerenone | heart failure, gynaecomastia, intolerance to spironolactone, Left Ventricular Dysfunction, lowered ejection fraction | Approved |
eplerenone | heart failure, gynaecomastia, intolerance to spironolactone, Left Ventricular Dysfunction, lowered ejection fraction | Approved renewal |
eplerenone | severe left ventricular systolic dysfunction | Approved |
eplerenone | severe left ventricular systolic dysfunction | Approved renewal |
erwinia asparaginase | acute lymphoblastic leukaemia, allergic reaction to PegAsparaginase | Approved |
erwinia asparaginase | acute lymphoblastic leukaemia, allergy to alternatives | Approved |
erwinia asparaginase | allergic reaction to PegAsparaginase, Lymphoblastic T-cell lymphoma | Approved |
erwinia asparaginase (crisantaspase) | ALL, allergic reaction to PegAsparaginase | Approved |
erwinia asparaginase (crisantaspase) | NK/T cell lymphoma | Approved |
erwinia asparaginase (crisantaspase) | NK/T cell lymphoma, allergy to alternatives | Approved |
erwinia asparaginase (crisantaspase) | NK/T cell lymphoma, allergy to pegaspargase | Approved |
erythropoietin | anaemia, transfusion dependent, t cell LGL | Approved |
erythropoietin alfa | anaemia, congenital nephrotic syndrome | Approved |
erythropoietin alfa | anaemia, congenital nephrotic syndrome | Approved renewal |
erythropoietin alfa | chronic anaemia, chronic kidney disease, membranous glomerulonephritis | Approved |
erythropoietin alfa | chronic anaemia, chronic kidney disease, membranous glomerulonephritis | Approved renewal |
erythropoietin alfa | chronic anaemia, chronic kidney disease, membranous glomerulonephritis | Approved renewal |
erythropoietin alfa | symptomatic anaemia, metastatic melanoma | Approved |
erythropoietin beta | anaemia, bilateral PE, renal calculus | Declined |
erythropoietin beta | myelodysplasia sideroblastic anaemia, chronic atrial fibrillation, chronic iron deficiency secondary to gastro intestinal bleeding, congestive heart failure, red cell antibodies, red cell crossmatch difficult, transfusion dependent | Approved |
erythropoietin beta | Red cell aplasia, chronic graft versus host disease, hurler's syndrome, post bone marrow transplant | Approved |
essential amino acid mix | arginase deficiency, essential amino acid deficiency, multiple vitamin deficiency, reduced bone density, Zinc Deficiency | Approved renewal |
essential amino acid mix | arginase deficiency, essential amino acid deficiency, multiple vitamin deficiency, reduced bone density, Zinc Deficiency | Approved renewal |
essential amino acid mix | hypoalbuminaemia and hypoproteinaemia, severe atopic dermatitis | Approved |
essential amino acid mix | Ornithine transcarbamylase deficiency, developmental delay | Approved |
essential amino acid mix | urea cycle disorder | Approved |
etanercept | idopathic pneumonia syndrome, deteriorating respiratory function, post allogenic transplant | Approved |
etanercept | juvenile idiopathic arthritis | Approved |
ethanol | recurrent infection, haemophilia A, prophylaxis | Approved |
etoricoxib | Behcet's disease, oral ulceration, painful arthropathy | Declined |
everolimus | hypoglycaemia due to insulinoma, liver metastases, metastatic pancreatic neuroendocrine tumour | Approved |
everolimus | metastatic atypical carcinoid, carcinoid syndrome, metastatic neuroendocrine tumour, neuroendocrine tumour | Declined |
everolimus | metastatic insulinoma, persistant hypoglycaemia | Approved |
everolimus | metastatic neuroendocrine tumour, ACTH secreting tumour, bilateral hip replacement, chronic infection of hip joint replacement, cushing's syndrome, FGF23 secreting tumour, osteomalacia | Declined |
everolimus | tuberous sclerosis, intellectual disability, rash, renal angiomyolipoma, risk of haemorrhage, subependymal giant cell astrocytomas | Declined |
ex tyr anamix infant powder | tyrosinemia type II | Approved |
febuxostat | Chronic gout, allopurinol hypersensitivity, kidney stone, sclerosing cholangitis, Ulcerative Colitis | Approved |
febuxostat | chronic tophaceous gout, amputation of leg, chronic kidney disease, obesity | Approved |
febuxostat | gout, Hepatitis B, hypertension, Unable to tolerate funded medicaton | Approved |
febuxostat | gout, probable renal calculi, renal impairment | Approved |
febuxostat | severe tophaceous gout, allopurinol hypersensitivity, Atrial fibrillation, chronic kidney disease, ischaemic heart disease, previous nephrolithiasis | Approved |
febuxostat | severe tophaceous gout, allopurinol hypersensitivity, congestive heart failure, persistent hyperuricemia | Approved |
febuxostat | severe tophaceous gout, bone destruction, chronic kidney disease, intolerant to allopurinol, nephrectomy | Approved |
febuxostat | severe tophaceous gout, congestive heart failure, intolerant to allopurinol, persistent hyperuricemia | Approved renewal |
febuxostat | tophaceous gout, acute renal failure, bilateral forniceal narrowing, degenerative disc disease, diffuse annular bulging, facet hypertrophy, iatrogenic Cushing’s syndrome, pulmonary embolism | Approved |
felbamate | Itractable epilepsy and non-convulsive status, Lennox-Gastaut variant, Neurodegenerative disease of unknown aetiology | Approved |
felbamate | Itractable epilepsy and non-convulsive status, Lennox-Gastaut variant, Neurodegenerative disease of unknown aetiology | Approved renewal |
felbamate | Itractable epilepsy and non-convulsive status, Lennox-Gastaut variant, Neurodegenerative disease of unknown aetiology | Approved renewal |
fenofibrate | atypical teratoid rhabdoid tumour (ATRT), constipation, deafness, gastrostomy, recurrent sinusitis, Vomiting | Approved |
ferric carboxymaltose | anaemia, end-stage renal disease, intolerance to alternatives, on transplant list | Approved |
ferric carboxymaltose | iron deficiency, end stage renal failure | Approved |
ferric carboxymaltose | iron deficiency, end stage renal failure | Approved renewal |
fexofenadine | indolent systemic mastocytosis, mast cell activation syndrome | Approved |
fexofenadine | indolent systemic mastocytosis, mast cell activation syndrome | Approved renewal |
filgrastim | colitis, severe neutropaenia | Approved |
filgrastim | Glycogen Storage Disease type 1b, congenital neutropaenia | Approved |
filgrastim | menorrhagia, severe neutropaenia, uterine fibroid | Approved |
filgrastim | systemic lupus erythematosus, neutropaenia, Thrombocytopaenia | Approved |
flucytosine | candida parapsilosis infection, Rheumatoid Arthritis | Approved |
flucytosine | cryptococcal infection | Approved |
flucytosine | Cryptococcal Meningitis, hepatitis C, HIV | Approved |
flucytosine | persitent candida vulvovaginitis | Approved |
flunarizine | ATP1A3 related neurologic disorder, dystonia, hemiplegia | Approved |
fluoxetine (Prozac) | Depression | Declined |
food thickener (Nutilis 900) | chronic dysphagia, spastic quadriplegia | Declined |
fortijuice | allergy to dairy, Oesophageal carcinoma | Approved |
fortijuice | bowel cancer, epilepsy, global cognitive delay | Approved |
fosfomycin | cholangitis, ESBL producer, unfit for surgery | Approved |
fosfomycin | ESBL Klebsiella UTI, prosthetic hip infection | Approved |
fosfomycin | proteus mirabilis UTI, diabetes, end-stage renal failure on CAPD, ESBL producer, HIV, hypertension, infected renal abscess | Approved |
fosfomycin | Recurrent ESBL E.coli UTI | Approved |
fosfomycin | Recurrent ESBL E.coli UTI | Approved |
fosfomycin | Recurrent ESBL E.coli UTI, chronic leg ulcers, ischaemic heart disease, renal failure | Approved |
fosfomycin | Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome | Approved |
fosfomycin | Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome | Approved |
fosfomycin | Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome | Approved renewal |
fosfomycin | Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome | Approved renewal |
fosfomycin | Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome | Approved renewal |
fosfomycin | recurrent urinary tract infections | Approved |
fosfomycin | recurrent UTI, urinary catheter | Approved |
fructose | congenital glucose galactose malabsorption | Approved |
fumagillin | microsporidia keratosis | Approved |
gabapentin | neuropathic pain | Approved |
gabapentin | nodular prurigo, Depression, eczema, obesity | Approved |
gabapentin | nystagmus, severe oscillopsia, Myeloproliferative disorder | Approved |
gabapentin | pubic symphysis diastasis, pregnant | Approved |
galactomin 19 | congenital glucose galactose malabsorption | Approved |
ganciclovir | anterior uveitis, Cytomegalovirus, fluctuating refraction and vision, ocular hypertension | Approved |
ganciclovir | anterior uveitis, Cytomegalovirus, fluctuating refraction and vision, ocular hypertension | Approved |
ganciclovir | bacterial keratitis, herpetic corneal ulcer | Approved |
ganciclovir | Cytomegalovirus | Approved |
ganciclovir | Cytomegalovirus | Approved renewal |
ganciclovir | herpes simplex infection, central corneal melt, graft failure | Approved |
gefitinib | EGFR positive, non-small cell carcinoma of lung | Approved |
gemcitabine | angiosarcoma of breast, breast cancer | Approved |
gemcitabine | cervical cancer, metastatic lung cancer, metastatic mediastinum | Approved |
gemcitabine | metastatic uterine leiomyo-sarcoma | Approved |
gemcitabine | metastatic uterine leiomyo-sarcoma, impaired left ventricle function | Approved |
gentamicin | intestinal failure, small intestinal bacterial overgrowth, failure to thrive, fatigue, gastrojejunostomy tube, muscle pain, severe gastroesophageal reflux | Approved |
gentamicin | intestinal failure, small intestinal bacterial overgrowth, failure to thrive, fatigue, gastrojejunostomy tube, muscle pain, severe gastroesophageal reflux | Approved renewal |
gentamicin | small intestinal bacterial overgrowth | Approved |
gentamicin | small intestinal bacterial overgrowth | Approved |
glucose | recurrent severe hypoglycaemia, Glycogen Storage Disease type 1b, neutropaenia, oral aversion | Approved |
glucose | recurrent severe hypoglycaemia, Glycogen Storage Disease type 1b, neutropaenia, oral aversion | Approved renewal |
glucose gel | hypoglycaemia, fructose 1,6-bisphosphatase deficiency | Approved |
glucose gel | hypoglycaemia, fructose 1,6-bisphosphatase deficiency | Approved renewal |
glucose gel | hypoglycaemia, Glycogen Storage Disease type 1b | Approved |
glucose gel | hypoglycaemia, Glycogen Storage Disease type 1b | Approved renewal |
glucose gel | hypoglycaemia, Glycogen Storage Disease type 1b | Approved renewal |
glucose test strips | diabetes type 1, developmental delay, poorly controlled diabetes | Approved |
glucose test strips | diabetes type 1, developmental delay, poorly controlled diabetes | Approved renewal |
glucose test strips | diabetes type 1, developmental delay, poorly controlled diabetes | Approved renewal |
glyceryl trinitrate | angina, funded alternative unsuitable | Approved |
glyceryl trinitrate | ischaemic heart disease, Atrial fibrillation, Osteoarthritis | Approved renewal |
glyceryl trinitrate (Nitrolingual Pump Spray) | ischaemic heart disease, Atrial fibrillation, Osteoarthritis | Approved |
glyceryl trinitrate (Nitrolingual Pump Spray) | paroxysmal af, aortic stenosis, Osteoarthritis, STEMI | Approved |
glyceryl trinitrate (Nitrolingual Pumpspray) | ischaemic heart disease, Osteoarthritis | Approved |
glycopyrrolate | excessive pooling oral secretions due to Bulbar palsy, Motor Neurone disease | Approved |
haemophilus influenzae type b vaccination | acute leukamia post bone marrow transplant, preventing infection of immunocompromised patient | Approved |
haemophilus influenzae type b vaccination | post allogeneic stem cell transplant | Approved |
histidine-tryptophan-ketoglutarate | cardiac surgery, Valve Replacement, Liver Failure, renal failure | Approved |
histidine-tryptophan-ketoglutarate | double coronary byoass graft, upcoming aortic valve replacement surgery, possible interposition aortic graft, possible limited hemi-arch replacement | Approved |
hpv recombinant vaccine | recurrent respiratory papillomatosis | Approved |
hpv recombinant vaccine | Severe recurrent respiratory papillomatosis refractory to surgical debulking | Approved |
hpv recombinant vaccine | Severe recurrent respiratory papillomatosis refractory to surgical debulking | Approved |
hyaluronic acid | post enucleation socket syndrome | Approved |
hyaluronic acid | post enucleation socket syndrome | Approved |
hyaluronic acid 20mg/ml and lidocaine 3 mg/ml | post enucleation socket syndrome | Approved renewal |
hydromorphone | chronic pain, Chronic Idiopathic Intestinal Pseudo-obstruction | Approved |
hydromorphone | chronic pain, Chronic Idiopathic Intestinal Pseudo-obstruction | Approved |
hydromorphone | chronic pain, Chronic Idiopathic Intestinal Pseudo-obstruction | Approved renewal |
hydromorphone | chronic pain, Chronic Idiopathic Intestinal Pseudo-obstruction | Approved renewal |
hydroxybutyrate | Alternating hemiplegia of childhood, glucose transporter abnormality | Declined |
hydroxybutyrate | Alternating hemiplegia of childhood, glucose transporter abnormality | Declined |
hydroxyurea | cerebral sickling, sickle cell anaemia | Approved |
hydroxyurea | Myeloproliferative disorder, Budd Chiari Syndrome, liver transplant | Approved |
hydroxyurea | Myeloproliferative disorder, Budd Chiari Syndrome, liver transplant | Approved renewal |
hydroxyzine hydrochloride | adjustment disorder, Depression, social anxiety, Chronic Idiopathic Intestinal Pseudo-obstruction | Approved |
hydroxyzine hydrochloride | adjustment disorder, Depression, social anxiety, Chronic Idiopathic Intestinal Pseudo-obstruction | Approved renewal |
hypromellose 0.3%, dextran 70 0.1% | conjunctivitis sicca, dry eyes, keratitis | Approved |
hypromellose 0.3%, dextran 70 0.1% | sjogrens syndrome, conjunctivitis sicca, dry eyes, keratitis | Approved renewal |
ibrutinib | AL amyloidosis, waldenstrom's macroglobulinaemia | Declined |
ibrutinib | splenic marginal zone lymphoma, post splenectomy | Declined |
icatibant | hereditary angioedema, congenital absence of thyroid gland | Approved |
icatibant | hereditary angioedema, congenital absence of thyroid gland | Approved renewal |
idebenone | MELAS | Approved |
imatinib | Hypereosinophilic Syndrome, secondary myelofibrosis, unacceptable side effects of steroid | Approved |
imatinib | Myeloproliferative neoplasm, eosinophilia, PDGFRA abnormality | Approved |
imatinib | philadelphia-positive precursor B cell acute lymphoblastic leukaemia | Approved |
imatinib | systemic mastocytosis, breast cancer in remission, diabetes type 2, previous IgA nephropathy | Approved |
imiquimod | extramammary Paget's Disease | Approved |
imiquimod | Genital Herpes, aciclovir resistant, HIV infection | Approved |
imiquimod | recurrent squamous cell carcinoma | Approved |
indomethacin | congenital nephrotic syndrome, oedema | Approved |
indomethacin | congenital nephrotic syndrome, proteinuria | Approved |
indomethacin | hemicrania continua | Approved |
indomethacin | hemicrania continua | Approved |
indomethacin | paroxysmal hemicrania, severe headaches | Approved |
indomethacin | paroxysmal hemicrania, severe headaches | Approved renewal |
infatrini | failure to gain weight, abnormal pulmonary venous drainage, aortic coarctation, dextroposition of the heart, multiple VSDs, transposition of the great arteries | Approved |
infatrini | failure to thrive | Approved |
infatrini | failure to thrive, Cleft palate, faltering growth, nasopharyngeal tube, pierre robin syndrome, stickler syndrome | Approved |
infatrini | failure to thrive, congenital heart disease, Previous heart failure, unrestricted pulmonary blood flow | Approved |
infatrini | failure to thrive, developmental delay, Feeding difficulties, swallowing dysfunction, very premature birth | Approved |
infatrini | failure to thrive, heart failure | Approved |
infatrini | failure to thrive, lower respiratory tract infection, micrognathia, previous nissen fundoplication, retrognathia, upper airway obstruction | Approved |
infatrini | faltering growth, Central hypotonia, Gastrooesophageal reflux, nystagmus | Approved |
infatrini | faltering growth, Central hypotonia, Gastrooesophageal reflux, nystagmus | Approved renewal |
infatrini | faltering growth, global development delay, preterm, very low birth weight | Approved |
infatrini | faltering growth, global development delay, preterm, very low birth weight | Approved renewal |
infatrini | Growth Failure, Congestive Heart Failure, ventricular septal defect | Approved |
infliximab | Behcet's disease, Cutaneous Vasculitis, optic neuritis, oral ulceration, vasculitic skin lesions | Approved |
infliximab | Behcet's disease, severe ulceration of bowel, diabetes type 2, Hypothyroidism, psychotic depression | Approved |
infliximab | Behcet's disease, severe ulceration of bowel, diabetes type 2, Hypothyroidism, psychotic depression | Approved renewal |
infliximab | bilateral chronic uveitis, granulomatous uveitis, cystoid macular oedema, keratopathy, sarcoidosis | Approved |
infliximab | cardiac sarcoidosis, severe heart failure | Approved |
infliximab | Crohn's diease | Approved |
infliximab | Erythema Nodosum Leprosum, multibacillary leprosy | Approved renewal |
infliximab | juvenile idiopathic arthritis, uveitis, cataract, cystoid macular oedema, keratopathy, ocular hypertension | Approved |
infliximab | neuro tuberculosis | Approved |
infliximab | neurosarcoidosis | Approved |
infliximab | neurosarcoidosis | Approved renewal |
infliximab | neurosarcoidosis, dyslipidaemia, IHD | Approved |
infliximab | neurosarcoidosis, dyslipidaemia, IHD | Approved renewal |
infliximab | neurosarcoidosis, Hydrocephalus, Panhypopituitarism | Approved |
infliximab | neurosarcoidosis, Hydrocephalus, Panhypopituitarism | Approved renewal |
infliximab | neurosarcoidosis, Hydrocephalus, Panhypopituitarism | Approved renewal |
infliximab | pyoderma gangrenosum | Approved |
infliximab | pyoderma gangrenosum | Approved renewal |
infliximab | pyoderma gangrenosum, anaemia | Approved |
infliximab | uveitis, juvenile idiopathic arthritis | Approved renewal |
insulin | type 1 diabetes, multiple suicide attempts, psychotic depression | Approved |
insulin pump | Cystic fibrosis, considered for lung transplant, insulin-dependent diabetes mellitus, pancreatic loss | Approved |
insulin pump consumables | Cystic fibrosis, considered for lung transplant, insulin-dependent diabetes mellitus, pancreatic loss | Approved |
interferon gamma-1b | chronic granulomatous disease, lung abscess, splenic abscesses | Approved |
interferon gamma-1b | Mycobacterium Avium Intracellulare infection, lymphopaenia | Approved |
interferon gamma-1b | Mycobacterium Avium Intracellulare infection, lymphopaenia | Approved |
irinotecan | adenocarcinoma | Approved |
irinotecan and oxaliplatin | pancreatic cancer | Approved |
isoleucine | Maple syrup urine disease | Approved |
isotretinoin | mycosis fungoides | Approved |
isotretinoin | mycosis fungoides, sezary syndrome | Approved |
isradipine | hypertension, Chronic Idiopathic Intestinal Pseudo-obstruction | Approved |
isradipine | hypertension, Chronic Idiopathic Intestinal Pseudo-obstruction | Approved renewal |
itraconazole | chronic ear infection aspergillus | Approved |
itraconazole | fungal prophylaxis, chronic granulomatous disease | Approved |
itraconazole | fungal prophylaxis, chronic granulomatous disease | Approved |
itraconazole | microsporum canis infection | Approved |
ivabradine | sinus tachycardia | Approved |
ketamine | acute myeloblastic leukaemia, bone marrow transplant, pain management, palliative care | Approved |
ketamine | chronic neuropathic pain, Multiple Sclerosis | Approved |
ketamine | Fistulating Anus, pain, rectal carcinoma | Approved |
ketamine | metastatic cervical cancer, palliative pain care | Approved |
ketamine | neuropathic pain, metastatic uterine leiomyo-sarcoma | Approved |
ketamine | pain, adenocarcinoma, metastatic disease | Approved |
ketamine | pain, palliative care | Approved |
ketamine | palliative pain care, lung cancer, stage IV | Approved |
ketamine | palliative pain care, lung cancer, stage IV | Approved renewal |
ketamine | Prostate carcinoma, Metastatic Bone Disease, pathological fracture, spinal cord compression | Approved |
ketamine | uncontrolled cancer pain | Approved |
ketamine | uncontrolled cancer pain, metastatic lung cancer | Approved |
ketocal 3:1 (Nutricia) | pyruvate dehydrogenase deficiency, developmental delay, seizures | Approved |
ketoconazole | cushing's syndrome, hypercortisolism, poor tolerance to metyrapone | Approved |
ketoconazole | hypercalcaemia, renal impairment, renal stones | Approved |
ketotifen | mast cell activation syndrome, mastocytosis, Anaphylaxis, asthma, eczema, multiple drug allergies, peripheral neuropathy, rhinitis | Approved |
ketotifen | mast cell activation syndrome, mastocytosis, anaphylaxis, conjunctivitis, monoclonal, rhinitis | Approved |
ketotifen | mast cell activation syndrome, mastocytosis, anaphylaxis, conjunctivitis, monoclonal, rhinitis | Approved renewal |
ketotifen | multiple food allergies, poor weight gain | Approved |
klean-prep | chronic constipation, restricted diet due to food allergies | Approved renewal |
lamivudine | aplastic anaemia, Agranulocytosis, HBV | Approved |
lamivudine | diffuse large B-cell lymphoma, hepatitis B core antigen positive | Approved |
lamivudine | donor core positive for hepatitis B, Congenital biliary atresia, post liver transplant | Approved |
lamivudine | Hepatitis B | Approved |
lamivudine | Hepatitis B | Approved renewal |
lamivudine | hepatitis B core antibody positive, awaiting stem cell transplant, Multiple Myeloma | Approved |
lamivudine | Hepatitis B prophylaxis prior to CHOP chemotherapy, acute myeloid leukaemia, hepatits C virus, liver fibrosis | Approved |
lamivudine | Hepatitis B, follicular lymphoma | Approved |
lamivudine | HIV, congestive heart failure, end-stage renal failure | Approved renewal |
l-arginine | hyperammonaemia, urea cycle disorder | Approved |
l-arginine | MELAS | Approved |
l-arginine | MELAS | Approved |
l-arginine | MELAS | Approved |
l-arginine | MELAS | Approved renewal |
l-arginine | MELAS, Cardiomyopathy, Seizures | Approved |
l-arginine | MELAS, stroke-like episodes, epilepsy, obsessive-complusive disorder features, sensorineural hearing loss | Approved |
l-arginine | MELAS, stroke-like episodes, epilepsy, obsessive-complusive disorder features, sensorineural hearing loss | Approved renewal |
l-arginine | MELAS, Wolff-Parkinson-White syndrome | Approved |
l-arginine | mitochondrial DNA deletion, stroke-like episodes, MELAS | Approved |
l-arginine | non-syndromic mitochondrial disease, basal ganglia calcification, intermittent psychiatric disturbance | Approved |
l-arginine | Pyridoxine responsive seizures, Down's syndrome | Approved |
l-arginine | Pyridoxine responsive seizures, Down's syndrome | Approved renewal |
laronidase | hurler's syndrome, dysostosis multiplex, Hydrocephalus, lumbar gibbus, obstructive sleep apnoea | Approved |
laronidase | hurler's syndrome, peri- BMT | Approved |
l-carnitine | Brown-Vialetto-Van Laere Syndrome | Approved |
l-carnitine | bulbar palsy, carnitine deficiency, global development delay, Incontinence, refractory epilepsy, respiratory infection | Approved |
l-carnitine | carnitine deficiency, glut-1 deficiency | Approved |
l-carnitine | carnitine deficiency, glut-1 deficiency | Approved renewal |
l-carnitine | carnitine deficiency, Undiagnosed neurological problem, gastrostomy feeding, global development delay, medically refractory seizures | Approved |
l-carnitine | carnitine uptake disorder | Approved |
l-carnitine | carnitine uptake disorder | Approved |
l-carnitine | carnitine uptake disorder | Approved |
l-carnitine | carnitine uptake disorder | Approved |
l-carnitine | carnitine uptake disorder | Approved renewal |
l-carnitine | carnitine uptake disorder | Approved renewal |
l-carnitine | carnitine uptake disorder | Approved renewal |
l-carnitine | carnitine uptake disorder | Approved renewal |
l-carnitine | carnitine-acylcarnitine translocase deficiency | Approved |
l-carnitine | carnitine-acylcarnitine translocase deficiency | Approved renewal |
l-carnitine | carnitine-acylcarnitine translocase deficiency | Approved renewal |
l-carnitine | glutaric aciduria type 1 | Approved |
l-carnitine | glutaric aciduria type 1 | Approved renewal |
l-carnitine | holocarboxylase synthetase deficiency | Approved |
l-carnitine | holocarboxylase synthetase deficiency | Approved |
l-carnitine | holocarboxylase synthetase deficiency | Approved renewal |
l-carnitine | holocarboxylase synthetase deficiency | Approved renewal |
l-carnitine | holocarboxylase synthetase deficiency | Approved renewal |
l-carnitine | holocarboxylase synthetase deficiency | Approved renewal |
l-carnitine | low L- carnatine secondary to ketogenic diet, doose syndrome, epileptic encephalopathy | Approved |
l-carnitine | methylmalonic acidemia | Approved |
l-carnitine | methylmalonic acidemia, brain injury, hyperammonaemia | Approved |
l-carnitine | methylmalonic acidemia, brain injury, hyperammonaemia | Approved |
l-carnitine | methylmalonic acidemia, brain injury, hyperammonaemia | Approved renewal |
l-carnitine | multiple acyl-coenzyme A dehydrogenase deficiency | Approved |
l-carnitine | possible carnitine uptake disorder, abnormal result on newborn screening test | Approved |
l-carnitine | Propionic Acidaemia | Approved |
lenalidomide | IgA multiple myeloma, bilateral diaphramatic paralysis secondary to bortezomib | Approved |
lenalidomide | Multiple Myeloma | Declined |
lenalidomide | myelodysplastic syndrome with 5q deletion | Approved |
lenalidomide | myelodysplastic syndrome with 5q deletion, anaemia, JAK-2 positive, myeloproliferative neoplasms | Approved |
lenalidomide | Myeloma, cervical spondylosis, chronic inflammatory demyelinating polyneuropathy, lumbar spondylosis | Declined |
lenalidomide | plasma cell myeloma, muscle wasting, severe peripheral neuropathy | Approved |
lenalidomide | plasma cell myeloma, muscle wasting, severe peripheral neuropathy | Approved renewal |
lenalidomide | plasma cell myeloma, Painful peripheral Neuropathy | Approved |
lenalidomide | plasma cell myeloma, Painful peripheral Neuropathy | Approved renewal |
lenalidomide | refractory multiple myeloma, hyperlipidaemia, hypertension, neuropathic pain | Declined |
lenalidomide | relapsed chronic lymphocytic leukaemia | Declined |
leuprorelin | metastatic prostate cancer, Haemophilia A | Approved |
levamisole | steroid dependent nephrotic syndrome, frequent flare-ups | Approved |
levetiracetam | temporal lobe epilepsy, Dysembryoplastic neuroepithelial tumor | Approved |
levocetirizine | chronic urticaria | Approved |
levofloxacin | drug reaction, MDR tuberculosis | Approved renewal |
levonorgestrel | dysmenorrhea, heavy menstrual bleeding, chronic vaginal discharge, Didelphic uterus | Approved |
levonorgestrel | heavy menstrual bleeding, on warfarin, Post Liver Transplant, pulmonary hypertension | Approved |
levonorgestrel | menorrhagia | Approved |
levonorgestrel | menorrhagia | Approved |
levonorgestrel | menorrhagia, endometriosis, frozen pelvis | Approved |
levonorgestrel (Mirena) | allergy to alternatives, menorrhagia | Approved |
levonorgestrel (Mirena) | contraception, Morbid Obesity | Approved |
levonorgestrel (Mirena) | dysfunctional uterine bleeding, menorrhagia, contraception, Morbid Obesity | Approved |
levonorgestrel (Mirena) | dysmenorrhea | Approved |
levonorgestrel (Mirena) | dysmenorrhea, menorrhagia, previous bowel surgery | Approved |
levonorgestrel (Mirena) | heavy menstrual bleeding, adenomyosis, hypertension, pelvic pain, very high BMI | Approved |
levonorgestrel (Mirena) | irregular menstrual bleeding, menorrhagia | Approved |
levonorgestrel (Mirena) | menorrhagia | Approved |
levonorgestrel (Mirena) | menorrhagia, Morbid Obesity | Approved |
levonorgestrel (Mirena) | menorrhagia, pelvic pain, endometriosis | Approved |
levonorgestrel (Mirena) | menorrhagia, pelvic pain, Severe endometriosis | Approved |
levothyroxine | Hashimoto's thyroiditis, Hypothyroidism | Approved |
lignocaine 2% | Epidermolysis Bullosa, ulceration of anal canal | Approved |
lignocaine hydrochloride | pain, acromegaly, Calciphylaxis, end-stage renal failure, severe ulceration | Approved |
linezolid | adverse reaction to daptomycin, allergy to vancomycin, Staphylococcus epidermidis infection | Approved |
linezolid | complex congenital heart disease, mediastinitis MRSA, respiratory infection, tracheobronchomalacia | Approved |
linezolid | corynebacterium infection, GORD, hypertension, infected hip joint replacement | Approved |
linezolid | corynebacterium infection, Infected Knee Joint, multi antibiotic resistance | Approved |
linezolid | corynebacterium infection, resistant microorganisms | Approved |
linezolid | enterococcus faecalis infection, multidrug resistant staph infection | Approved |
linezolid | infected hip joint replacement, Klebsiella infection | Approved |
linezolid | MDR Cellulitis, Renal Impairment | Approved |
linezolid | MDR tuberculosis | Approved |
linezolid | MDR tuberculosis | Approved |
linezolid | MDR tuberculosis, hearing loss, psoas abscess, Spinal Abscess | Approved |
linezolid | MDR tuberculosis, pulmonary tuberculosis | Approved |
linezolid | multidrug-resistant TB | Approved |
linezolid | multidrug-resistant tuberculosis | Approved |
linezolid | multidrug-resistant tuberculosis | Approved |
linezolid | multidrug-resistant tuberculosis | Approved renewal |
linezolid | mycobacterium infection | Approved |
liothyronine | dependent T3 replacement | Approved |
liothyronine | dependent T3 replacement | Approved renewal |
liothyronine | Hypothyroidism, post thyroidectomy, radioiodine ineffective | Approved |
liothyronine | Hypothyroidism, post thyroidectomy, radioiodine ineffective | Approved renewal |
lipistart | Very long chain acyl-CoA dehydrogenase (VLCAD) deficiency, excessive weight gain, low zinc and iron, rhabdomyolysis | Approved |
liposomal doxorubicin | kaposi's sarcoma, AIDS | Approved |
lorazepam | medically refractory seizures | Approved |
lorenzo's oil | adrenoleukodystrophy | Approved |
l-ornithine l aspartate | hepatic encephalopathy, end stage liver disease | Approved |
l-ornithine l aspartate | hepatic encephalopathy, end stage liver disease | Approved renewal |
l-ornithine l aspartate | hepatic encephalopathy, Hepatitis C, liver cirrhosis | Approved |
l-ornithine l aspartate | hepatic encephalopathy, refractory to other treatments | Approved |
l-ornithine l aspartate | hepatic encephalopathy, refractory to other treatments | Approved renewal |
low protein baking mix | methylmalonic acidemia | Approved |
low protein pasta | methylmalonic acidemia | Approved |
macrogol | anxiety, Central sensitisation syndrome, chronic abdominal pain, Chronic Nausea, Chronic severe constipation, Gastrooesophageal reflux, gastrostomy feeding, Past history of rheumatic fever | Approved |
magnesium chloride | Gitelman's syndrome, hypokalaemia, hypomagnesaemia | Approved renewal |
magnesium chloride | short bowel syndome, allergy to sulphur, endometriosis complications | Approved |
magnesium oxide | renal wasting of magnesium, cycling vomiting, hypertension, low magnesium, menieres disease | Approved |
mannitol | Cystic fibrosis, CF related diabetes, depression, steroid-induced osteopenia | Approved |
mannitol | Cystic fibrosis, CF related diabetes, depression, steroid-induced osteopenia | Approved renewal |
mct peptide | Langerhans cell histiocytosis, enteropathy, poor growth, probable lymphangiectasia | Approved |
mechlorethamine | mycosis fungoides | Approved |
melatonin | Insomnia, delerium, Long term wean from ventilator following pseudomonas bronchopneumonia | Approved |
mepacrine | cutaneous systemic lupus erythematosus | Approved |
mepacrine | discoid lupus erythematosis, systemic lupus erythematosus | Approved |
mepacrine | discoid lupus erythematosis, systemic lupus erythematosus | Approved renewal |
mepacrine | Refractory giardiasis | Approved |
mepacrine | Refractory giardiasis | Approved |
mepacrine | SLE, Arthritis, hepatosteatosis | Approved |
mepacrine | systemic lupus erythematosus, arthralgia, glomerulonephritis, multiple fractures, myalgia, osteoporosis, pericarditis | Approved |
mepacrine | systemic lupus erythematosus, arthralgia, glomerulonephritis, multiple fractures, myalgia, osteoporosis, pericarditis | Approved renewal |
metformin with sitagliptin | diabetes type 2 | Declined |
methylphenidate extended release (Ritalin LA) | narcolepsy | Approved |
methylphenidate sr | hypotension, tetraplegia | Approved |
metoclopramide | intractable vomiting, chronic fatigue syndrome, short bowel | Approved |
metronidazole | bacterial infection, necrotic pelvic tumour, stage IV sigmoid adenocarcinoma | Approved |
metronidazole | deep tissue infection, Invasive squamous cell carcinoma | Approved |
mexiletine | annular tear | Approved |
mexiletine | asthma, pelvic athropathy in pregnancy | Approved |
mexiletine | cardiac arrhythmias, Hypertrophic cardiomyopathy | Approved |
mexiletine | Chest Pain, neuropathic pain in pregnancy, SLE | Approved |
mexiletine | endometriosis, pelvic pain | Approved |
mexiletine | myotonia congenita, Thomsen's condition | Approved |
mexiletine | neuropathic pain in pregnancy, lumbar disc prolapse | Approved |
mexiletine | pain, painful arthropathy, pregnancy | Approved |
micronised progesterone | cervical incompetence | Approved |
micronised progesterone | pregnancy, cervical incompetence | Approved |
mifepristone | relapsed meningioma | Approved |
milrinone | severe dilated cardiomyopathy of unknown aetology, heart failure, severe left ventricular impairment | Approved |
minims prednisolone | conjunctivitis sicca, dry eyes, keratitis | Approved |
mitotane | adrenal cortical carcinoma | Approved |
mitotane | adrenal cortical carcinoma | Approved |
mitotane | adrenal cortical carcinoma | Approved |
mitotane | adrenal cortical carcinoma, metastatic disease | Approved |
mitotane | adrenal cortical carcinoma, metastatic disease | Approved renewal |
mitotane | adrenocortical carcinoma | Approved |
mitotane | adrenocortical carcinoma | Approved |
mitotane | adrenocortical carcinoma | Approved |
mitotane | adrenocortical carcinoma | Approved |
mitotane | adrenocortical carcinoma | Approved |
mitotane | adrenocortical carcinoma | Approved renewal |
mitotane | adrenocortical carcinoma, Atrial fibrillation, cushing's syndrome, severe hypertension | Approved |
mitotane | adrenocortical carcinoma, cushing's syndrome | Approved |
mitotane | adrenocortical carcinoma, liver metastases, pituitary dependent Cushings syndrome, seizures | Approved |
mitotane | carcinoma of adrenal gland, liver metastases | Approved |
mitotane | grade 4, metastatic adrenocortical carcinoma, unresectable | Approved |
mitotane | lung metastases, metastatic adenocarcinoma | Approved |
mitotane | metastatic adrenocortical carcinoma | Approved |
mitotane | metastatic adrenocortical carcinoma | Approved |
mitotane | metastatic adrenocortical carcinoma | Approved |
mitotane | metastatic adrenocortical carcinoma, cushing's syndrome | Approved |
mitotane | metastatic adrenocortical carcinoma, history of, oesophageal cancer | Approved |
mitotane | metastatic adrenocortical carcinoma, obesity, obstructive sleep apnoea | Approved |
montelukast | angioneurotic oedema | Approved |
montelukast | asthma, Asperger's syndrome, atopy, autism spectrum disorder | Declined |
montelukast | asthma, atopic eczema, gastro-oesophageal reflux disease | Declined |
montelukast | asthma, Hypothyroidism, ischaemic heart disease | Approved |
montelukast | bronchiolitis obliterans syndrome, Graft Versus Host Disease | Approved |
montelukast | bronchiolitis obliterans, acute myeloid leukaemia, chronic graft versus host disease | Approved |
montelukast | cold urticaria, Anaphylaxis | Approved |
montelukast | diabetes type 2, multiple drug allergies, multiple food allergies, Samter's triad, severe asthma | Approved |
montelukast | Graft versus host disease of lungs, GvHD post allogeneic transplant, relapsed AML | Approved |
montelukast | Graft versus host disease of lungs, GvHD post allogeneic transplant, relapsed AML | Approved renewal |
montelukast | Graft versus host disease of lungs, history allogeneic stem cell transplant, history of acute lymphoblastic leukemia | Approved |
montelukast | systemic mastocytosis | Approved |
montelukast | systemic mastocytosis | Approved |
montelukast | systemic mastocytosis | Approved |
montelukast | systemic mastocytosis | Approved renewal |
morphine/bupivicaine/clonidine | bowel cancer, uncontrolled pain | Approved |
morphine/bupivicaine/clonidine | metastatic colon cancer, metastatic disease, severe pain | Approved |
moxifloxacin | asbestosis, MDR pneumococcal bacteraemia | Approved |
moxifloxacin | bacteraemia, enterococcus faecalis infection | Approved |
moxifloxacin | bronchiectasis, Chronic back pain, chronic renal impairment, clostridium infection, severe COPD | Approved |
moxifloxacin | bronchiectasis, multi drug resistant streptococcus pneumoniae infection | Approved |
moxifloxacin | cellulitis | Approved |
moxifloxacin | cellulitis, ulceration | Approved |
moxifloxacin | cerebellar brain abscess, nocardia farcinica infection | Approved |
moxifloxacin | community acquired pneumonia | Approved |
moxifloxacin | deep soft tissue infection | Approved |
moxifloxacin | Discitis | Approved |
moxifloxacin | fungal empyema, Streptococcus pneumoniae infection | Approved |
moxifloxacin | Genital mycoplasma infection | Approved |
moxifloxacin | Infection due to Mycobacterium abscessus | Approved |
moxifloxacin | Infection due to Mycobacterium abscessus | Approved renewal |
moxifloxacin | lower respiratory tract infection, adenocarcinoma of the oesophagus | Approved |
moxifloxacin | meningitis | Approved |
moxifloxacin | multi antibiotic resistant streptococcus pneumoniae chest infection | Approved |
moxifloxacin | multi antibiotic resistant streptococcus pneumoniae chest infection, Bilateral chronic bronchiectasis | Approved |
moxifloxacin | multi drug resistant streptococcus pneumoniae infection, severe COPD | Approved |
moxifloxacin | multi resistant staphylococcus epidermidis, prosthetic joint infection | Approved |
moxifloxacin | multidrug-resistant streptococcus pneumoniae infection, COPD, infective exacerbation | Approved |
moxifloxacin | multidrug-resistant streptococcus pneumoniae infection, eye infection | Approved |
moxifloxacin | multidrug-resistant streptococcus pneumoniae infection, eye infection | Approved renewal |
moxifloxacin | multidrug-resistant streptococcus pneumoniae pneumonia | Approved |
moxifloxacin | multidrug-resistant streptococcus pneumoniae pneumonia, community acquired pneumonia | Approved |
moxifloxacin | Mycobacterium Avium Intracellulare infection, bronchiectasis, Cystic fibrosis | Approved |
moxifloxacin | Mycobacterium fortuitum infection, Osteomyelitis | Approved |
moxifloxacin | mycobacterium marinum infection, GORD, SVT | Approved |
moxifloxacin | mycobacterium xenopi infection | Approved |
moxifloxacin | mycoplasma genitalium infection | Approved |
moxifloxacin | mycoplasma genitalium infection | Approved |
moxifloxacin | mycoplasma genitalium infection | Approved |
moxifloxacin | mycoplasma genitalium infection | Approved |
moxifloxacin | mycoplasma genitalium infection, bacterial vaginosis | Approved |
moxifloxacin | mycoplasma genitalium infection, persistant non gonococcal urethritis | Approved |
moxifloxacin | mycoplasma genitalium infection, unresponsive to azithromycin | Approved |
moxifloxacin | Mycoplasmal pelvic inflammatory disease | Approved |
moxifloxacin | pneumococcal meningitis, mastoiditis, Otitis Media | Approved |
moxifloxacin | pneumonia, Underlying CLL | Approved |
moxifloxacin | presumed tuberculous meningitis | Approved |
moxifloxacin | presumed tuberculous meningitis | Approved |
moxifloxacin | Staphylococcus epidermidis infection, Prosthetic Knee Joint Infection | Approved |
moxifloxacin | Streptococcal pneumonia, fungal empyema | Approved |
moxifloxacin | Streptococcus pneumoniae infection, COPD | Approved |
moxifloxacin | Tuberculous meningitis | Approved |
moxifloxacin | Tuberculous meningitis | Approved |
moxifloxacin | wound infection, mediastinitis, Staphylococcus epidermidis infection | Approved |
moxifloxacin (Avelox) | Genital mycoplasma infection | Approved |
moxifloxacin iv | discitis | Approved |
msud amino 5 | Maple syrup urine disease | Approved |
multivitamins | Epidermolysis Bullosa, inadequate nutrition, recurrent mouth ulceration | Approved |
mycophenolate | Batten's disease | Approved |
mycophenolate | systemic sclerosis, Rapidly progressing | Approved |
mycophenolate mofetil | autoimmune hepatitis | Approved |
mycophenolate mofetil | autoimmune lymphoproliferative syndrome | Approved |
mycophenolate mofetil | systemic lupus erythematosus, lupus nephritis class IIIa | Approved renewal |
mycophenolic acid | lupus nephritis, end stage renal failure, post renal transplant | Approved renewal |
naloxone hydrochloride | Chait tube, G tube, ileostomy, J tube, morphine related itch, progressive gut failure, TPN dependent | Approved |
naltrexone | progressive familial intrahepatic cholestasis, pruritus, awaiting liver transplant | Approved |
nanovm powder (4-8 years) | myoclonic astatic epilepsy, Intractable Epilepsy | Approved |
nanovm powder (4-8 years) | myoclonic astatic epilepsy, Intractable Epilepsy | Approved renewal |
naproxen/esomeprazole | Gastric reflux, Osteoarthritis | Declined |
nasal spray bottle plus consumables | fentanyl nasal spray delivery | Approved |
natalizumab | Multiple Sclerosis | Declined |
natalizumab | relapsing remitting Multiple Sclerosis | Declined |
natalizumab | relapsing remitting Multiple Sclerosis, intolerance to funded alternative | Declined |
natamycin | fungal keratitis | Approved |
neomycin | short bowel syndome, multiple central line infections, small bowel bacterial overgrowth | Approved |
nicorandil | refractory angina | Approved |
nicorandil | refractory angina, ischaemic heart disease | Approved |
nilotinib | Chronic Myeloid Leukaemia | Approved |
nilotinib | Chronic Myeloid Leukaemia | Approved |
nilotinib | Chronic Myeloid Leukaemia | Approved renewal |
nilotinib | Chronic Myeloid Leukaemia | Approved renewal |
nilotinib | Chronic Myeloid Leukaemia | Approved renewal |
nilotinib | Chronic Myeloid Leukaemia, Ca Thyroid currently in remission | Approved |
nilotinib | Chronic Myeloid Leukaemia, chronic phase, interstitial lung disease, Unable to tolerate funded medicaton | Approved |
nilotinib | Chronic Myeloid Leukaemia, imatinib and dasatinib refractory | Approved |
nilotinib | Chronic Myeloid Leukaemia, imatinib refractory, intolerant to dasatinib | Approved |
nilotinib | Chronic Myeloid Leukaemia, intolerance to imatinib/dasatinib | Approved |
nilotinib | Chronic Myeloid Leukaemia, intolerance to imatinib/dasatinib | Approved |
nilotinib | Chronic Myeloid Leukaemia, post burn scarring, PTSD | Approved |
nilotinib | CML, intolerant to dasatinib, resistant to imatinib | Approved |
nilotinib | CML, intolerant to dasatinib, resistant to imatinib | Approved renewal |
nimodipine | reversible cerebral vasoconstriction syndrome | Approved |
nimodipine | reversible cerebral vasoconstriction syndrome | Approved |
nitazoxanide | cryptosporidium | Approved |
nitazoxanide | Giardiasis | Approved |
nitazoxanide | metronidazole resistant recurrent giardiasis | Approved |
nitazoxanide | refractory giardiasis | Approved |
nitazoxanide | refractory giardiasis | Approved renewal |
nivolumab | metastatic melanoma | Approved |
obinutuzumab | 17p deleted chronic lymphocytic leukaemia, hepatitis B reactivation, shingles | Declined |
octreotide | Complex muscular disease, GIT pseudo-obstruction | Approved |
octreotide | high output ileostomy | Approved |
octreotide | metastatic endometrial cancer, profound diarrhoea post radiotherapy | Approved |
octreotide | Pancreatic neuroendocrine tumor, deafness, speech difficulties | Approved |
octreotide | Pleural Effusion, advanced adenocarcinoma of the lung | Approved |
octreotide | post pancreatectomy for cancer | Approved |
octreotide | progressive gut failure, Chait tube, G tube, j tube, palliative care, severe abdominal pain, TPN dependent | Approved |
octreotide lar | gastrointestinal failure, Chronic Nausea, diaphragmatic hernia, gastric dysmotility, lung hypoplasia, possible mitochondrial disorder, total parenteral nutrition dependent, Vomiting | Approved |
octreotide lar | protein losing enteropathy, congenital heart disease, hypoalbuminaemia, hypogammaglobulinaemia | Approved |
octreotide lar | recurrent meningioma, somatostatin receptor expression | Approved |
octreotide short acting | dumping syndrome | Approved |
oestradiol | Hypopituitarism, Septo-optic dysplasia | Approved |
olanzapine | bipolar affective disorder, psychotic symptoms | Approved |
olanzapine | Schizophrenia | Approved |
olanzapine | Schizophrenia | Approved renewal |
olanzapine (Zyprexa) | psychotic disorder, drug reaction, papular urticaria | Approved |
olanzapine inj | bipolar affective disorder type 1 | Approved |
omalizumab | anaphylactic reaction to bee venom, Anaphylaxis, failed bee venom immunotherapy | Approved renewal |
omalizumab | chronic severe asthma | Approved |
omalizumab | chronic urticaria | Declined |
omalizumab | chronic urticaria, hypertension, intolerance to cyclosporin, osteoporosis, Steroid dependent | Declined |
optifast | Morbid Obesity, charcot's neuroarthropathy, diabetes type 2, Immobile | Declined |
oral elemental feed 1kcal/ml | Food sensitivities, Ehlers danlos syndrome, Jejunostomy | Approved |
oral feed 1.5kcal/ml (Fortisip) | inadequate nutrition, primary biliary cirrhosis | Approved |
oxaliplatin | Adenocarcinoma of the stomach, chronic renal impairment | Approved |
oxaliplatin | gastroesophageal junction carcinoma | Approved |
oxaliplatin | metastatic small bowel adenocarcinoma | Approved |
oxaliplatin | Stage II (T4bNOMO) adenocarcinoma of bowel invading liver (completely resected) | Approved |
oxandrolone | bone marrow failure, Fanconi Anaemia | Approved |
oxandrolone | bone marrow failure, Fanconi Anaemia | Approved renewal |
oxcarbazepine | epilepsy | Approved |
oxcarbazepine | epilepsy | Approved renewal |
oxcarbazepine | epilepsy | Approved renewal |
oxcarbazepine | Intractable epilepsy, mild hemipharesis, neuronal migration defect, previous surgery | Approved |
oxybutynin | neurogenic bladder, Spina Bifida | Approved |
palivizumab | chronic neonatal lung disease, Cytomegalovirus Hepatitis, Premature birth, previous intraventricular haemorrhage, sepsis | Approved |
palivizumab | neonatal chronic lung disease | Approved |
palivizumab | prophylaxis of RSV, congenital heart block, neonatal chronic lung disease, very premature birth | Declined |
pancreatin (Pancrex V) | Cystic fibrosis, pancreatic insufficiency | Approved |
papillomavirus vaccine | prevention of human papilloma virus | Approved |
papillomavirus vaccine | recurrent respiratory papillomatosis | Approved |
papillomavirus vaccine | recurrent respiratory papillomatosis | Approved |
papillomavirus vaccine | recurrent respiratory papillomatosis | Approved |
papillomavirus vaccine | recurrent respiratory papillomatosis | Approved |
papillomavirus vaccine | recurrent respiratory papillomatosis | Approved |
papillomavirus vaccine | recurrent respiratory papillomatosis | Approved |
papillomavirus vaccine | recurrent respiratory papillomatosis, HPV virus | Approved |
papillomavirus vaccine | respiratory papillomatosis, Down's syndrome | Approved |
para-amino salicylic acid | MDR tuberculosis | Approved |
para-amino salicylic acid | multidrug-resistant TB | Approved |
para-amino salicylic acid | multidrug-resistant tuberculosis | Approved |
paracetamol | pain, Chronic Nausea, chronic vomiting, gastrointestinal failure, IV nutrition dependent, possible mitochondrial disorder | Approved |
paracetamol | severe headaches, terminal bowel cancer | Approved |
paracetamol (Perfalgan) | intestinal dysmotility, tracheo-oesophageal fistula | Approved |
paraffin (Duoleum Ointment) | Nethertons Syndrome, lack of skin integrity | Approved |
paraffin liquid 50%/white soft paraffin 50% | atopic dermatitis, atopic eczema | Approved |
paraffin liquid 50%/white soft paraffin 50% | atopic eczema | Approved |
paraffin liquid and soft white paraffin | eczema | Approved renewal |
paraffin liquid and white soft paraffin | congenital ichthyosis, preterm | Approved |
paraffin liquid/soft white paraffin (Duoleum) | severe eczema, diarrhoea, failure to thrive | Approved |
paraffin liquid/white soft ointment 50% | congenital bullous ichthyosiform erythroderma | Approved |
paromomycin | entamoeba histolytica intestinal colonisation | Approved |
paromomycin | entamoeba histolytica intestinal colonisation | Approved |
paromomycin | entamoeba histolytica intestinal colonisation | Approved |
paromomycin | metronidazole resistant recurrent giardiasis | Approved |
paromomycin | metronidazole resistant recurrent giardiasis | Approved |
paromomycin | Resistant trichomoniasis, Depression | Approved |
paromomycin | Resistant trichomoniasis, funded is contraindicated, peripheral neuropathy from funded alternative | Approved |
pasireotide | acromegaly, diabetes type 2, hypertension, Hypopituitarism | Declined |
pazopanib | acute pancreatitis secondary to sunitinib | Approved |
pazopanib | bilateral non-pigmented retinal tumours, Pancreatic neuroendocrine tumor, renal cell carcinoma | Approved renewal |
pazopanib | desmoplastic small round cell tumour | Declined |
pazopanib | follicular carcinoma of thyroid, bone metastases, liver metastases | Approved |
pazopanib | metastatic sarcoma, soft tissue sarcoma | Declined |
pazopanib | thyroid carcinoma | Approved |
pediasure | failure to thrive, gastrostomy feeding, Growth hormone deficiency, nausea, nephropathic cystinosis, renal fanconi syndrome, Vomiting | Approved |
pegasparaginase | Acute Lymphoblastic Leukaemia | Declined |
pegasparaginase | Acute Lymphoblastic Leukaemia | Declined |
pegasparaginase | Lymphoblastic T-cell lymphoma | Declined |
pegvisomant | pituitary adenoma, pituitary gigantism | Approved |
pegvisomant | pituitary adenoma, pituitary gigantism | Approved renewal |
pegylated inteferon | Chronic Myeloid Leukaemia, pregnancy | Approved |
pegylated interferon | essential thrombocythaemia | Approved |
pegylated interferon | essential thrombocythaemia | Approved renewal |
pegylated interferon | essential thrombocythaemia | Approved renewal |
pegylated interferon alfa | essential thrombocythaemia, CALR mutation positive | Approved |
pegylated interferon alpha-2a | Chronic Myeloid Leukaemia, intolerance to alternatives | Approved |
pembrolizumab | adenocarcinoma of the bladder, metastatic adenocarcinoma | Declined |
pembrolizumab | Hodgkin's lymphoma, Allogeneic stem cell transplant, bridge to transplant, refractory disease, relapsed lymphoma | Declined |
pembrolizumab | metastatic vaginal melanoma, aortic stenosis, history of hodgkins disease, low grade B-cell non-hodgkin's lymphoma, low grade bronchogenic neoplasm of the lung | Declined |
pemetrexed | malignant epithelioid peritoneal mesothelioma | Approved |
pemetrexed | malignant mesothelioma | Approved |
pemetrexed | Malignant mesothelioma | Approved |
pemetrexed | malignant mesothelioma | Approved |
pemetrexed | malignant mesothelioma | Approved |
pemetrexed | malignant mesothelioma | Approved |
pemetrexed | malignant mesothelioma | Approved |
pemetrexed | malignant mesothelioma | Approved |
pemetrexed | malignant mesothelioma | Approved |
pemetrexed | malignant mesothelioma | Approved |
pemetrexed | malignant mesothelioma | Approved |
pemetrexed | malignant mesothelioma | Approved renewal |
pemetrexed | malignant mesothelioma, Atrial fibrillation, hypertension, impaired glucose tolerance, polymyalgia rheumatica, severe COPD | Approved |
pemetrexed | malignant mesothelioma, hypertension, not eligible for ACC | Approved |
pemetrexed | malignant mesothelioma, not eligible for ACC | Approved |
pemetrexed | malignant mesothelioma, peritoneal mesothelioma | Approved |
pemetrexed | malignant pleural mesothelioma | Approved |
pemetrexed | malignant pleural mesothelioma | Approved |
pemetrexed | malignant pleural mesothelioma | Approved |
pemetrexed | malignant pleural mesothelioma | Approved |
pemetrexed | malignant pleural mesothelioma | Approved |
pemetrexed | malignant pleural mesothelioma | Approved |
pemetrexed | malignant pleural mesothelioma | Approved |
pemetrexed | malignant pleural mesothelioma | Approved |
pemetrexed | malignant pleural mesothelioma | Approved |
pemetrexed | malignant pleural mesothelioma | Approved |
pemetrexed | malignant pleural mesothelioma | Approved |
pemetrexed | malignant pleural mesothelioma, asthma, diabetes type 2, hypertension | Approved |
pemetrexed | malignant pleural mesothelioma, asthma, diabetes type 2, hypertension | Approved renewal |
pemetrexed | malignant pleural mesothelioma, previous asbestos exposure | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved |
pemetrexed | mesothelioma | Approved renewal |
pemetrexed | mesothelioma, breast cancer | Approved |
pemetrexed | mesothelioma, neuropathy | Approved |
pemetrexed | mesothelioma, not eligible for ACC | Approved |
pemetrexed | mesothelioma, not eligible for ACC, previous asbestos exposure | Approved |
pemetrexed | mesothelioma, previous asbestos exposure | Approved |
pemetrexed | mesothelioma, Prostate cancer, renal cancer | Approved |
pemetrexed | mesothelioma, Rheumatoid Arthritis | Approved |
pemetrexed | mesothelioma, Sarcomatoid pleural tumour | Approved |
pemetrexed | peritoneal mesothelioma | Approved |
pemetrexed | peritoneal mesothelioma | Approved |
pemetrexed | peritoneal mesothelioma | Approved |
pemetrexed | peritoneal mesothelioma | Approved |
pemetrexed | peritoneal mesothelioma | Approved renewal |
pemetrexed | peritoneal mesothelioma, breast cancer in remission | Approved |
pemetrexed | pleural mesothelioma | Approved |
pemetrexed | pleural mesothelioma | Approved |
pemetrexed | pleural mesothelioma | Approved |
pemetrexed | pleural pulmonary mesothelioma | Approved |
pemetrexed | pleural pulmonary mesothelioma, autosomal dominant polycystic kidney disease | Approved |
pemetrexed | sarcomatous mesothelioma, infiltrating ductal carcinoma | Approved |
peptide based oral feed | short gut syndrome, abnormal liver function, Premature birth | Approved |
peptide based oral feed | short gut syndrome, abnormal liver function, Premature birth | Approved renewal |
phosphate ions | osteopaenia | Approved |
pimecrolimus | atopic dermatitis, food allergies, rickets | Approved |
pimecrolimus | severe eczema, intra ocular pressure, unacceptable long term effects of steroids | Approved |
pimecrolimus | severe psoriasis | Approved |
pipobroman | adverse reaction to hydroxyurea, essential thrombocythaemia | Approved |
pipobroman | adverse reaction to hydroxyurea, essential thrombocythaemia | Approved renewal |
pipobroman | adverse reaction to hydroxyurea, essential thrombocytosis, JAK-2 positive | Approved |
pipobroman | diabetes, essential thrombocythaemia, severe vascular ulceration | Approved |
pipobroman | diabetes, essential thrombocythaemia, severe vascular ulceration | Approved renewal |
pipobroman | diabetes, essential thrombocythaemia, severe vascular ulceration | Approved renewal |
pipobroman | diabetes, essential thrombocythaemia, severe vascular ulceration | Approved renewal |
pipobroman | essential thrombocythaemia | Approved |
pipobroman | essential thrombocythaemia | Approved |
pipobroman | essential thrombocythaemia, angina, bilateral pulmonary emboli, myelofibrosis | Approved |
pipobroman | essential thrombocythaemia, angina, bilateral pulmonary emboli, myelofibrosis | Approved renewal |
pipobroman | essential thrombocythaemia, angina, bilateral pulmonary emboli, myelofibrosis | Approved renewal |
pipobroman | essential thrombocythaemia, angina, bilateral pulmonary emboli, myelofibrosis | Approved renewal |
pipobroman | essential thrombocythaemia, asthma, hypertension, ischaemic heart disease, JAK-2 positive, MGUS, osteoarthritis | Approved |
pipobroman | essential thrombocythaemia, asthma, hypertension, ischaemic heart disease, JAK-2 positive, MGUS, osteoarthritis | Approved renewal |
pipobroman | essential thrombocythaemia, Heart failure on anagrelide, Non-responsive to anagrelide, Skin ulcers on hydroxyurea | Approved |
pipobroman | essential thrombocythaemia, polycythaemia vera | Approved |
pipobroman | essential thrombocythaemia, polycythaemia vera | Approved renewal |
pipobroman | essential thrombocythaemia, polycythaemia vera | Approved renewal |
pipobroman | essential thrombocythaemia, polycythaemia vera | Approved renewal |
pipobroman | essential thrombocythaemia, previous TIAs | Approved |
pipobroman | essential thrombocythaemia, previous TIAs | Approved renewal |
pipobroman | essential thrombocythaemia, previous TIAs | Approved renewal |
pipobroman | essential thrombocytosis, JAK-2 positive, diverticulosis, Emphysema, hypertension, primary hypogonadism, secondary pancreatitis to azathioprine, Ulcerative Colitis | Approved |
pipobroman | essential thrombocytosis, JAK-2 positive, diverticulosis, Emphysema, hypertension, primary hypogonadism, secondary pancreatitis to azathioprine, Ulcerative Colitis | Approved renewal |
pipobroman | essential thrombocytosis, polycythaemia rubra vera | Approved |
pipobroman | essential thrombocytosis, polycythaemia rubra vera | Approved renewal |
pipobroman | polycythaemia rubra vera | Approved |
pipobroman | polycythaemia rubra vera | Approved |
pipobroman | polycythaemia rubra vera | Approved |
pipobroman | polycythaemia rubra vera | Approved renewal |
pipobroman | polycythaemia vera | Approved |
pipobroman | polycythaemia vera, ventricular arrhythmias | Approved |
pipobroman | polycythaemia vera, ventricular arrhythmias | Approved renewal |
pipobroman | Primary Thrombocythaemia | Approved |
pirfenidone | dyskeratosis congenita, Kartagener's syndrome, progressive lung fibrosis | Approved |
pirfenidone | idiopathic pulmonary fibrosis | Declined |
pirfenidone | idiopathic pulmonary fibrosis | Declined |
pirfenidone | idiopathic pulmonary fibrosis, hypogonadism, Hypothyroidism | Approved |
plerixafor | autologous stem cell transplant | Approved |
plerixafor | autologous stem cell transplant, failed stem cell mobilisation, Multiple Myeloma | Approved |
plerixafor | autologous stem cell transplant, stem cell harvest | Approved |
plerixafor | diffuse B cell lymphoma, for stem cell mobilisation | Approved |
plerixafor | failed stem cell mobilisation | Approved |
plerixafor | failed stem cell mobilisation | Approved |
plerixafor | failed stem cell mobilisation | Approved |
plerixafor | failed stem cell mobilisation, autologous stem cell transplant | Approved |
plerixafor | failed stem cell mobilisation, autologous stem cell transplant, Multiple Myeloma | Approved |
plerixafor | failed stem cell mobilisation, awaiting stem cell transplant, T-cell lymphoma | Approved |
plerixafor | failed stem cell mobilisation, diffuse large b-cell lymphoma | Approved |
plerixafor | failed stem cell mobilisation, diffuse large b-cell lymphoma | Approved |
plerixafor | failed stem cell mobilisation, diffuse large b-cell lymphoma, peripheral stem cell harvesting | Approved |
plerixafor | failed stem cell mobilisation, follicular lymphoma | Approved |
plerixafor | failed stem cell mobilisation, for stem cell mobilisation | Approved |
plerixafor | failed stem cell mobilisation, for stem cell mobilisation, diffuse large b-cell lymphoma | Approved |
plerixafor | failed stem cell mobilisation, for stem cell mobilisation, Myeloma | Approved |
plerixafor | failed stem cell mobilisation, for stem cell mobilisation, Myeloma | Approved |
plerixafor | failed stem cell mobilisation, lymphoma | Approved |
plerixafor | failed stem cell mobilisation, Multiple Myeloma | Approved |
plerixafor | failed stem cell mobilisation, Multiple Myeloma | Approved |
plerixafor | failed stem cell mobilisation, Multiple Myeloma | Approved |
plerixafor | failed stem cell mobilisation, Multiple Myeloma | Approved |
plerixafor | failed stem cell mobilisation, Multiple Myeloma | Approved |
plerixafor | failed stem cell mobilisation, Myeloma for stem cell transplant | Approved |
plerixafor | failed stem cell mobilisation, Non-hodgkin's lymphoma | Approved |
plerixafor | failed stem cell mobilisation, relapsed folicular lymphoma | Approved |
plerixafor | for stem cell mobilisation | Approved |
plerixafor | for stem cell mobilisation | Approved |
plerixafor | for stem cell mobilisation | Approved |
plerixafor | for stem cell mobilisation, diffuse large b-cell lymphoma | Approved |
plerixafor | for stem cell mobilisation, failed stem cell mobilisation, relapsed Hodgkin's lymphoma | Approved |
plerixafor | for stem cell mobilisation, Hodgkin's lymphoma | Approved |
plerixafor | for stem cell mobilisation, mantle cell lymphoma | Approved |
plerixafor | for stem cell mobilisation, mantle cell lymphoma | Approved |
plerixafor | for stem cell mobilisation, Multiple Myeloma | Approved |
plerixafor | for stem cell mobilisation, Multiple Myeloma | Approved |
plerixafor | for stem cell mobilisation, Testicular cancer, failed stem cell mobilisation | Approved |
plerixafor | relapsed Hodgkin's lymphoma | Approved |
plerixafor | Stem Cell Transplant, relapsed multiple myeloma | Approved |
plerixafor | triple hit lymphoma, failed stem cell mobilisation | Approved |
pneumococcal conjugate vaccine (pcv13) | acute leukamia post bone marrow transplant, preventing infection of immunocompromised patient | Approved |
pneumococcal conjugate vaccine (pcv13) | awaiting cochlear implant, prophylaxis to prevent infection, sensorineural hearing loss | Approved |
pneumococcal conjugate vaccine (pcv13) | high risk of infection, pneumococcus infection, Rheumatic Heart Disease | Approved |
pneumococcal conjugate vaccine (pcv13) | high risk of re-infection, prophylaxis to prevent infection, COPD, Severe pneumonia, strep pneumonia septicaemia | Approved |
pneumococcal conjugate vaccine (pcv13) | immunisation, pneumococcal bacteraemia | Approved |
pneumococcal conjugate vaccine (pcv13) | pneumococcal meningitis, prophylaxis to prevent infection | Approved |
pneumococcal conjugate vaccine (pcv13) | pneumococcus infection, bacteraemia, intensive care admissions, prophylaxis to prevent infection | Approved |
pneumococcal conjugate vaccine (pcv13) | post splenectomy, prophylaxis to prevent infection, adenocarcinoma, Emphysema, severe COPD | Approved |
pneumococcal conjugate vaccine (pcv13) | post transplant reimmunisation, Acute Myeloid Leukaemia, post allo-transplant | Approved |
pneumococcal conjugate vaccine (pcv13) | preventing infection of immunocompromised patient, awaiting renal transplant, renal failure | Approved |
pneumococcal conjugate vaccine (pcv13) | prophylaxis to prevent infection | Approved |
pneumococcal conjugate vaccine (pcv13) | recent ICU for pneumonia, complex effusion/ empyema | Approved |
pneumococcal conjugate vaccine (pcv13) | splenectomy | Approved |
pneumococcal conjugate vaccine (pcv13) | Streptococcus pneumoniae infection, meningitis, monoclonal gammopathy, Septic arthritis, smouldering myeloma | Approved |
pneumococcal polysaccaride vaccine | acute leukamia post bone marrow transplant, preventing infection of immunocompromised patient | Approved |
pneumococcal polysaccaride vaccine | pneumococcal meningitis, prophylaxis to prevent infection | Approved |
pneumococcal polysaccaride vaccine | pneumococcus infection, bacteraemia, intensive care admissions, prophylaxis to prevent infection | Approved |
pneumococcal polysaccaride vaccine | post allogeneic stem cell transplant | Approved |
pneumococcal polysaccaride vaccine | post allogeneic stem cell transplant | Approved |
pneumococcal polysaccaride vaccine | preventing infection of immunocompromised patient, awaiting renal transplant, renal failure | Approved |
pneumococcal polysaccharide conjugate vaccine 13 | post allogeneic stem cell transplant | Approved |
pneumococcal polysaccharide vaccine 13 (Prevenar 13) | compound skull fracture, prophylaxis | Approved |
pneumococcal polysaccharide vaccine 23 (Pneumovax 23) | prophylaxis, compound skull fracture | Approved |
poly(hexamethylenebiguanide) hydrochloride | acanthamoeba keratitis | Approved |
poly(hexamethylenebiguanide) hydrochloride | acanthamoeba keratitis | Approved |
poly(hexamethylenebiguanide) hydrochloride | acanthamoeba keratitis | Approved |
poly(hexamethylenebiguanide) hydrochloride | acanthamoeba keratitis | Approved |
poly(hexamethylenebiguanide) hydrochloride | acanthamoeba keratitis, pellucid marginal degeneration | Approved |
polyethylene glycol | chronic constipation, restricted diet due to food allergies | Approved |
polyethylene glycol | chronic constipation, restricted diet due to food allergies | Approved renewal |
polyethylene glycol | chronic constipation, restricted diet due to food allergies | Approved renewal |
polyethylene glycol | corneal ulcers, brain stem schwanoma, facial nerve palsy | Approved |
pomalidomide | Myeloma, epilepsy | Declined |
ponatinib | Chronic Myeloid Leukaemia, T315l mutation, asbestosis, Pleural Effusion | Declined |
ponatinib | Philadelphia positive acute lymphoblastic leukemia, T315l mutation | Declined |
ponatinib | Philidelphia positive ALL, T315l mutation | Declined |
posaconazole | adverse reaction to voriconazole, Pulmonary Aspergillosis, chronic lymphocytic leukaemia | Approved |
posaconazole | Altenaria sp. infection, adverse reaction to alternatives, post renal transplant | Approved |
posaconazole | aspergillus bronchitis, Cystic fibrosis | Approved |
posaconazole | bronchopulmonary aspergillosis, Unable to tolerate funded medicaton | Approved renewal |
posaconazole | BSLT for sarcoidosis, aspergillus in lung | Approved |
posaconazole | BSLT for sarcoidosis, aspergillus in lung | Approved renewal |
posaconazole | fungal prophylaxis, Graft Versus Host Disease, Stem Cell Transplant | Approved |
posaconazole | fungal prophylaxis, Graft Versus Host Disease, Stem Cell Transplant | Approved renewal |
posaconazole | high risk of infection, adverse reaction to voriconazole, Invasive Aspergillus infection, post lung transplant, stent surgery planned | Approved |
posaconazole | Invasive Aspergillosis, intolerance to alternatives, post lung transplant | Approved |
posaconazole | invasive fungal infection, severe pulmonary haemorrhage | Approved |
posaconazole | invasive rhino-cerebral mucormycosis, Rhizopus oryzae infection, acute kidney injury, adverse reaction to alternatives, hepato-renal syndrome | Approved |
posaconazole | mucormycosis, acute kidney injury | Approved |
posaconazole | paecilomyces lung infection | Approved |
posaconazole | prophylaxis antifungal, Post Liver Transplant, Severe Aplastic Anaemia | Approved |
posaconazole | Pulmonary Aspergillosis, Acute Lymphoblastic Leukaemia, immunosuppressed secondary to chemotherapy | Approved |
posaconazole | pulmonary mucomycosis, leukaemia | Approved |
posaconazole | recurrent aspergillus infection, adverse reaction to voriconazole, chronic lung allograft dysfunction (CLAD), Cystic Fibrosis | Approved |
potassium chloride | Bartter syndrome, Gitelman's syndrome | Approved |
potassium chloride | brainstem infarct, Cardiomyopathy, gastrostomy, locked-in syndrome, PEG feeding | Approved |
potassium chloride | cystinosis, hypokalaemia, renal fanconi syndrome, failure to thrive, global development delay | Approved |
potassium chloride | cystinosis, hypokalaemia, renal fanconi syndrome, failure to thrive, global development delay | Approved renewal |
potassium chloride | Gitelman's syndrome, pregnancy | Approved |
potassium chloride | Gitelman's syndrome, pregnancy | Approved renewal |
potassium chloride | hypokalaemia , enlarged left kidney, pulmonary hypoplasia, renal dysplasia right kidney, severe pelvicalyceal dilatation | Approved |
potassium chloride | hypokalaemia, atrial fibrillation, CHF, gout, hypertension, previous CVA, temporal arteritis | Approved |
potassium chloride | hypokalaemia, chronic peritoneal dialysis, end-stage renal failure, hypoxic ischemic injury | Approved |
potassium chloride | hypokalaemia, enlarged left kidney, pulmonary hypoplasia, renal dysplasia right kidney, severe pelvicalyceal dilatation | Approved |
potassium chloride | hypokalaemia, ileostomy, Total Colectomy | Approved |
potassium chloride | hypokalaemia, J tube feeding requires dispersible tab, PEG tube drainage | Approved |
potassium chloride | hypokalaemia, Kearns Sayres, mitochondrial disorder, renal disease | Approved renewal |
potassium citrate | cystinuria | Approved |
potassium citrate | cystinuria | Approved |
potassium citrate | distal renal tubular acidosis, severe hypokalaemia, renal stones, sjogrens syndrome | Approved |
potassium citrate | distal renal tubular acidosis, severe hypokalaemia, renal stones, sjogrens syndrome | Approved renewal |
potassium citrate | electrolyte imbalance, chronic kidney disease, Cystinosis, Growth Failure | Approved renewal |
potassium citrate | electrolyte imbalance, chronic kidney disease, Growth Failure, nephropathic cystinosis | Approved renewal |
potassium citrate | hypercalciuria, Hyperoxaluria, recurrent nephrolithiasis | Approved |
potassium citrate | hypocalcaemia, hypocitraturia, Ankylosing spondylitis, chronic kidney disease, dyslipidaemia, hypertension, nephrolithiasis, Ulcerative Colitis | Approved |
potassium citrate | hypocitraturia, nephrolithiasis, Alagille's syndrome, chronic kidney disease, Chronic Liver Disease, hypersplenism | Approved |
potassium citrate | hypocitraturia, recurrent nephrolithiasis | Approved |
potassium citrate | hypocitraturia, recurrent nephrolithiasis, dyslipidaemia, hypertension, intolerance to alternatives | Approved |
potassium citrate | hypocitraturia, recurrent nephrolithiasis, dyslipidaemia, hypertension, intolerance to alternatives | Approved renewal |
potassium citrate | hypocitraturia, recurrent nephrolithiasis, dyslipidaemia, hypertension, intolerance to alternatives | Approved renewal |
potassium citrate | kidney stone, hypercalciuria, Hyperoxaluria, hypocitraturia | Approved |
potassium citrate | kidney stone, hypercalciuria, Hyperoxaluria, hypocitraturia | Approved |
potassium citrate | kidney stone, hypercalciuria, Hyperoxaluria, hypocitraturia | Approved renewal |
potassium citrate | kidney stone, hypercalciuria, Hyperoxaluria, hypocitraturia | Approved renewal |
potassium citrate | nephrocalcinosis, developmental delay, Genetic testing re undiagnosed syndrome, hearing loss, hypercalciuria presumed idiopathic, short stature | Approved |
potassium citrate | Proximal tubular acidosis, arthrogryposis renal dysfunction cholestasis syndrome | Approved |
potassium citrate | recurrent nephrolithiasis, Dent's disease | Approved |
potassium citrate | renal dysplasia | Approved |
potassium citrate | renal dysplasia | Approved renewal |
potassium citrate | renal dysplasia | Approved renewal |
potassium citrate | uric acid renal stone | Approved |
potassium dihydrogen phosphate | osteopaenia of prematurity | Approved |
potassium dihydrogen phosphate | osteopenia of prematurity | Approved |
potassium perchlorate | amiodarone induced thyrotoxicosis, paroxysmal af | Approved |
prasugrel | cerebral aneurysm, clopidogrel resistance, stent implant | Approved |
prasugrel | clopidogrel resistance, inracranial aneurysm requiring stent, breast carcinoma | Approved |
prasugrel | clopidogrel resistance, inracranial aneurysm requiring stent, breast carcinoma | Approved renewal |
prasugrel | clopidogrel resistance, intracranial stent | Approved |
prasugrel | intracranial stent thrombosis | Approved |
prednisolone | atypical CNS inflammatory disorder, polymyalgia rheumatica, diabetes type 2, previous DVT | Approved renewal |
prednisolone | decompensating corneal graft, epitheliopathy, previous graft rejection | Approved |
prednisolone | decompensating corneal graft, epitheliopathy, previous graft rejection | Approved renewal |
prednisolone | eczema, epilepsy, florrid dermatitis, intellectual disability | Approved |
prednisolone | mucous build up, eosinophilic oesophagitis, PEG feeding | Approved |
prednisolone | nephrotic syndrome, Cornelia de Lange syndrome, gastrostomy feeding, Severe cerebral palsy, unable to swallow, wheelchair bound | Approved |
prednisolone | nephrotic syndrome, Cornelia de Lange syndrome, gastrostomy feeding, Severe cerebral palsy, unable to swallow, wheelchair bound | Approved renewal |
prednisolone | oesophageal cancer, Hypothyroidism, palliative care | Approved |
prednisolone | polymyalgia rheumatica, Crohn's diease, ileostomy | Approved |
prednisolone | polymyalgia rheumatica, diabetes type 2, previous DVT | Approved |
prednisolone | polymyalgia rheumatica, diabetes type 2, previous DVT | Approved renewal |
prednisolone | rectal bleeding, developmental delay, severe crohn's disease, Total Colectomy | Approved |
prednisolone eye drops | chronic keratinisation of lid margins, common variable immunodeficiency, keratopathy, vernal blepharoconjunctivitis | Approved |
prednisolone eye drops | linear IgA dermatosis, cicatricial conjunctivitis | Approved |
prednisolone minims | chronic blepharo kerato conjuntivitis | Approved renewal |
prednisolone minims | chronic blepharo kerato conjuntivitis | Approved renewal |
prednisolone minims | corneal decompensation, ocular inflammation, glaucoma | Approved renewal |
prednisolone minims | keratitis | Approved |
prednisolone sodium phosphate | allergic eye disease, corneal ulcers, Herpes Simplex Keratitis | Approved |
prednisolone sodium phosphate | allergic eye disease, corneal ulcers, Herpes Simplex Keratitis | Approved renewal |
prednisolone sodium phosphate | atopic keratoconjunctivitis | Approved |
prednisolone sodium phosphate | atopic keratoconjunctivitis | Approved renewal |
prednisolone sodium phosphate | chronic blepharo kerato conjuntivitis | Approved |
prednisolone sodium phosphate | chronic blepharo kerato conjuntivitis | Approved |
prednisolone sodium phosphate | corneal decompensation, ocular inflammation, glaucoma | Approved |
prednisolone sodium phosphate | ocular surface inflammatory disease, Failed corneal transplant | Approved |
prednisolone sodium phosphate | Penetrating keratoplasty, topical preservative sensitivity | Approved |
prednisolone sodium phosphate | Ulcerative Colitis, ileostomy bag, Nephrotic Syndrome | Approved renewal |
pregabalin | chronic neuropathic pain, chronic musculoskeletal pain, intermittant visceral pain, pompe disease, respiratory failure | Approved |
pregabalin | chronic pain syndrome | Approved |
pregabalin | generalised pain, mucolipidosis type 3, Neuropathic pain | Declined |
pregabalin | low grade malignant nerve sheath tumour, neuropathic pain | Approved |
pregabalin | Neuropathic pain, bronchiectasis, dystonia, global development delay, kernicterus, scoliosis, spasticity | Approved |
pregabalin | pain, schwannomatosis | Approved |
premature birth formula (S-26 LBW Gold RTF) | Premature birth | Approved |
primaquine | malaria | Approved |
primidone | epilepsy, asthma, hypertension, osteoporosis, post polio exhaustion | Approved renewal |
pristinamycin | Methicillin-resistant Staphylococcus aureus | Approved |
pristinamycin | Methicillin-resistant Staphylococcus aureus | Approved renewal |
pristinamycin | multidrug-resistant organism, mycoplasma genitalium infection | Approved |
pristinamycin | mycoplasma genitalium infection | Approved |
pristinamycin | mycoplasma genitalium infection | Approved |
pristinamycin | mycoplasma genitalium infection | Approved |
progesterone | cervical incompetence | Approved |
progesterone | cervical incompetence, risk of pre-term labour | Approved |
progesterone | history of preterm labour | Approved |
progesterone | history of preterm labour, pregnant, Previous LLETZ | Approved |
progesterone | Prevent miscarriage, twin pregnancy | Approved |
progesterone | prevention of preterm labour, allergy to alternatives | Approved |
progesterone | recurrent previous miscarraige | Approved |
progesterone | risk of pre-term labour | Approved |
progesterone | risk of pre-term labour | Approved |
progesterone | risk of pre-term labour | Approved |
progesterone | risk of pre-term labour, cervical incompetence, short cervix | Approved |
progesterone | risk of pre-term labour, pregnant, previous miscarraige, short cervix | Approved |
progesterone | short cervix | Approved |
progesterone | short cervix, risk of pre-term labour | Approved |
progesterone | threatened premature labour | Approved |
progesterone | threatened premature labour, Bicornuate Uterus, Two Cervices | Approved |
progesterone | threatened premature labour, history of preterm labour, pregnant | Approved |
progesterone | threatened premature labour, history of preterm labour, pregnant | Approved |
progesterone | threatened premature labour, history of preterm labour, previous still birth | Approved |
progesterone | threatened premature labour, pregnant, short cervix | Approved |
progesterone (Utrogestan) | cervical incompetence | Approved |
progesterone (Utrogestan) | risk of pre-term labour, short cervix | Approved |
progesterone (Utrogestan) | threatened premature labour, cervical incompetence, history of preterm labour | Approved |
progesterone pessary | cancer of cervix, history of preterm labour | Approved |
progesterone pessary | history of preterm labour | Approved |
progesterone pessary | history of preterm labour | Approved |
progesterone pessary | history of preterm labour | Approved |
progesterone pessary | recurrent previous miscarraige | Approved |
progesterone pessary | risk of pre-term labour | Approved |
progesterone pessary | risk of pre-term labour | Approved |
progesterone pessary | risk of pre-term labour | Approved |
progesterone pessary | risk of pre-term labour | Approved |
progesterone pessary | risk of pre-term labour, cervical incompetence | Approved |
progesterone pessary | risk of pre-term labour, cervical incompetence, short cervix | Approved |
progesterone pessary | risk of pre-term labour, history of preterm labour, short cervix | Approved |
progesterone pessary | risk of pre-term labour, ovarian torsion | Approved |
progesterone pessary | risk of pre-term labour, short cervix | Approved |
progesterone pessary | short cervix | Approved |
progesterone pessary | twin pregnancy, history of preterm labour, short cervix | Approved |
propranolol | atrial flutter, Cardiomyopathy | Approved |
propranolol | cardiac arrhythmias, Hypertrophic cardiomyopathy | Approved |
propranolol | Cardiomyopathy, arrhythmia | Approved |
propranolol | congenital cardiac condition, Premature birth, tetralogy of fallot | Approved |
propranolol | haemangioma | Approved |
propranolol | haemangioma | Approved |
propranolol | infantile haemangioma | Approved |
propranolol | infantile haemangioma | Approved |
propranolol | infantile haemangioma | Approved |
propranolol | infantile haemangioma | Approved |
propranolol | infantile haemangioma | Approved |
propranolol | infantile haemangioma | Approved |
propranolol | infantile haemangioma | Approved |
propranolol | infantile haemangioma | Approved |
propranolol | infantile haemangioma | Approved |
propranolol | infantile haemangioma | Approved |
propranolol | infantile haemangioma | Approved |
propranolol | infantile haemangioma, laryngomaiacia | Approved |
propranolol | infantile haemangioma, rectal bleeding | Approved |
propranolol | long QT syndrome | Approved |
propranolol | paroxysmal supraventricular tachycardia | Approved |
propranolol | Recurrent SVT | Approved |
propranolol | subglottic haemangioma | Approved |
propranolol | SVT | Approved |
propranolol | tetralogy of fallot | Approved |
propranolol | atrial tachycardias, supraventricular tachycardia | Approved |
propranolol | congenital cardiac condition, Premature birth, tetralogy of fallot | Approved |
propranolol | infantile haemangioma | Approved |
propranolol | infantile haemangioma | Approved |
propranolol | infantile haemangioma, skin ulceration | Approved |
propranolol | infantile haemangioma | Approved |
prothionamide | MDR tuberculosis | Approved |
prothionamide | multidrug-resistant tuberculosis | Approved |
pseudoephedrine hydrochloride | severe postural hypotension, autonomic dysreflexia, tetraplegia | Approved renewal |
pseudoephidrine hydrochloride | severe postural hypotension, autonomic dysreflexia, tetraplegia | Approved |
pyridoxal 5 phosphate | epileptic encephalopathy, infantile spasms | Approved |
pyridoxal 5-phosphate | brain malformation, epilepsy, Epileptic encephalopathy, global development delay, medically refractory seizures | Approved |
pyridoxal 5-phosphate | Epileptic encephalopathy, cognitive delay, refractory epilepsy | Approved |
pyridoxal 5-phosphate | Epileptic encephalopathy, epilepsy, global development delay | Approved |
pyridoxal 5-phosphate | Epileptic encephalopathy, epilepsy, global development delay | Approved |
pyridoxal 5-phosphate | Epileptic encephalopathy, epilepsy, global development delay | Approved renewal |
pyridoxal 5-phosphate | Epileptic encephalopathy, epilepsy, global development delay | Approved renewal |
pyridoxal 5-phosphate | epileptic encephalopathy, possible PNPO deficiency, nasogastric tube | Approved |
pyridoxal 5-phosphate | global development delay, Intractable Epilepsy, visual impairment | Approved |
pyridoxal 5-phosphate | infantile spasms, global development delay, refractory seizures | Approved |
pyridoxal 5-phosphate | refractory epilepsy, global development delay | Approved |
pyridoxal 5-phosphate | refractory epilepsy, global development delay, severe movement disorder | Approved |
pyrimethamine | acute lymphoblastic leukemia post unrelated transplant, toxoplasmosis prophylaxis | Approved |
pyrimethamine | acute ocular toxoplasmosis | Approved |
pyrimethamine | AML, Graft Versus Host Disease, neutropenia | Approved |
pyrimethamine | cerebral toxoplasmosis, bone marrow transplant, Congenital Immune Deficiency, immunocompromised | Approved |
pyrimethamine | Cerebral toxoplasmosis, Glioblastoma Multiforme | Approved |
pyrimethamine | Cerebral toxoplasmosis, Glioblastoma Multiforme | Approved renewal |
pyrimethamine | cerebral toxoplasmosis, Ocular Toxoplasmosis, immunocompetent | Approved |
pyrimethamine | prophylaxis of toxoplasmosis, graft vs host disease post bone marrow transplant | Approved |
pyrimethamine | toxoplasmosis prophylaxis, abnormal liver function tests, chronic graft versus host disease, graft vs host disease, matched unrelated donor transplant, post stem cell transplant, Thrombocytopaenia | Approved |
quinacrine | refractory giardiasis | Approved |
quinacrine | SLE, Arthritis, Hashimoto's thyroiditis, Severe photosensitive rash | Approved renewal |
quinacrine | SLE, Arthritis, Hashimoto's thyroiditis, Severe photosensitive rash | Approved renewal |
quinacrine | systemic lupus erythematosus, epilepsy, steroid sparing agent | Approved |
quinacrine | systemic lupus erythematosus, epilepsy, steroid sparing agent | Approved renewal |
quinacrine | systemic lupus erythematosus, epilepsy, steroid sparing agent | Approved renewal |
quinacrine | treatment resistant recurrent giardiasis | Approved |
quinacrine (aka mepacrine) | SLE, Arthritis, Hashimoto's thyroiditis, Severe photosensitive rash | Approved |
quinidine | brugada syndrome, inflammatory bowel disease | Approved |
quinidine | early repolarisation syndrome, ventricular arrhythmias, cardiac arrest | Approved |
quinidine | implantable cardioverter defribrillator (ICD), ventricular fibrillation | Approved |
quinidine | ventricular arrhythmias, brugada syndrome, implantable cardioverter defribrillator (ICD) | Approved |
quinidine | ventricular arrhythmias, brugada syndrome, implantable cardioverter defribrillator (ICD) | Approved renewal |
quinidine | ventricular fibrillation, brugada syndrome | Approved |
quinidine | ventricular fibrillation, coronary disease, implanted cardiac defibrillator, prolonged QT | Approved |
raltitrexed | 5FU/Capecitabine induced angina, adenocarcinoma of the colon, ischaemic heart disease | Approved |
raltitrexed | 5FU/Capecitabine induced angina, metastatic rectal cancer | Approved |
raltitrexed | 5FU/Capecitabine induced angina, metastatic rectal cancer | Approved |
raltitrexed | 5FU/Capecitabine induced angina, metastatic rectal cancer | Approved renewal |
raltitrexed | adenocarcinoma of the colon | Approved |
raltitrexed | Metastatic colon cancer with widespread peritoneal disease | Approved |
raltitrexed | rectal adenocarcinoma, cardiotoxicity with capecitabine, stage IV | Approved |
raltitrexed | rectal cancer, 5FU/Capecitabine induced angina | Approved |
ranibizumab | diabetic macular oedema | Approved |
ranibizumab | diabetic macular oedema | Approved renewal |
ranibizumab | diabetic macular oedema | Approved renewal |
reboxetine | ADHD, Borderline Personality disorder, Depressive disorder | Approved |
regorafenib | GIST, gastrointestinal stromal tumour, metastatic tumours | Declined |
ribavirin | acquired via infected blood, chronic hepatitis C | Approved |
ribavirin | cHCV | Approved |
ribavirin | chronic hepatitis C | Approved |
ribavirin | chronic hepatitis C | Approved |
ribavirin | chronic hepatitis C | Approved |
ribavirin | chronic hepatitis C | Approved |
ribavirin | chronic hepatitis C | Approved renewal |
ribavirin | Chronic hepatitis C decompensated cirrhosis (Genotype 1) | Approved |
ribavirin | chronic Hepatitis C genotype 3 | Approved |
ribavirin | chronic Hepatitis C genotype 3, cirrhosis | Approved |
ribavirin | chronic Hepatitis C genotype 3, liver cirrhosis | Approved |
ribavirin | chronic Hepatitis C genotype 3, liver cirrhosis | Approved renewal |
ribavirin | chronic Hepatitis C genotype 3A, cirrhosis, mood instability, post-traumatic epilepsy | Approved |
ribavirin | chronic Hepatitis C genotype 3A, oesophageal varices | Approved |
ribavirin | chronic Hepatitis C genotype 3A, oesophageal varices | Approved renewal |
ribavirin | chronic hepatitis C, chronic pain, Depression, oesophageal varices | Approved |
ribavirin | chronic hepatitis C, cirrhosis | Approved |
ribavirin | chronic hepatitis C, cirrhosis | Approved |
ribavirin | chronic hepatitis C, cirrhosis, biliary anastomic leak, hepatic artery stenosis, Post Liver Transplant | Approved |
ribavirin | chronic hepatitis C, cryoglobulinaemia | Approved |
ribavirin | chronic hepatitis C, cryoglobulinaemia, renal impairment | Approved |
ribavirin | chronic hepatitis C, decompensated liver cirrhosis | Approved |
ribavirin | chronic hepatitis C, decompensated liver cirrhosis, genotyoe 1 | Approved |
ribavirin | chronic hepatitis C, decompensated liver cirrhosis, HCC | Approved |
ribavirin | chronic hepatitis C, decompensated liver function, hepatic encephalopathy, Recent septic right hip due to osteoarthritis | Approved |
ribavirin | chronic hepatitis C, decompensated liver function, hepatic encephalopathy, Recent septic right hip due to osteoarthritis | Approved renewal |
ribavirin | chronic hepatitis C, Depressive disorder | Approved |
ribavirin | chronic hepatitis C, genotype 1 | Approved |
ribavirin | chronic hepatitis C, genotype 1 | Approved |
ribavirin | chronic hepatitis C, genotype 1 | Approved renewal |
ribavirin | chronic hepatitis C, hepatic encephalopathy, variceal bleeding | Approved |
ribavirin | chronic hepatitis C, Hepatitis B, hypertension, post liver transplant diabetes, Ulcerative Colitis | Approved |
ribavirin | chronic hepatitis C, Post Liver Transplant, renal dysfunction | Approved |
ribavirin | chronic norovirus infection, chronic diarrhoea, Weight Loss | Approved |
ribavirin | decompensated HCV cirrhosis | Approved |
ribavirin | genotype 1 hepatitis C, liver cirrhosis | Approved |
ribavirin | Hepatitis C | Approved |
ribavirin | Hepatitis C | Approved |
ribavirin | Hepatitis C | Approved |
ribavirin | Hepatitis C | Approved |
ribavirin | Hepatitis C | Approved |
ribavirin | Hepatitis C | Approved |
ribavirin | hepatitis C virus cirrhosis | Approved |
ribavirin | hepatitis C virus cirrhosis, cryoglobulinaemia | Approved |
ribavirin | hepatitis C virus cirrhosis, HIV infection | Approved |
ribavirin | Hepatitis C, cirrhosis, liver transplant | Approved |
ribavirin | Hepatitis C, cryoglobulinaemia, MGUS, rheumatoid arthritis | Approved |
ribavirin | recurrent hepatitis C virus | Approved |
ribavirin | recurrent hepatitis C virus, liver transplant | Approved |
ribavirin | recurrent hepatitis C virus, liver transplant | Approved |
ribavirin | recurrent hepatitis C virus, Post Liver Transplant | Approved |
riboflavin | Brown-Vialetto-Van Laere Syndrome | Approved |
riboflavin | Brown-Vialetto-Van Laere Syndrome, auditory neuropathy, cerebellar disturbance, ophthalmoplegia | Approved |
riboflavin | Complex 1 deficiency secondary to NUBPL gene mutations, mitochondrial cytopathy | Approved |
riboflavin | Complex 1 deficiency secondary to NUBPL gene mutations, mitochondrial cytopathy | Approved renewal |
riboflavin | Complex 1 deficiency secondary to NUBPL gene mutations, mitochondrial cytopathy | Approved renewal |
riboflavin | MELAS | Approved |
riboflavin | MELAS | Approved renewal |
riboflavin | multiple acyl-coenzyme A dehydrogenase deficiency | Approved |
riboflavin | multiple acyl-coenzyme A dehydrogenase deficiency | Approved |
riboflavin | multiple acyl-coenzyme A dehydrogenase deficiency | Approved renewal |
riboflavin | multiple acyl-coenzyme A dehydrogenase deficiency | Approved renewal |
riboflavin | multiple acyl-coenzyme A dehydrogenase deficiency, severe developmental delay | Approved |
riboflavin | multiple acyl-coenzyme A dehydrogenase deficiency, severe developmental delay | Approved renewal |
riboflavin | possible mitochondrial disorder | Approved renewal |
riboflavin | riboflavin transporter deficiency | Approved |
riboflavin | riboflavin transporter deficiency | Approved |
riboflavin vitamin b2 | ataxia, epilepsy, fatigue, MELAS, mitochondrial cytopathy, Wolff-Parkinson-White syndrome | Approved |
riboflavin vitamin b2 | ataxia, epilepsy, fatigue, MELAS, mitochondrial cytopathy, Wolff-Parkinson-White syndrome | Approved renewal |
riboflavin vitamin b2 | ataxia, epilepsy, fatigue, MELAS, mitochondrial cytopathy, Wolff-Parkinson-White syndrome | Approved renewal |
rifaximin | bacterial infection, gastroschisis, micronutrient deficiency, Short Gut Syndrome, TPN dependent | Approved |
rifaximin | bacterial infection, gastroschisis, micronutrient deficiency, Short Gut Syndrome, TPN dependent | Approved renewal |
rifaximin | Cholangiocarcinoma, hepatic encephalopathy, post-operative biliary stricture | Approved |
rifaximin | Chronic Bacterial Colonisation, gastroschisis, intestinal failure, multiple episodes line sepsis | Approved |
rifaximin | chronic encepholapathy, awaiting liver transplant, cryptogenic cirrhosis | Approved |
rifaximin | chronic hepatic encepholapathy, decompensated liver cirrhosis, hypertension, osteoporosis | Approved |
rifaximin | chronic hepatic encepholapathy, liver failure due to hepatitis C virus cirrhosis | Approved |
rifaximin | cirrhosis, hepatic encephalopathy | Approved |
rifaximin | cirrhosis, hepatic encephalopathy | Approved |
rifaximin | Clostridium Difficile Diarrhoea, bronchiolitis obliterans, diabetes mellitus, Graft vs Host Disease, IgA myeloma, Severe pneumonia | Approved |
rifaximin | end stage liver failure, alcohol abuse, hepatitis C | Approved |
rifaximin | hepatic encephalopathy | Approved |
rifaximin | hepatic encephalopathy | Approved |
rifaximin | hepatic encephalopathy | Approved |
rifaximin | hepatic encephalopathy | Approved |
rifaximin | hepatic encephalopathy | Approved |
rifaximin | hepatic encephalopathy | Approved |
rifaximin | hepatic encephalopathy | Approved |
rifaximin | hepatic encephalopathy | Approved renewal |
rifaximin | hepatic encephalopathy, adenocarcinoma, IVC tear | Approved |
rifaximin | hepatic encephalopathy, alcohol abuse, chronic end stage liver disease, hepatitis C | Approved |
rifaximin | hepatic encephalopathy, alcohol abuse, chronic end stage liver disease, hepatitis C | Approved renewal |
rifaximin | hepatic encephalopathy, alcoholic hepatitis | Approved |
rifaximin | hepatic encephalopathy, alcoholic liver disease | Approved |
rifaximin | hepatic encephalopathy, alcoholic liver disease | Approved renewal |
rifaximin | hepatic encephalopathy, alcoholic liver disease, chronic hepatitis B virus cirrhosis | Approved |
rifaximin | hepatic encephalopathy, alcoholic liver disease, copd, oesophageal varices | Approved |
rifaximin | hepatic encephalopathy, alcoholic liver disease, gastric bypass, gastric ulcer | Approved |
rifaximin | hepatic encephalopathy, alcoholic liver disease, liver cirrhosis | Approved |
rifaximin | hepatic encephalopathy, ALD, cirrhosis | Approved |
rifaximin | hepatic encephalopathy, ALD, diabetes mellitus, HCC, hyperlididaemia, Hypothyroidism | Approved |
rifaximin | hepatic encephalopathy, ascites, liver cirrhosis, Portal Hypertension | Approved |
rifaximin | hepatic encephalopathy, asthma, Cirrhosis, dyslipidaemia, hypertension, ischaemic heart disease, Myasthenia Gravis | Approved |
rifaximin | hepatic encephalopathy, augmentin induced liver injury | Approved |
rifaximin | hepatic encephalopathy, autism spectrum disorder, down's syndrome, end stage liver disease secondary to Hepatitis C | Approved |
rifaximin | hepatic encephalopathy, autism spectrum disorder, down's syndrome, end stage liver disease secondary to Hepatitis C | Approved renewal |
rifaximin | hepatic encephalopathy, autoimmune hepatitis, Cirrhosis | Approved |
rifaximin | hepatic encephalopathy, autoimmune liver disease, autoimmune thyroid disease, Portal Hypertension | Approved |
rifaximin | hepatic encephalopathy, autoimmune liver disease, autoimmune thyroid disease, Portal Hypertension | Approved |
rifaximin | hepatic encephalopathy, autosomal dominant polycystic kidney disease, congenital hepatic fibrosis, Portal Hypertension | Approved |
rifaximin | hepatic encephalopathy, Budd Chiari Syndrome, polycystic kidney disease | Approved |
rifaximin | hepatic encephalopathy, cardiac dysrhythmia, chronic abdominal pain, chronic diarrhoea, diabetes type 2, diabetic retinopathy, diuretic resistant ascites, gout, microalbuminuria, neuropathy, primary myelofibrosis, splenomegaly | Approved |
rifaximin | hepatic encephalopathy, chronic hepatitis C | Approved |
rifaximin | hepatic encephalopathy, chronic renal impairment, HCV cirrhosis, previous CVA | Approved |
rifaximin | hepatic encephalopathy, cirrhosis, hepatitis C, Portal Hypertension, Thrombocytopaenia | Approved |
rifaximin | hepatic encephalopathy, cirrhosis, Portal Hypertension, transplant planned | Approved |
rifaximin | hepatic encephalopathy, cryptogenic cirrhosis | Approved |
rifaximin | hepatic encephalopathy, cryptogenic cirrhosis with diuretic resistant ascites | Approved |
rifaximin | hepatic encephalopathy, decompensated liver cirrhosis, hepatitis C | Approved |
rifaximin | hepatic encephalopathy, decompensated liver cirrhosis, hepatitis C | Approved renewal |
rifaximin | hepatic encephalopathy, diabetes type 2, Hepatitis B, ischa cardio, liver cirrhosis, Non-alcoholic steatohepatitis, renal failure | Approved |
rifaximin | hepatic encephalopathy, diabetes type 2, hernia | Approved |
rifaximin | hepatic encephalopathy, diabetes type 2, hernia | Approved renewal |
rifaximin | hepatic encephalopathy, diuretic resistant ascites, liver cirrhosis, primary biliary cirrhosis, TIPSS | Approved |
rifaximin | hepatic encephalopathy, encephalopathy, GI bleed, Hepatitis B, liver cirrhosis, TIPSS | Approved |
rifaximin | hepatic encephalopathy, end stage liver disease | Approved |
rifaximin | hepatic encephalopathy, end stage liver disease | Approved |
rifaximin | hepatic encephalopathy, end stage liver disease | Approved |
rifaximin | hepatic encephalopathy, end stage liver disease secondary to Hepatitis C | Approved |
rifaximin | hepatic encephalopathy, end stage liver disease secondary to Hepatitis C | Approved renewal |
rifaximin | hepatic encephalopathy, end stage liver disease secondary to Hepatitis C | Approved renewal |
rifaximin | hepatic encephalopathy, end stage liver disease, NASH | Approved |
rifaximin | hepatic encephalopathy, hepatic venous outflow obstruction, post liver transplant, TIPSS | Approved |
rifaximin | hepatic encephalopathy, hepatic venous outflow obstruction, post liver transplant, TIPSS | Approved renewal |
rifaximin | hepatic encephalopathy, hernia, hyponatraemia | Approved |
rifaximin | hepatic encephalopathy, IHD, Liver disease | Approved |
rifaximin | hepatic encephalopathy, liver cirrhosis | Approved |
rifaximin | hepatic encephalopathy, liver cirrhosis | Approved |
rifaximin | hepatic encephalopathy, liver cirrhosis | Approved |
rifaximin | hepatic encephalopathy, liver cirrhosis, multifocal hepatocellular carcinoma | Approved |
rifaximin | hepatic encephalopathy, liver cirrhosis, NASH | Approved |
rifaximin | hepatic encephalopathy, liver cirrhosis, Portal Hypertension | Approved |
rifaximin | hepatic encephalopathy, liver cirrhosis, Portal Hypertension | Approved renewal |
rifaximin | hepatic encephalopathy, liver cirrhosis, TIPSS | Approved |
rifaximin | hepatic encephalopathy, liver failure due to hepatitis C virus cirrhosis | Approved |
rifaximin | hepatic encephalopathy, Liver Failure, post liver transplant | Approved |
rifaximin | hepatic encephalopathy, Portal Hypertension | Approved |
rifaximin | hepatits C virus cirrhosis, Liver Failure | Approved |
rifaximin | hepatits C virus cirrhosis, Liver Failure | Approved renewal |
rifaximin | recurrent clostidium difficile infection, bronchiectasis, cerebral palsy, gastro tube fed, gastro-oesophageal reflux disease, spastic quadriplegia | Approved |
rifaximin | recurrent severe hepatic encephalopathy, hepatitis C, Liver Transplant | Approved |
rifaximin | small intestinal bacterial overgrowth | Approved |
rifaximin | small intestinal bacterial overgrowth, gastroschisis, micronutrient deficiency, Short Gut Syndrome, TPN dependent | Approved renewal |
rituximab | acute neuromyelitis optica | Approved |
rituximab | amegakaryocytic thrombocytopaenia, diabetes, hyperlipidaemia, hypertension, retinopathy | Approved |
rituximab | ANCA negative, pauci immune crescentic glomerulonephritis | Approved |
rituximab | ANCA positive vasculitis, bronchiectasis, squamous cell skin cancer | Approved |
rituximab | ANCA positive vasculitis, granulomatous polyangiitis, Wegener's Granulomatosis | Approved |
rituximab | ANCA positive vasculitis, PR3-positive, Autoimmune hypothyroidism, diabetes type 1, focal glomerulonephritis, recurrent pulmonary haemorrhage, relapse on mycophenolate | Approved |
rituximab | Anti Hu associated paraneoplastic encephalitis, sensory neuropathy, ovarian carcinoma | Approved |
rituximab | antibody mediated, lung transplant rejection | Approved |
rituximab | anti-nmda receptor encephalitis | Approved |
rituximab | anti-nmda receptor encephalitis | Approved |
rituximab | antisynthetase syndrome, asthma, hypertension, multiple PE | Approved renewal |
rituximab | antisynthetase syndrome, dermatomyositis, interstitial lung disease | Approved |
rituximab | antisynthetase syndrome, respiratory involvement | Approved |
rituximab | autoimmune encephalomyelitis, Neuroblastoma, sensory neuropathy | Approved |
rituximab | autoimmune haemolytic anaemia | Approved |
rituximab | autoimmune haemolytic anaemia, Atrial fibrillation, Renal Impairment | Approved |
rituximab | autoimmune haemolytic anaemia, chronic leg ulcers | Approved |
rituximab | autoimmune haemolytic anaemia, Chronic Liver Disease, jaundice, Portal Hypertension | Approved |
rituximab | autoimmune haemolytic anaemia, chronic lympocytic leukaemia | Approved |
rituximab | autoimmune haemolytic anaemia, diabetes, NHL | Approved |
rituximab | autoimmune haemolytic anaemia, evans syndrome, Refractory ITP | Approved |
rituximab | autoimmune haemolytic anaemia, Pancytopenia, relapsed hairy cell leukaemia | Approved |
rituximab | autoimmune haemolytic anaemia, previous CLL | Approved |
rituximab | autoimmune hepatitis, systemic lupus erythematosus | Approved |
rituximab | autoimmune limbic encephalitis, GABA-B receptor antibody mediated | Approved |
rituximab | autoimmune neutropaenia, ITP | Approved |
rituximab | autoimmune pancreatitis, IgG4 related disease, myocarditis, diabetes type 2, hepatosteatosis, HLA B27 uveitis | Approved |
rituximab | autoimmune retinopathy | Approved |
rituximab | autoimmune retinopathy, punctate inner choroidopathy | Approved |
rituximab | CANOMAD: Chronic Ataxic Neuropathy Ophthalmoplegia IgM paraprotein cold Agglutinins Disialosyl antibodies | Approved renewal |
rituximab | cerebral vasculitis | Approved |
rituximab | chronic graft versus host disease, Sclerodermoid chronic graft-versus-host disease, AML, matched unrelated stem cell transplant, Scleroderma | Approved |
rituximab | chronic immune mediated thrombocytopaenia, diabetes type 2, Leiomyosarcoma, thymoma | Approved |
rituximab | chronic inflammatory demyelinating polyneuropathy | Approved |
rituximab | chronic inflammatory demyelinating polyneuropathy | Approved |
rituximab | chronic lymphocytic leukaemia, autoimmune haemolytic anaemia | Approved |
rituximab | cicatricial pemphigoid | Approved |
rituximab | cicatricial pemphigoid | Approved renewal |
rituximab | cicatricial pemphigoid, severe ocular cicatricial | Approved |
rituximab | cicatricial pemphigoid, severe ocular cicatricial, ulceration of mouth | Approved |
rituximab | cold agglutinin disease requiring regular transfusions | Approved |
rituximab | cold haemagglutinin disease | Approved |
rituximab | cold haemagglutinin disease | Approved |
rituximab | cold haemagglutinin disease, congestive heart failure | Approved |
rituximab | cryoglobulinaemic vasculitis, Hepatitis C | Approved |
rituximab | diffuse scleroderma, Severe Polyarticular Arthritis, interstitial lung disease, intolerence to Humira | Approved |
rituximab | fibrillary glomerulonephritis, diabetes type 2, dyslipidaemia, hypertension, paroxysmal af | Approved |
rituximab | Focal Segmental Glomerulosclerosis, post kidney transplant, immunosuppression post transplant, intolerance to funded alternative, proteinuria | Approved |
rituximab | Follicular bronchiolitis, polynesian castlemans disease, idiopathic plasmacytic lymphadenopathy | Approved |
rituximab | follicular non-hodgkin's lymphoma, lymphoma, relapsed lymphoma | Approved |
rituximab | glomerulonephritis, JAK-2 positive, Myeloproliferative disorder | Approved |
rituximab | granulomatous angiitis of CNS, primary cerebral vasculitis | Approved |
rituximab | granulomatous angiitis of CNS, primary cerebral vasculitis | Approved renewal |
rituximab | granulomatous polyangiitis, GORD, hypertension, renal impairment | Approved |
rituximab | granulomatous polyangiitis, neutropenia, subglottic stenosis | Approved |
rituximab | Graves' thyrotoxicosis, thyroid-related orbitopathy, thyroidectomy | Approved |
rituximab | GvHD, acute lymphoblastic leukaemia, membranous nephropathy, post stem cell transplant, pulmonary fibrosis | Approved |
rituximab | GvHD, fasciitis, steroid refractory, synovitis, T cell lymphoma | Approved |
rituximab | GvHD, fasciitis, steroid refractory, synovitis, T cell lymphoma | Approved renewal |
rituximab | haemophagocytic lymphocytosis, high epstein�Barr virus load, Hodgkin's lymphoma | Approved |
rituximab | Hodgkin's lymphoma | Approved |
rituximab | Hyper IgG4 disease | Approved |
rituximab | idiopathic thrombocytopaenic purpura, SLE | Approved |
rituximab | IgG4 related disease | Approved |
rituximab | immune thrombocytopaenia, renal impairment | Approved |
rituximab | immune thrombocytopaenic purpura | Approved |
rituximab | immune thrombocytopaenic purpura, anaemia of chronic renal disease, cognitive impairment, hyperuricaemia, Myocardial Infarction | Approved |
rituximab | immune thrombocytopaenic purpura, diabetes type 2, dyslipidaemia, hypertension, steatohepatitis | Approved |
rituximab | immune thrombocytopaenic purpura, osteopenia | Approved |
rituximab | ITP | Approved |
rituximab | ITP, bleeding problems | Approved |
rituximab | membranoproliferative glomerulonephritis, recurrent disease, ESRF, post kidney transplant, steroid resistance | Approved |
rituximab | membranous glomerulonephritis, Nephrotic Syndrome | Approved renewal |
rituximab | mucous membrane pemphigoid | Approved |
rituximab | multicentric castlemans disease | Approved |
rituximab | multicentric castlemans disease | Approved renewal |
rituximab | Myasthenia Gravis | Approved |
rituximab | Myasthenia Gravis | Approved |
rituximab | Myasthenia gravis | Approved |
rituximab | Myasthenia gravis | Approved renewal |
rituximab | NEMO immune deficiency, chronic GvH post BMT, EBV encephalitis, EBV viremia | Approved |
rituximab | nephrotic syndrome, Focal Segmental Glomerulosclerosis, post renal transplant | Approved |
rituximab | nephrotic syndrome, severe recurrent membranous nephropathy, Second renal transplant | Approved |
rituximab | nephrotic syndrome, steroid resistance | Approved |
rituximab | neuromyelitis optica | Approved |
rituximab | neuromyelitis optica | Approved |
rituximab | neuromyelitis optica | Approved |
rituximab | neuromyelitis optica | Approved |
rituximab | neuromyelitis optica | Approved renewal |
rituximab | neuromyelitis optica, aquarporin-4 antibody positive | Approved |
rituximab | Neurosarcoidosis, Cauda Equina syndrome, Gadolinium enhancement of the lower spinal cord | Approved |
rituximab | Neurosarcoidosis, Cauda Equina syndrome, Gadolinium enhancement of the lower spinal cord | Approved renewal |
rituximab | Neurosarcoidosis, Cauda Equina syndrome, Gadolinium enhancement of the lower spinal cord | Approved renewal |
rituximab | neurosarcoidosis, pancytopaenia, paraparesis | Approved |
rituximab | nmda receptor encephalitis | Approved |
rituximab | nmda receptor encephalitis | Approved |
rituximab | nmda receptor encephalitis | Approved |
rituximab | nmda receptor encephalitis | Approved |
rituximab | opsoclonus myoclonus syndrome | Approved |
rituximab | orbital disease, sinus IgG4 related disease | Approved |
rituximab | orbital disease, sinus IgG4 related disease | Approved renewal |
rituximab | pemphigus vulgaris | Approved |
rituximab | Pemphigus Vulgaris | Approved |
rituximab | pemphigus vulgaris, diabetes type 2, hypertension, Morbid Obesity, previous hepatitis B | Approved |
rituximab | post transplant GvHD, Sclerodermoid chronic graft-versus-host disease | Approved |
rituximab | primary cerebral vasculitis, coeliac disease | Approved |
rituximab | pulmonary rheumatoid nodules, risk of further lung collapse | Approved |
rituximab | pulmonary rheumatoid nodules, risk of further lung collapse | Approved renewal |
rituximab | pure red cell aplasia secondary to chronic lymphocytic leukaemia | Approved |
rituximab | pure red cell aplasia secondary to chronic lymphocytic leukaemia | Approved |
rituximab | Rasmussen's encephalitis, focal seizures | Approved |
rituximab | Rasmussen's encephalitis, focal seizures | Approved renewal |
rituximab | recurrent severe GVHD | Approved |
rituximab | Refractory ITP, obesity, SLE | Approved |
rituximab | refractory myasthenia gravis | Approved |
rituximab | refractory myasthenia gravis | Approved renewal |
rituximab | relapsed chronic lymphocytic leukaemia, febrile | Approved |
rituximab | relapsed hairy cell leukaemia, legionella pneumonia | Approved |
rituximab | relapsing remitting Multiple Sclerosis | Declined |
rituximab | Rheumatoid Arthritis, felty's syndrome, latent cmv infection, Pancytopenia | Approved |
rituximab | rheumatoid vasculitis, Painful Leg Ulcers, peripheral ulcerative keratitis | Approved |
rituximab | scleroderma related interstitial lung disease | Approved |
rituximab | Sclerodermatous graft versus host disease post allogeneic stem cell transplant failing multiple lines of immunosuppression, Burkitt lymphoma, diabetes, EBV reactivation, myelodysplasia therapy related | Approved |
rituximab | Sclerodermoid chronic graft-versus-host disease, diabetes type 2, dyslipidaemia, hypertension, ineffective alternatives | Approved |
rituximab | Sclerodermoid chronic graft-versus-host disease, MDS, pneumocystis jiroveci pneumonia, reactivation of CMV | Approved |
rituximab | seropositive rhuematoid vasculitis, osteoporosis | Approved |
rituximab | seropositive rhuematoid vasculitis, osteoporosis | Approved renewal |
rituximab | severe bullous pemphigoid | Approved |
rituximab | severe bullous pemphigoid, steriod induced macular eye disease | Approved |
rituximab | Severe Polyarticular Arthritis | Approved |
rituximab | Severe thrombocytopaenia | Approved |
rituximab | SLE, amputation of arm, amputation of leg, avascular necrosis of hips, Chronic Bronchitis, Coronary Artery Disease, previous DVT and PE | Approved |
rituximab | SLE, nephritis | Approved |
rituximab | steroid dependent nephrotic syndrome | Approved |
rituximab | Steroid Resistant Nephrotic Syndrome | Approved |
rituximab | Steroid Resistant Nephrotic Syndrome | Approved renewal |
rituximab | sub-glottic stenosis, Wegener's Granulomatosis | Approved |
rituximab | systemic lupus erythematosus, severe neuropsychiatric complications | Approved |
rituximab | Thrombotic thrombocytopaenic purpura | Approved |
rituximab | warm autoimmune haemolytic anaemia | Approved |
rituximab | warm autoimmune haemolytic anaemia, Cerebrovascular accident, pancreatitis | Approved |
rituximab | warm autoimmune haemolytic anaemia, history of, ITP, lower extremety DVT, splenectomy, steroid induced diabetes mellitus | Approved |
rituximab | Wegener's Granulomatosis | Approved |
rituximab | Wegener's Granulomatosis, sub-glottic stenosis | Approved |
rituxumab | neuromyelitis optica | Approved |
ropivacaine | severe pain unresponsive to alternates, Advanced Metastatic Breast cancer, Infected Knee Joint, pain secondary to femur fracture | Approved |
rose bengal | metastatic melanoma | Approved |
rose bengal | metastatic melanoma | Approved |
rufinamide | atypical absence seizures, medically refractory seizures, myoclonic seizures, epileptic encephalopathy | Approved |
rufinamide | atypical absence seizures, medically refractory seizures, myoclonic seizures, epileptic encephalopathy | Approved renewal |
rufinamide | epilepsy, frontal lobe seizures | Approved renewal |
rufinamide | epilepsy, frontal lobe seizures | Approved renewal |
rufinamide | Epileptic encephalopathy, global development delay, severe drop seizures | Approved |
rufinamide | Epileptic encephalopathy, Intractable Epilepsy | Approved |
rufinamide | Epileptic encephalopathy, Intractable Epilepsy | Approved renewal |
rufinamide | epileptic encephalopathy, medically refractory seizures, autism spectrum disorder | Approved |
rufinamide | epileptic encephalopathy, medically refractory seizures, developmental regression, HLAB1502 allele positive | Approved |
rufinamide | epileptic encephalopathy, medically refractory seizures, developmental regression, HLAB1502 allele positive | Approved renewal |
rufinamide | epileptic encephalopathy, refractory seizures, autism spectrum disorder, severe drop seizures | Approved |
rufinamide | Intractable epilepsy, autism spectrum disorder, Hypomelanosis of Ito, intellectual disability | Approved |
rufinamide | Intractable epilepsy, autism, Lennox-Gastaut syndrome | Approved |
rufinamide | Intractable epilepsy, autism, Lennox-Gastaut syndrome | Approved renewal |
rufinamide | Intractable Epilepsy, Cognitive deficit, epilepsy secondary to neonatal meningitis, intellectual disability, partial epilepsy | Approved |
rufinamide | Intractable Epilepsy, Cognitive deficit, epilepsy secondary to neonatal meningitis, intellectual disability, partial epilepsy | Approved renewal |
rufinamide | Intractable Epilepsy, Cognitive deficit, epilepsy secondary to neonatal meningitis, intellectual disability, partial epilepsy | Approved renewal |
rufinamide | Intractable Epilepsy, Cognitive deficit, epilepsy secondary to neonatal meningitis, intellectual disability, partial epilepsy | Approved renewal |
rufinamide | Intractable epilepsy, cognitive impairment, Hydrocephalus | Approved |
rufinamide | Intractable epilepsy, GORD, neutropenia, osteoporosis, severe developmental delay | Approved |
rufinamide | Lennox�Gastaut syndrome, Chromosomal abnormality, epilepsy | Approved |
rufinamide | Lennox�Gastaut syndrome, Chromosomal abnormality, epilepsy | Approved renewal |
rufinamide | Lennox�Gastaut syndrome, Chromosomal abnormality, epilepsy | Approved renewal |
rufinamide | Lennox�Gastaut syndrome, Chromosomal abnormality, epilepsy | Approved renewal |
rufinamide | Lennox-Gastaut syndrome | Approved |
rufinamide | Lennox-Gastaut syndrome, Chromosomal abnormality, epilepsy | Approved renewal |
rufinamide | Lennox-Gastaut syndrome, learning difficulties | Approved |
rufinamide | Lennox-Gastaut syndrome, learning difficulties | Approved renewal |
rufinamide | Lennox-Gastaut syndrome, learning difficulties | Approved renewal |
rufinamide | Lennox-Gastaut syndrome, learning difficulties | Approved renewal |
rufinamide | Lennox-Gastaut syndrome, nonconvulsive status epilepticus, refractory epilepsy, Astrocytoma Grade 2, atonic attacks, drop attacks, frequent cyanotic spells | Approved |
rufinamide | Lennox-Gastaut syndrome, nonconvulsive status epilepticus, refractory epilepsy, Astrocytoma Grade 2, atonic attacks, drop attacks, frequent cyanotic spells | Approved renewal |
rufinamide | Lennox-Gastaut syndrome, refractory epilepsy | Approved |
rufinamide | Lennox-Gastaut syndrome, refractory epilepsy | Approved |
rufinamide | Lennox-Gastaut syndrome, refractory seizures, autism, intellectual disability | Approved |
rufinamide | medically refractory seizures, intellectual disability | Approved |
rufinamide | myoclonic astatic epilepsy, refractory epilepsy | Approved |
rufinamide | myoclonic astatic epilepsy, refractory epilepsy | Approved renewal |
rufinamide | refractory epilepsy | Approved |
rufinamide | refractory epilepsy | Approved renewal |
rufinamide | refractory epilepsy | Approved renewal |
rufinamide | refractory epilepsy, Lennox-Gastaut syndrome | Approved |
rufinamide | refractory epilepsy, severe drop seizures, tonic seizures, Lennox-Gastaut syndrome, severe autism | Approved |
rufinamide | refractory epilepsy, severe drop seizures, tonic seizures, Lennox-Gastaut syndrome, severe autism | Approved renewal |
rufinamide | refractory epilepsy, severe drop seizures, tonic seizures, Lennox-Gastaut syndrome, severe autism | Approved renewal |
rufinamide | Refractory seizure disorder, severe drop seizures, subcortical band heterotopia, challenging behaviour, intellectual disability | Approved |
rufinamide | Refractory seizure disorder, severe drop seizures, subcortical band heterotopia, challenging behaviour, intellectual disability | Approved renewal |
rufinamide | Refractory seizure disorder, severe drop seizures, subcortical band heterotopia, challenging behaviour, intellectual disability | Approved renewal |
sevalamer | end-stage renal disease, hyperphosphataemia, secondary hyperparathyroidism | Approved |
sevelamer | end stage renal disease, Steroid Resistant Nephrotic Syndrome | Approved |
sevelamer | end stage renal disease, Steroid Resistant Nephrotic Syndrome | Approved renewal |
sevelamer | end stage renal failure, hyperphosphataemia, hypoplastic kidney, Unable to tolerate funded medicaton, diabetes type 2, diabetic neuropathy, gout, hypercalcaemia, hypertension, Hypothyroidism | Approved |
sevelamer | end stage renal failure, hyperphosphataemia, hypoplastic kidney, Unable to tolerate funded medicaton, diabetes type 2, diabetic neuropathy, gout, hypercalcaemia, hypertension, Hypothyroidism | Approved renewal |
sevelamer | hyperphosphataemia, ANCA positive vasculitis, chronic peritoneal dialysis, Chronic Renal Failure | Approved |
sevelamer | hyperphosphataemia, ANCA positive vasculitis, chronic peritoneal dialysis, Chronic Renal Failure | Approved renewal |
sevelamer | painful dystrophic calcification, tertiary hyperparathyroidism, tumoural calcinosis, CF related diabetes, Cystic fibrosis, end stage kidney disease, liver transplant, surgery contraindicated | Approved renewal |
sevelamer | secondary hyperparathyroidism, end-stage renal disease, hyperphosphataemia | Approved |
sevelamer | severe hyperparathyroidism, ineffective alternatives, surgery contraindicated | Approved |
sildenafil | bridge to transplant, Chronic Renal Failure | Approved renewal |
sildenafil | bridge to transplant, Chronic Renal Failure | Approved renewal |
sildenafil | bridge to transplant, PAH secondary to lung disease, interstitial lung disease | Approved |
sildenafil | bridge to transplant, PAH secondary to lung disease, interstitial lung disease | Approved renewal |
sildenafil | bridge to transplant, PAH secondary to lung disease, interstitial lung disease | Approved renewal |
sildenafil | constrictive pericarditis, pulmonary hypertension, left heart disease, pericardiectomy, Right Heart Failure | Approved |
sildenafil | CREST syndrome, raynauds phenomenon | Approved |
sildenafil | CREST syndrome, raynauds phenomenon | Approved renewal |
sildenafil | diffuse cutaneous systemic sclerosis, Scleroderma, ulceration | Approved |
sildenafil | end stage heart failure, pulmonary hypertension | Approved |
sildenafil | end stage left heart disease, on transplant list, Severe dilated cardiomyopathy, left ventricular impairment, LV thrombus, Renal Impairment | Approved |
sildenafil | familial dilated cardiomyopathy, left heart disease | Approved |
sildenafil | haemangioma, lymphangioma of tongue | Approved |
sildenafil | pulmonary arterial hypertension, congenital systemic pulmonary shunts | Approved |
sildenafil | pulmonary hypertension, Cardiac Transplant, Severe dilated cardiomyopathy | Approved |
sildenafil | pulmonary hypertension, lung transplant candidate, pulmonary fibrosis | Approved |
sildenafil | raynauds phenomenon | Approved |
sildenafil | raynauds phenomenon | Approved |
sildenafil | raynaud's syndrome | Approved |
sildenafil | raynaud's syndrome, critical ischaemia left foot, discoid lupus, Peripheral Vascular disease, secondary non-healing ulcer | Approved |
sildenafil | reactive pulmonary hypertension, congenital diaphragmatic hernia | Approved |
sildenafil | Scleroderma, digital ischaemia | Approved |
sildenafil (Avigra) | PAH, complex congenital heart disease, cyanosis | Approved |
sirolimus | adenoma sebaceum, tuberous sclerosis | Approved |
sirolimus | adenoma sebaceum, tuberous sclerosis | Approved renewal |
sirolimus | CNS lesions, renal angiomyolipoma, arteriovenous malformations, intractable seizures, tuberous sclerosis | Approved renewal |
sirolimus | facial angiofibromas | Approved |
sirolimus | facial angiofibromas, ADHD, epilepsy, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, epilepsy, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, renal angiomyolipoma, subependymal giant cell astrocytomas, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, renal angiomyolipoma, subependymal giant cell astrocytomas, tuberous sclerosis | Approved renewal |
sirolimus | facial angiofibromas, subungual angiofibromas, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved renewal |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved renewal |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved renewal |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved renewal |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved renewal |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved renewal |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved renewal |
sirolimus | facial angiofibromas, tuberous sclerosis | Approved renewal |
sirolimus | facial angiofibromas, tuberous sclerosis, attention deficit hyperactivity disorder, epilepsy, Mild to Moderate Intellectual Impairment | Approved |
sirolimus | facial angiofibromas, tuberous sclerosis, epilepsy, mental handicap | Approved |
sirolimus | facial angiofibromas, tuberous sclerosis, epilepsy, mental handicap | Approved renewal |
sirolimus | gastrointestinal bleeding, Blue Rubber Bleb Naevus Syndrome (BRBNS) | Approved |
sirolimus | gastrointestinal bleeding, Blue Rubber Bleb Naevus Syndrome (BRBNS) | Approved |
sirolimus | Gorham-Stout disease | Approved |
sirolimus | hyperinsulinemic hypoglycaemia, hyperinsulinism in infant | Approved |
sirolimus | hyperinsulinemic hypoglycaemia, hyperinsulinism in infant | Approved |
sirolimus | hyperinsulinemic hypoglycaemia, hyperinsulinism in infant | Approved |
sirolimus | hyperinsulinemic hypoglycaemia, hyperinsulinism in infant | Approved |
sirolimus | lymphovascular malformation | Approved |
sirolimus | lymphovascular malformation | Approved renewal |
sirolimus | metastatic uterine perivascular epithelioid cell tumour | Approved |
sirolimus | PASLI-R1 syndrome | Approved |
sirolimus | PASLI-R1 syndrome | Approved renewal |
sirolimus | perivascular epithelioid cell tumour | Approved |
sirolimus | perivascular epithelioid cell tumour | Approved renewal |
sirolimus | PIK3CA-related segmental overgrowth, Klippel-Trenaunay Syndrome | Approved |
sirolimus | pulmonary lymphangioleiomyomatosis | Approved |
sirolimus | renal angiomyolipoma, risk of haemorrhage, tuberous sclerosis, intellectual disability, rash | Approved |
sirolimus | renal angiomyolipoma, severe tuberous sclerosis | Approved |
sirolimus | renal angiomyolipoma, severe tuberous sclerosis | Approved renewal |
sirolimus | renal angiomyolipoma, severe tuberous sclerosis, arteriovenous malformations, nephrectomy, risk of haemorrhage | Approved |
sirolimus | renal angiomyolipoma, tuberous sclerosis | Approved |
sirolimus | renal angiomyolipoma, tuberous sclerosis, Extensive skin disease | Approved |
sirolimus | renal angiomyolipoma, tuberous sclerosis, Extensive skin disease | Approved renewal |
sirolimus | tuberous sclerosis | Approved |
sirolimus | tuberous sclerosis | Approved |
sirolimus | tuberous sclerosis | Approved |
sirolimus | tuberous sclerosis | Approved renewal |
sirolimus | tuberous sclerosis, renal angiomyolipoma | Approved |
sirolimus ointment | facial angiofibromas, tuberous sclerosis | Approved |
sirolimus ointment | facial angiofibromas, tuberous sclerosis | Approved |
sitagliptin | allergy to insulin, diabetes type 2, hypertension | Approved |
slow sodium | hyponatraemia secondary to SIADH | Approved |
sodium benzoate | Citrullinaemia type 1 | Approved renewal |
sodium benzoate | hyperammonaemia | Approved |
sodium benzoate | hyperammonaemia, urea cycle disorder | Approved |
sodium benzoate | non-ketotic hyperglycinaemia | Approved |
sodium benzoate | OTC Deficiency, urea cycle disorder | Approved |
sodium benzoate | Propionic Acidaemia | Approved |
sodium benzoate | secondary hyperammonaemia, Portal Hypertension, portal vein thrombosis, Portosystemic connections, tetralogy of fallot repair | Approved |
sodium chloride | appendectomy, hyponatraemia, partial cystectomy, post right hemicolectomy, post thyroidectomy, right uretic JJ stent, severe COPD, stroke, tonsillectomy | Approved |
sodium chloride | Congestive Heart Failure, restrictive cardiomyopathy, hyponatraemia | Approved |
sodium chloride | corneal oedema | Approved |
sodium chloride | Crohns Disease, bowel resection | Approved |
sodium chloride | Crohns Disease, bowel resection | Approved renewal |
sodium chloride | Crohn's disease, bowel resection | Approved renewal |
sodium chloride | hyponatraemia, enlarged left kidney, pulmonary hypoplasia, renal dysplasia right kidney, severe pelvicalyceal dilatation | Approved |
sodium chloride | hyponatraemia, Schizophrenia, small bowel fistula | Approved |
sodium chloride | SIADH, Small Cell lung Cancer | Approved |
sodium chloride (Muro 128) | decompensating corneal graft | Approved |
sodium chloride (Slow Sodium) | hyponatraemia, Pancreatic neuroendocrine tumor, SIADH | Approved |
sodium chloride (Slow Sodium) | low sodium levels, Crohn's diease, Hodgkin's lymphoma | Approved |
sodium chloride (Slow Sodium) | Approved | |
sodium chloride solution | Cystic fibrosis, meconium ileus at birth | Approved |
sodium citrate | metabolic acidosis, reflux nephropathy | Approved |
sodium dihydrogen phosphate | metabolic bone disease of the neonate, Premature birth | Approved |
sodium dl 3 hydroxybutyrate | glut-1 deficiency, Behavioural problems, epilepsy, intellectual disability | Approved |
sodium phenylbutyrate | carnitine-acylcarnitine translocase deficiency, PEG feeding | Approved |
sodium phenylbutyrate | hyperammonia, multiple oesophageal varices, portal hypertension, portal vein thrombosis, Portosystemic connections | Approved |
sodium phenylbutyrate | hyperammonia, multiple oesophageal varices, portal hypertension, portal vein thrombosis, Portosystemic connections | Approved renewal |
sodium phenylbutyrate | OTC Deficiency, urea cycle disorder | Approved |
sodium picosulfate | chronic constipation, epilepsy, malone's appendicostomy for antegrade continence enema | Approved renewal |
sodium picosulfate | Chronic severe constipation, anxiety, developmental delay, epilepsy, Paediatric autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS) | Approved |
sodium picosulfate | familial mitochondrial myopathy, idiopathic intestinal pseudo obstruction | Approved |
sodium picosulfate | slow transit constipation, appendicostomy | Approved |
sodium picosulfate magnesium oxide citric acid | constipation, Hirschsprung's disease | Approved |
sofosbuvir | chronic Hepatitis C genotype 3A, Diabetes Mellitus | Declined |
sofosbuvir | HCV cirrhosis, Hepatocellular carcinoma, HIV infection, Kaposi's sarcoma | Declined |
sofosbuvir plus ledipasvir | chronic Hepatitis C genotype 3A, hepatits C virus cirrhosis, acquired via infected blood products, haemophilia, hepatocellular carcinoma, Post Liver Transplant | Declined |
sofosbuvir plus ledipasvir | chronic hepatitis C, hepatic fibrosis, acquired via infected blood products, von Willebrand disease | Declined |
sofosbuvir plus ledipasvir | chronic hepatitis C, liver cirrhosis, methadone maintenance, prior depression | Declined |
sofosbuvir plus ledipasvir | chronic hepatitis C, liver fibrosis, acquired via infected blood products, haemophilia, Head Injury, secondary epilepsy | Declined |
sofosbuvir plus ledipasvir | decompensated HCV cirrhosis, Head Injury, hepatocellular carcinoma, hypertension | Declined |
sofosbuvir plus ledipasvir | genotype 1 hepatitis C, acquired via infected blood products, liver fibrosis | Declined |
sofosbuvir plus ledipasvir | genotype 1 hepatitis C, hepatitis C virus cirrhosis, acquired via infected blood | Declined |
sofosbuvir plus ledipasvir | genotype 1 hepatitis C, hepatitis C virus cirrhosis, acquired via infected blood | Declined |
sofosbuvir plus ledipasvir | genotype 1 hepatitis C, hepatitis C virus cirrhosis, acquired via infected blood products | Declined |
sofosbuvir plus ledipasvir | genotype 1 hepatitis C, liver fibrosis, acquired via infected blood | Declined |
sofosbuvir plus ledipasvir | genotype 1 hepatitis C, liver fibrosis, acquired via infected blood | Declined |
sofosbuvir plus ledipasvir | genotype 1 hepatitis C, liver fibrosis, acquired via infected blood products | Declined |
sofosbuvir plus ledipasvir | hepatitis C virus cirrhosis, acquired via infected blood products, chronic Hepatitis C genotype 3A, haemophilia, Post Liver Transplant | Declined |
sofosbuvir plus ledipasvir | hepatitis C virus cirrhosis, acquired via infected blood products, chronic kidney disease | Declined |
somatropin | GH deficiency, adverse reaction to alternatives, hypoglycaemia, Panhypopituitarism | Approved |
sorafenib | aggressive fibromatosis, desmoid tumour | Approved |
sorafenib | aggressive fibromatosis, desmoid tumour | Approved renewal |
sorafenib | follicular carcinoma of thyroid, hurthle cell carcinoma of the thyroid | Declined |
sorafenib | follicular carcinoma of thyroid, refractory thyroid cancer, metastatic to lungs | Declined |
sorafenib | Metastatic Thyroid cancer, papillary carcinoma of the thyroid, refractory to radiotherapy | Declined |
sorafenib | papillary carcinoma of the thyroid | Declined |
spiramycin | foetal toxoplasmosis infection, maternal toxoplasmosis | Approved |
spiramycin | foetal toxoplasmosis infection, maternal toxoplasmosis | Approved |
spiramycin | maternal toxoplasmosis | Approved |
spiramycin | toxoplasmosis in pregnancy | Approved |
spiramycin | toxoplasmosis in pregnancy | Approved |
stanozolol | hereditary angioedema | Approved renewal |
stanozolol | hereditary angioedema, intolerance to alternatives | Approved |
stiripentol | dravet's syndrome, severe myoclonic epilepsy of infancy, learing impairment | Approved |
streptozocin | duodenal tumour, neuroendocrine tumour, unresectable, diabetes type 2, gout | Approved |
streptozocin | duodenal tumour, neuroendocrine tumour, unresectable, diabetes type 2, gout | Approved renewal |
streptozocin | hypoglycaemia due to insulinoma, metastatic pancreatic neuroendocrine tumour, liver metastases | Approved |
streptozocin | metastatic atypical carcinoid, neuroendocrine tumour | Approved |
streptozocin | metastatic neuroendocrine tumour | Approved |
streptozocin | metastatic neuroendocrine tumour | Declined |
streptozocin | metastatic pancreatic carinoma, hypoglycaemia | Approved |
streptozocin | metastatic pancreatic neuroendocrine tumour | Declined |
streptozocin | Pancreatic neuroendocrine tumor | Approved |
sulfadiazine | cerebral toxoplasmosis, Ocular Toxoplasmosis, immunocompetent | Approved |
sulindac | desmoid fibromatosis | Approved |
sulindac | desmoid fibromatosis | Approved |
sulindac | desmoid fibromatosis | Approved |
sulphadiazine | Cerebral toxoplasmosis, Glioblastoma Multiforme | Approved |
sulphadiazine | Cerebral toxoplasmosis, Glioblastoma Multiforme | Approved renewal |
sulthiame | continuous spike wave in slow wave sleeep, Epileptic encephalopathy, Landau-Kleffner Syndrome | Approved renewal |
sulthiame | electrical status epilepticus in slow wave sleep, epileptic encephalopathy | Approved |
sulthiame | electrical status epilepticus in slow wave sleep, epileptic encephalopathy | Approved renewal |
sulthiame | epilepsy aphasia disorder, epileptic encephalopathy | Approved |
sulthiame | Intractable Epilepsy, cerebral palsy, dystonia, Excessive drooling, Insomnia, intellectual handicap, scoliosis | Approved |
sulthiame | Lennox-Gastaut syndrome, drop attacks, Intellectual Handicap, mild cerebral palsy, myoclonic seizures, tonic clonic seizures | Approved |
sunitinib | angiosarcoma of the pericardium | Approved |
sunitinib | ascites, GIST relapse, imatinib refractory, peritoneal metastases | Approved |
sunitinib | extraskeletal myxoid chondrosarcoma | Approved |
sunitinib | imatinib refractory GIST | Approved |
sunitinib | imatinib refractory, nilotinib resistance, GIST relapse | Approved |
sunitinib | metastatic translocation renal variant renal tumour, extensive nodal disease | Approved |
sunitinib | progressive metastatic gastrointestinal stromal tumour | Approved |
sunitinib | refractory to chemotherapy, thymic carcinoma | Declined |
tacrolimus | angio immunoblastic T cell lymphoma, aplastic anaemia | Approved |
tacrolimus | angio immunoblastic T cell lymphoma, aplastic anaemia | Approved renewal |
tacrolimus | aplastic anaemia | Approved |
tacrolimus | aplastic anaemia | Approved |
tacrolimus | aplastic anaemia | Approved renewal |
tacrolimus | Corneal stem cell failure, possible graft versus host disease, Stevens-Johnson Syndrome | Approved |
tacrolimus | Crohn's disease | Approved |
tacrolimus | Crohns Disease, coeliac disease, refractory to other treatments, refractory to standard treatments | Approved |
tacrolimus | Crohn's disease, coeliac disease, refractory to other treatments, refractory to standard treatments | Approved renewal |
tacrolimus | Crohn's disease, coeliac disease, refractory to other treatments, refractory to standard treatments | Approved renewal |
tacrolimus | Crohn's disease, poor growth | Approved |
tacrolimus | Crohn's disease, poor growth | Approved renewal |
tacrolimus | Crohns Disease, sclerosing cholangitis | Approved |
tacrolimus | dermatitis of the vulva/external genitalia, Staphylococcus aureus infection, velocardiofacial (DiGeorge) syndrome | Approved renewal |
tacrolimus | dermatitis of thh vulva/external genitalia, Staphylococcus aureus infection | Approved |
tacrolimus | Erythoderma psoriasis | Approved |
tacrolimus | Focal Segmental Glomerulosclerosis, cyclosporin dependent, gingival hyperplania, Nephrotic Syndrome, short stature, steroid dependent, tremor | Approved |
tacrolimus | Focal Segmental Glomerulosclerosis, cyclosporin dependent, gingival hyperplania, Nephrotic Syndrome, short stature, steroid dependent, tremor | Approved renewal |
tacrolimus | Focal Segmental Glomerulosclerosis, cyclosporin dependent, gingival hyperplania, Nephrotic Syndrome, short stature, steroid dependent, tremor | Approved renewal |
tacrolimus | Focal Segmental Glomerulosclerosis, cyclosporin ineffective, renal dysfunction | Approved |
tacrolimus | Focal Segmental Glomerulosclerosis, Nephrotic Syndrome | Approved renewal |
tacrolimus | Focal Segmental Glomerulosclerosis, Nephrotic Syndrome | Approved renewal |
tacrolimus | Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome | Approved |
tacrolimus | Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome | Approved |
tacrolimus | Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment | Approved |
tacrolimus | Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment | Approved renewal |
tacrolimus | Ig A nephropathy | Approved |
tacrolimus | Ig A nephropathy | Approved renewal |
tacrolimus | Ig A nephropathy | Approved renewal |
tacrolimus | immunosuppression secondary to liver transplant, Refractory rejection | Approved |
tacrolimus | liver transplant, Cognitive deficit, previous graft rejection | Approved renewal |
tacrolimus | metastatic Crohn's disease of skin | Approved |
tacrolimus | minimal change nephrotic syndrome, steroid dependent nephrotic syndrome, asthma, cerebral palsy, Chronic lung disease, developmental delay | Approved |
tacrolimus | Nephrotic Syndrome | Approved |
tacrolimus | Nephrotic Syndrome | Approved |
tacrolimus | nephrotic syndrome | Approved |
tacrolimus | Nephrotic Syndrome | Approved renewal |
tacrolimus | Pure Red Cell Aplasia | Approved |
tacrolimus | pyoderma gangrenosum, Crohn's disease, post surgery | Approved |
tacrolimus | Renal Impairment, Severe Aplastic Anaemia | Approved renewal |
tacrolimus | Renal Impairment, Severe Aplastic Anaemia | Approved renewal |
tacrolimus | severe acquired aplastic anaemia | Approved |
tacrolimus | Severe Aplastic Anaemia | Approved |
tacrolimus | Severe Aplastic Anaemia | Approved |
tacrolimus | Severe Aplastic Anaemia, anaemia, Thrombocytopaenia | Approved |
tacrolimus | Severe Aplastic Anaemia, liver impairment | Approved |
tacrolimus | severe atopic dermatitis | Approved |
tacrolimus | steroid dependent minimal change glomerulonephritis | Approved |
tacrolimus | steroid dependent minimal change glomerulonephritis, frequently relapsing, possible follicular carcinoma of thyroid | Approved |
tacrolimus | steroid dependent nephrotic syndrome | Approved |
tacrolimus | steroid dependent nephrotic syndrome | Approved |
tacrolimus | steroid dependent nephrotic syndrome | Approved |
tacrolimus | steroid dependent nephrotic syndrome | Approved renewal |
tacrolimus | Steroid Resistant Nephrotic Syndrome | Approved |
tacrolimus | Steroid Resistant Nephrotic Syndrome | Approved |
tacrolimus | Steroid Resistant Nephrotic Syndrome | Approved renewal |
tacrolimus | Steroid Resistant Nephrotic Syndrome | Approved renewal |
tacrolimus | Steroid Resistant Nephrotic Syndrome | Approved renewal |
tacrolimus | Steroid Resistant Nephrotic Syndrome | Approved renewal |
tacrolimus | Steroid Resistant Nephrotic Syndrome, cyclophosphamide toxicity, cyclosporin unsuitable | Approved |
tacrolimus | Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis | Approved |
tacrolimus | Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis | Approved |
tacrolimus | Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis | Approved renewal |
tacrolimus | Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis | Approved renewal |
tacrolimus | Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis | Approved renewal |
tacrolimus | Steroid Resistant Nephrotic Syndrome, gum hypertrophy, hirsutism, renal impairment | Approved |
tacrolimus | Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment | Approved |
tacrolimus | Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment | Approved renewal |
tacrolimus | Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment | Approved renewal |
tacrolimus | Steroid Resistant Nephrotic Syndrome, hypoalbuminaemia, minimal change nephrotic syndrome | Approved |
tacrolimus | Steroid Resistant Nephrotic Syndrome, hypoalbuminaemia, minimal change nephrotic syndrome | Approved renewal |
tacrolimus | ulcerative proctitis | Approved |
tacrolimus | ulcerative proctitis | Approved renewal |
tacrolimus ointment | hypertrophic conjunctival spring catarrh, glaucoma | Approved |
tacrolimus ointment | metastatic Crohn's disease of skin | Approved renewal |
tacrolimus ointment | metastatic Crohn's disease of skin | Approved renewal |
tacrolimus ointment | non-healing wound, post surgery, protectomy, severe crohn's disease | Approved |
tacrolimus ointment | Refractory to steroids, vulval crohn's disease | Approved |
taurolidine | recurrent line sepsis, gastric dysmotility, Hirschsprung's disease, TPN dependent | Approved |
taurolidine | recurrent line sepsis, gastric dysmotility, Hirschsprung's disease, TPN dependent | Approved renewal |
taurolidine | recurrent line sepsis, gastric dysmotility, Hirschsprung's disease, TPN dependent | Approved renewal |
taurolidine | recurrent line sepsis, gastric dysmotility, Hirschsprung's disease, TPN dependent | Approved renewal |
taurolidine | recurrent port infections, haemophilia | Approved |
telaprevir | hepatitis C | Approved |
temozolomide | anaplastic astrocytoma | Approved |
temozolomide | anaplastic ependymoma, Spinal Metastases | Approved |
temozolomide | duodenal gastrinoma, metastatic neuroendocrine tumour, unresectable, zollinger-ellison syndrome | Approved |
temozolomide | Ewings sarcoma | Approved |
temozolomide | ewings sarcoma, metastatic | Approved |
temozolomide | insulinoma, metastatic pancreatic neuroendocrine tumour | Approved |
temozolomide | intermediate grade NET, hypertension | Approved |
temozolomide | intermediate grade NET, liver metastases | Approved |
temozolomide | liver metastases, lung cancer, neuroendocrine tumour | Approved |
temozolomide | liver metastases, lung cancer, neuroendocrine tumour | Approved renewal |
temozolomide | meningioma | Approved |
temozolomide | metastatic carcinoid tumour, hepatomegaly, liver metastases | Approved |
temozolomide | metastatic ewings sarcoma | Approved |
temozolomide | metastatic ewings sarcoma | Approved |
temozolomide | metastatic ewings sarcoma | Approved |
temozolomide | metastatic neuroendocrine tumour | Approved |
temozolomide | metastatic neuroendocrine tumour | Approved |
temozolomide | metastatic neuroendocrine tumour | Approved |
temozolomide | metastatic neuroendocrine tumour | Approved |
temozolomide | metastatic neuroendocrine tumour | Approved |
temozolomide | metastatic neuroendocrine tumour | Approved |
temozolomide | metastatic neuroendocrine tumour | Approved |
temozolomide | metastatic neuroendocrine tumour | Approved |
temozolomide | metastatic neuroendocrine tumour | Approved |
temozolomide | metastatic neuroendocrine tumour | Approved |
temozolomide | metastatic neuroendocrine tumour | Approved |
temozolomide | metastatic neuroendocrine tumour | Approved |
temozolomide | metastatic neuroendocrine tumour | Approved renewal |
temozolomide | metastatic neuroendocrine tumour, carcinoid syndrome | Approved |
temozolomide | metastatic neuroendocrine tumour, carcinoid syndrome | Approved |
temozolomide | metastatic neuroendocrine tumour, carcinoid syndrome | Approved |
temozolomide | metastatic neuroendocrine tumour, cushing's syndrome | Approved |
temozolomide | metastatic neuroendocrine tumour, Hypercalcaemia of Malignancy | Approved |
temozolomide | metastatic neuroendocrine tumour, hypercholesterolaemia | Approved |
temozolomide | metastatic neuroendocrine tumour, hypercholesterolaemia, hypertension, ischaemic heart disease | Approved |
temozolomide | metastatic neuroendocrine tumour, hypertension | Approved |
temozolomide | metastatic neuroendocrine tumour, hypertension, pernicious anaemia | Approved |
temozolomide | metastatic neuroendocrine tumour, hypertension, pernicious anaemia | Approved renewal |
temozolomide | metastatic neuroendocrine tumour, hypertension, pernicious anaemia | Approved renewal |
temozolomide | metastatic neuroendocrine tumour, intermediate grade NET | Approved |
temozolomide | metastatic neuroendocrine tumour, liver metastases, peritoneum metastases, small bowel metastases | Approved |
temozolomide | metastatic neuroendocrine tumour, Lung Metastases, relapse following chemotherapy, tracheal compression | Approved |
temozolomide | metastatic neuroendocrine tumour, neuroendocrine tumour | Approved |
temozolomide | metastatic neuroendocrine tumour, neuroendocrine tumour, intermediate grade NET | Approved |
temozolomide | metastatic neuroendocrine tumour, neuroendocrine tumour, intermediate grade NET | Approved renewal |
temozolomide | metastatic neuroendocrine tumour, stage IV, hypertension | Approved |
temozolomide | metastatic neuroendocrine tumour, widespread metastases | Approved |
temozolomide | metastatic neuroendocrine tumour, widespread metastases | Approved renewal |
temozolomide | metastatic neuroendocrine tumour, widespread metastases | Approved renewal |
temozolomide | metastatic pancreatic neuroendocrine tumour | Approved |
temozolomide | metastatic pancreatic neuroendocrine tumour | Approved |
temozolomide | metastatic pancreatic neuroendocrine tumour | Approved |
temozolomide | metastatic pancreatic neuroendocrine tumour | Approved |
temozolomide | metastatic pancreatic neuroendocrine tumour | Approved |
temozolomide | metastatic pancreatic neuroendocrine tumour, atrial fibrillation, dyslipidaemia, hyperkalaemia, hypertension, previous st jude mitral replacement | Approved |
temozolomide | metastatic paraganglioma, metastatic neuroendocrine tumour | Approved |
temozolomide | metastatic small cell neuroendocrine carcinoma of anorectal junction | Approved |
temozolomide | neuroendocrine cancer | Approved |
temozolomide | neuroendocrine cancer | Approved renewal |
temozolomide | neuroendocrine cancer, Hypothyroidism | Approved |
temozolomide | neuroendocrine cancer, liver metastases | Approved |
temozolomide | neuroendocrine tumour | Approved |
temozolomide | neuroendocrine tumour, intermediate grade NET | Approved |
temozolomide | Pancreatic neuroendocrine tumor | Approved |
temozolomide | Pancreatic neuroendocrine tumor | Approved |
temozolomide | Pancreatic neuroendocrine tumor | Approved |
temozolomide | Pancreatic neuroendocrine tumor | Approved |
temozolomide | Pancreatic neuroendocrine tumor | Approved |
temozolomide | Pancreatic neuroendocrine tumor | Approved |
temozolomide | Pancreatic neuroendocrine tumor | Approved renewal |
temozolomide | Pancreatic neuroendocrine tumor | Approved renewal |
temozolomide | Pancreatic neuroendocrine tumor | Approved renewal |
temozolomide | Pancreatic neuroendocrine tumor, Angina, liver metastases, pacemaker, renal cell carcinoma | Approved |
temozolomide | Pancreatic neuroendocrine tumor, Insulin-Dependent Diabetes Mellitus, pancreatectomy | Approved |
temozolomide | Pancreatic neuroendocrine tumor, Insulin-Dependent Diabetes Mellitus, pancreatectomy | Approved renewal |
temozolomide | Pancreatic neuroendocrine tumor, Insulin-Dependent Diabetes Mellitus, pancreatectomy | Approved renewal |
temozolomide | Pancreatic neuroendocrine tumor, liver metastases | Approved |
temozolomide | Pancreatic neuroendocrine tumor, non insulin-dependent diabetes mellitus | Approved |
temozolomide | Pancreatic neuroendocrine tumor, Portal Hypertension, portal vein thrombosis, splenomegaly | Approved |
temozolomide | pituitary macroadenoma | Approved |
temozolomide | primary CNS lymphoma | Approved |
temozolomide | primary CNS lymphoma, relapsed lymphoma | Approved |
temozolomide | pulmonary neuroendocrine tumour | Approved |
temozolomide | recurrent medulloblastoma | Approved |
temozolomide | recurrent medulloblastoma | Approved |
temozolomide | recurrent pancreatic neuroendocrine tumour, insulinoma, liver metastases | Approved |
temozolomide | relapsed CNS lymphoma | Approved |
temozolomide | relapsed Ewings sarcoma | Approved |
temozolomide | relapsed Ewings sarcoma | Approved |
temozolomide | relapsed Ewings sarcoma | Approved |
temozolomide | relapsed Ewings sarcoma | Approved |
temozolomide | relapsed Ewings sarcoma | Approved |
temozolomide | relapsed Ewings sarcoma | Approved |
temozolomide | relapsed neuroblastoma, metastatic neuroblastoma | Approved |
temozolomide | rhabdomyosarcoma | Approved |
teniposide | IgA multiple myeloma, plasmacytoma, Thrombocytopaenia | Approved |
teniposide | IgG multiple myeloma, acute renal failure, hyperkalaemia | Approved |
teniposide | Lymphoblastic T-cell lymphoma | Approved |
teniposide | lytic bone lesions, Myeloma | Approved |
teniposide | Multiple Myeloma | Approved |
teniposide | Multiple Myeloma | Approved |
teniposide | Multiple Myeloma | Approved |
teniposide | Multiple Myeloma | Approved |
teniposide | Multiple Myeloma | Approved |
teniposide | Multiple Myeloma | Approved |
teniposide | Multiple Myeloma | Approved |
teniposide | Multiple Myeloma | Approved |
teniposide | Multiple Myeloma | Approved |
teniposide | Multiple Myeloma | Approved |
teniposide | Multiple Myeloma | Approved |
teniposide | Multiple Myeloma | Approved |
teniposide | Multiple Myeloma | Approved |
teniposide | Multiple Myeloma | Approved |
teniposide | Multiple Myeloma | Approved renewal |
teniposide | Multiple Myeloma | Approved renewal |
teniposide | Multiple Myeloma | Approved renewal |
teniposide | Multiple Myeloma, anaemia, renal impairment | Approved |
teniposide | Multiple Myeloma, bone disease | Approved |
teniposide | Multiple Myeloma, bone disease | Approved |
teniposide | Multiple Myeloma, bone disease | Approved |
teniposide | Multiple Myeloma, bone disease, Moderate renal impairment | Approved |
teniposide | Multiple Myeloma, bone disease, Moderate renal impairment | Approved renewal |
teniposide | Multiple Myeloma, bone disease, renal impairment | Approved |
teniposide | Multiple Myeloma, Bone disease, with incipient cord compression | Approved |
teniposide | Multiple Myeloma, bone metastases | Approved |
teniposide | Multiple Myeloma, Crohn's diease | Approved |
teniposide | Multiple Myeloma, hypertension, renal impairment, spinal stenosis | Approved |
teniposide | Multiple Myeloma, intermittent AF | Approved |
teniposide | Multiple Myeloma, lytic bone lesions | Approved |
teniposide | Multiple Myeloma, mds, refractory anaemia with ringed sideroblasts (RARS), secondary to lenalidomide | Approved |
teniposide | Multiple Myeloma, mitral valve prolapse | Approved |
teniposide | Multiple Myeloma, non insulin-dependent diabetes mellitus, osteoarthritis of the spine | Approved |
teniposide | Multiple Myeloma, plasma cell leukaemia | Approved |
teniposide | Multiple Myeloma, plasma cell leukaemia, end-stage renal failure on dialysis | Approved |
teniposide | Multiple Myeloma, renal impairment | Approved |
teniposide | Myeloma | Approved |
teniposide | Myeloma, cast nephropathy | Approved |
teniposide | Myeloma, thoracic compression fracture | Approved |
teniposide | plasma cell myeloma, back pain, haemochromatosis | Approved |
teniposide | plasma cell myeloma, deep vein thrombosis, squamous cell skin cancer | Approved |
teniposide | primary central nervous system lymphoma | Approved |
teniposide | primary central nervous system lymphoma | Approved |
teniposide | primary CNS lymphoma | Approved |
teniposide | primary CNS lymphoma | Approved |
teniposide | primary CNS lymphoma, chronic active hepatitis | Approved |
teniposide | refractory multiple myeloma | Approved |
teniposide | refractory multiple myeloma | Approved |
teniposide | refractory multiple myeloma, Pancytopenia, renal impairment | Approved |
teniposide | relapsed multiple myeloma | Approved |
teniposide | relapsed multiple myeloma | Approved |
teniposide | relapsed multiple myeloma | Approved |
teniposide | relapsed multiple myeloma | Approved |
teniposide | relapsed multiple myeloma | Approved |
teniposide | relapsed multiple myeloma | Approved |
teniposide | relapsed multiple myeloma, hypercalcaemia | Approved |
teniposide | relapsed multiple myeloma, hypercalcaemia | Approved |
teniposide | relapsed multiple myeloma, Renal Impairment | Approved |
teniposide | relapsed myeloma, bone disease, Diabetes Mellitus | Approved |
teniposide | relapsed plasma cell myeloma, hypertension | Approved |
teniposide | T cell acute lymphoblastic leukemia | Approved |
teniposide | T cell acute lymphoblastic leukemia | Approved |
teriparatide | bisphosphonate related osteonecrosis of the jaw, stage III | Approved |
teriparatide | bisphosphonate related osteoradionecrosis of the jaw | Approved |
teriparatide | osteogenesis imperfecta | Approved |
testosterone | hypogonadism, fibromuscular dysplasia, migraines | Approved |
testosterone gel | Congenital hypopituitarism, funded alternative unsuitable | Approved |
thalidomide | angioimmunoblastic T cell lymphoma | Approved |
thalidomide | arteriovenous malformations, refractory intestinal bleeding | Approved |
thalidomide | Behcet's disease, duodenal carcinoma, fungal pneumonia, pulmonary embolism, renal calculus | Approved |
thalidomide | Behcet's disease, duodenal carcinoma, fungal pneumonia, pulmonary embolism, renal calculus | Approved renewal |
thalidomide | chromosomal translocation t(11;14)(q13;q32) and nuclear cyclin D1 overexpression, relapsed mantle cell lymphoma | Approved |
thalidomide | chronic anaemia, Hereditary hemorrhagic telangiectasia | Approved |
thalidomide | chronic anaemia, Hereditary hemorrhagic telangiectasia | Approved renewal |
thalidomide | chronic pruritus, nodular prurigo | Approved |
thalidomide | chronic recurrent gastric vascular ectasia, syncope with bleeding events, cerebrovascular disease, CREST syndrome, history of stroke, primary biliary cirrhosis | Approved |
thalidomide | Erythema Nodosum Leprosum | Approved |
thalidomide | gastrointestinal bleeding, myelodysplasia, small bowel angiodysplasia | Approved |
thalidomide | GI bleeds, cerebrovascular disease, Peripheral Vascular disease, polymyalgia, small bowel vascular ectasia, subclavian steal syndrome | Approved renewal |
thalidomide | multibacillary leprosy, relapsed erythema nodosum leprosum | Approved |
thalidomide | multibacillary leprosy, relapsed erythema nodosum leprosum, foot ulcer | Approved |
thalidomide | recurrent GI bleeding, severe crohn's disease | Approved renewal |
thalidomide | recurrent GI bleeding, severe crohn's disease | Approved renewal |
thalidomide | recurrent GI bleeding, small bowel angioectasia | Approved |
thalidomide | recurrent GI bleeding, small bowel angioectasia | Approved renewal |
thalidomide | recurrent GI bleeding, small bowel angioectasia | Approved renewal |
thalidomide | recurrent GI bleeding, small bowel angioectasia | Approved renewal |
thalidomide | refractory small bowel bleeding | Approved |
thalidomide | Refractory small intestinal bleeding | Approved |
thalidomide | Refractory small intestinal bleeding | Approved renewal |
thalidomide | severe crohn's disease | Approved |
thiothixene | paranoid schizophrenia | Approved |
ticagrelor | antiphospholipid syndrome, ischaemic heart disease, VF cardiac arrest | Approved |
ticagrelor | Coronary Artery Disease, dyslipidaemia, post stenting | Approved |
ticagrelor | coronary artery disease, multiple allergies, STEMI | Approved |
ticagrelor | coronary artery disease, multiple allergies, STEMI | Approved renewal |
ticagrelor | post stenting, intolerance to funded alternative | Approved |
timolol and travaprost | glaucoma, allergy to preservative | Approved |
timolol and travaprost | glaucoma, allergy to preservative | Approved renewal |
timolol maleate eye drops | essential iris atrophy left eye, glaucoma | Approved |
timolol minims | glaucoma, allergy to preservative | Approved |
tinidazole | Resistant trichomoniasis | Approved |
tinidazole | Resistant trichomoniasis, Depression | Approved |
tizanidine | dystonia, Dopamine-2-receptor antibody encephalitis, spasticity | Approved |
tobramycin | bronchiectasis, chronic colinisiation, developmental delay, hypogammaglobulinaemia, seizures | Approved |
tobramycin | bronchiectasis, macrophage activation syndrome, systemic onset juvenile idiopathic arthritis | Approved |
tobramycin | respiratory syncytial virus, severe chronic lung disease, bronchiolitis, possible cystic fibrosis, pseudomonas aeruginosa | Approved |
tocilizumab | adult onset Stills disease, folliculis, hepatosplenomegaly, myocarditis, pericarditis | Approved |
tocilizumab | castleman's disease | Declined |
tocilizumab | castleman's disease | Declined |
tocilizumab | juvenile idiopathic arthritis, uveitis, glaucoma, juvenile idiopathic uveitis, ocular inflammation, Positive ANA | Approved |
tocilizumab | multicentric castlemans disease | Declined |
tocilizumab | multicentric castlemans disease, aspiration pneumonia, Congestive Heart Failure, meningococcal septicaemia, mitral regurgitation, nephrectomy, Past history of rheumatic fever | Declined |
tocilizumab | polyarticular juvenile idiopathic arthritis, Anaphylaxis to rituxumab, refractory to standard treatments, unacceptable side effects of high dose steroid treatment | Approved |
tocilizumab | polyarticular juvenile idiopathic arthritis, Anaphylaxis to rituxumab, refractory to standard treatments, unacceptable side effects of high dose steroid treatment | Approved renewal |
tocilizumab | polymyalgic syndrome, refractory to other treatments, obstructive sleep apnoea | Approved renewal |
tocilizumab | systemic onset juvenile idiopathic arthritis, early macrophage activation syndrome | Approved |
tolvaptan | SIADH, hypertension, ischaemic heart disease, post operative knee surgery, post surgery | Approved |
tolvaptan | SIADH, hypertension, ischaemic heart disease, post operative knee surgery, post surgery | Approved renewal |
topotecan | neuroblastoma stage 4 | Approved |
topotecan | neuroblastoma stage 4 | Approved |
topotecan | neuroblastoma stage 4 | Approved renewal |
topotecan | wilm's tumour, liver metastases | Approved |
tramadol | pain, hydrocephalus with shunt, Spina Bifida, swallowing dysfunction | Declined |
tramadol sr | pain management, Spina Bifida | Approved |
tramadol sr | pain management, Spina Bifida | Approved renewal |
tranexamic acid | fungating left breast primary, metastatic breast cancer, pulmonary embolism | Approved |
trastuzumab | breast cancer, Her2 positive, controlled intracranial metastases, No systemic progression | Approved |
trastuzumab | breast cancer, Her2 positive, locally advanced breast cancer | Approved |
trastuzumab | breast cancer, Her2 positive, locally advanced breast cancer | Approved renewal |
travoprost bak-free | glaucoma | Approved |
travoprost bak-free | glaucoma | Approved renewal |
travoprost bak-free | glaucoma, allergy to preservative | Approved |
travoprost bak-free | glaucoma, allergy to preservative | Approved renewal |
travoprost bak-free | glaucoma, allergy to preservative | Approved renewal |
travoprost bak-free | glaucoma, asthma, multiple allergies | Approved renewal |
travoprost bak-free | glaucoma, asthma, multiple allergies | Approved renewal |
travoprost bak-free | primary open glaucoma, meibomian gland dysfunction | Approved renewal |
travoprost bak-free | primary open glaucoma, meibomian gland dysfunction | Approved renewal |
treosulphan | conditioning for stem cell transplant, Severe combined immune deficiency | Approved |
treosulphan | Severe combined immune deficiency, allogeneic transplant, awaiting stem cell transplant | Approved |
treprostinil | raynaud's syndrome, severe peripheral ischaemia, risk of further amputation, skin ulceration, very poor venous access | Approved |
triamcinolone acetonide | macular oedema, retinal vein occlusion, allergy to preservative | Approved renewal |
triamcinolone acetonide | macular oedema, vitrectomy | Approved renewal |
triamcinolone hexacetonide | macular oedema, retinal vein occlusion, allergy to preservative | Approved |
triamcinolone hexacetonide | macular oedema, vitrectomy | Approved |
trientine | Wilson's disease | Approved |
trientine | Wilson's disease, daibetes type 1 | Approved |
trientine dihydrochloride | Wilson's disease | Approved renewal |
trientine hydrochloride | Wilson's disease, diabetes type 1 | Approved renewal |
trientine hydrochloride | Wilson's disease, diabetes type 1 | Approved renewal |
trihexyphenidyl | cerebral palsy, choreoathetoid cerebral palsy, dystonia, kernicterus | Approved |
trihexyphenidyl | Complex Mitochondrial Disorder, choreoathetoid movements, excessive oral secretions, excessive sweating, global development delay, hyponatraemia, severe GI dysmotility | Approved |
trihexyphenidyl | Complex Mitochondrial Disorder, choreoathetoid movements, excessive oral secretions, excessive sweating, global development delay, hyponatraemia, severe GI dysmotility | Approved renewal |
trihexyphenidyl | dystonia | Approved |
trihexyphenidyl | dystonia, Dopamine-2-receptor antibody encephalitis, spasticity | Approved |
trihexyphenidyl | dystonia, hypoxic ischaemic encophalopathy, Neonatal Seizures | Approved |
trihexyphenidyl | dystonic cerebral palsy, aspiration pneumonia, Excessive drooling, global development delay, seizures | Approved |
triiodothyroacetic acid | Allan-Herndon-Dudley Syndrome | Approved |
triiodothyroacetic acid | Allan-Herndon-Dudley Syndrome | Approved |
triiodothyroacetic acid | Allan-Herndon-Dudley Syndrome, MCT8 thyroid transported defect, gastrostomy feeding, severe developmental delay, Severe GORD, sleep disturbance | Approved |
tyr anamix infant | tyrosinaemia non-type I | Approved |
tyr anamix junior | tyrosinaemia type I | Approved |
tyr anamix junior | tyrosinaemia type I | Approved renewal |
tyr anamix junior | tyrosinaemia type III | Approved |
tyr anamix junior | tyrosinaemia type III | Approved renewal |
tyr anamix junior | tyrosinaemia type III | Approved renewal |
ubiquinone | Brown-Vialetto-Van Laere Syndrome | Approved |
ursodeoxycholic acid | bile reflux, painful gastropathy | Approved |
ursodeoxycholic acid | bile reflux, painful gastropathy | Approved renewal |
ursodeoxycholic acid | biliary atresia, awaiting liver transplant, pruritus secondary to cholestasis, recurrent Cholangitis | Approved |
ursodeoxycholic acid | biliary atresia, failing kasai portoenterostomy | Approved |
ursodeoxycholic acid | biliary atresia, failing kasai portoenterostomy | Approved renewal |
ursodeoxycholic acid | cholangiopathy, intra-hepatic stones, post liver transplant, Roux reconstruction | Approved |
ursodeoxycholic acid | cholelithiasis, pancreatitis, surgery contraindicated | Approved |
ursodeoxycholic acid | cholestasis, Liver disease, short bowel syndome | Approved |
ursodeoxycholic acid | cholestatic hepatitis, cholestatic jaundice | Approved |
ursodeoxycholic acid | chronic cholestatis, ABCB4 mutation causing premature complicated gallstone disease | Approved |
ursodeoxycholic acid | deranged liver enzymes, GvHD post allogeneic transplant | Approved |
ursodeoxycholic acid | intractable pruritus, Biliary Atresia, kasai procedure, liver transplant | Approved |
ursodeoxycholic acid | intractable pruritus, cholestatic liver disease | Approved |
ursodeoxycholic acid | intractable pruritus, primary sclerosing cholangitis, Ulcerative Colitis | Approved |
ursodeoxycholic acid | liver graft verus host disease, acute myeloid leukaemia, hypertension, mild renal impairment | Declined |
ursodeoxycholic acid | PBC | Approved renewal |
ursodeoxycholic acid | primary biliary cirrhosis | Approved |
ursodeoxycholic acid | primary biliary cirrhosis, hypertension, splenomegaly | Approved |
ursodeoxycholic acid | primary sclerosing cholangitis | Approved |
ursodeoxycholic acid | primary sclerosing cholangitis, autoimmune hepatitis, inflammatory bowel disease | Approved |
ursodeoxycholic acid | primary sclerosing cholangitis, autoimmune hepatitis, inflammatory bowel disease | Approved renewal |
ursodeoxycholic acid | primary sclerosing cholangitis, autoimmune hepatitis, inflammatory bowel disease | Approved renewal |
ursodeoxycholic acid | primary sclerosing cholangitis, pancolitis | Approved renewal |
ursodeoxycholic acid | progressive familial intrahepatic cholestasis | Approved |
ursodeoxycholic acid | pruritus secondary to cholestasis, Liver Failure, oesophageal varices | Approved |
ursodeoxycholic acid | recurrent choledocholithiasis, asthma, diabetes insipidus | Approved |
ursodeoxycholic acid | recurrent intrahepatic stone disease | Approved |
ursodeoxycholic acid | severe pruritus, cirrhosis, intrahepatic biliary strictures, primary sclerosing cholangitis, Ulcerative Colitis | Approved |
ursodeoxycholic acid | severe pruritus, cirrhosis, intrahepatic biliary strictures, primary sclerosing cholangitis, Ulcerative Colitis | Approved renewal |
ustekinumab | severe chronic plaque psoriasis, treatment refractory | Approved |
ustekinumab | severe chronic plaque psoriasis, treatment refractory | Approved renewal |
valaciclovir | disseminated varicella zoster virus infection, AML, bone marrow transplant, prophylaxis | Approved |
valaciclovir | gingivostomatitis, immunosuppressed patient, Recurrent herpes simplex | Approved |
valaciclovir | HSV keratitis with stromal disease, scarring and neovascularistion, eczema on mycophenolate, Herpes Simplex Keratitis | Approved |
valaciclovir | prophylaxis to prevent infection, post bone marrow transplant, recurrent herpes zoster flares | Approved |
valaciclovir | Recurrent herpes simplex, Herpes Simplex Keratitis, virus not controlled on Acyclovir | Approved |
valaciclovir | shingles | Approved |
valganciclovir | Active Hepatitis, Acute Lymphoblastic Leukaemia, Congenital Heart Disease, high EBV load | Approved |
valganciclovir | acute leukamia post bone marrow transplant, treatment of CMV disease | Approved |
valganciclovir | Acute Lymphoblastic Leukaemia, reactivation of CMV | Approved |
valganciclovir | Acute Myeloid Leukaemia, CMV viraemia, post bone marrow transplant, secondary pancytopenia | Approved |
valganciclovir | anterior uveitis, CMV, glaucoma, post LASIK surgery, reduced endothelial cell count, secondary cataract | Approved |
valganciclovir | anterior uveitis, CMV, glaucoma, post LASIK surgery, reduced endothelial cell count, secondary cataract | Approved renewal |
valganciclovir | cmv colitis | Approved |
valganciclovir | CMV disease post lung transplant | Approved |
valganciclovir | CMV disease post renal transplant | Approved |
valganciclovir | cmv infection post allo-transplant | Approved |
valganciclovir | CMV myocarditis, immunocompetent, pulmonary oedema | Approved |
valganciclovir | Crohn's diease, Cytomegalovirus induced haemophagocytic lymphohistiocytosis | Approved |
valganciclovir | cytomegalovirus infection, Epstein Barr Virus, post renal transplant | Approved |
valganciclovir | cytomegalovirus infection, GvHD, T cell lymphoma | Approved |
valganciclovir | cytomegalovirus infection, Hypothyroidism, idiopathic thrombocytopaenic purpura, polycystic kidney disease, post splenectomy, systemic lupus erythematosus | Approved |
valganciclovir | high EBV replication, post renal transplant | Approved |
valganciclovir | high EBV replication, post renal transplant | Approved renewal |
valganciclovir | Kaposi's sarcoma associated HHV-8, castleman's disease, HIV infection | Approved |
valganciclovir | Kidney Transplant, Prophylaxis of CMV | Approved |
valganciclovir | post bone marrow transplant, reactivation of CMV | Approved |
valganciclovir | post bone marrow transplant, reactivation of CMV | Approved |
valganciclovir | Prophylaxis of CMV | Approved |
valganciclovir | Prophylaxis of CMV, polycystic kidney disease, post kidney transplant | Approved |
valganciclovir | reactivation of CMV | Approved |
valganciclovir | reactivation of CMV, conditioned with cyclophosphamide, fludarabine treatment, post allogeneic stem cell transplant, received ATG treatment in hospital | Approved |
valganciclovir | reactivation of CMV, post bone marrow transplant | Approved |
valganciclovir | Renal Transplant, CMV mismatch, hypertension | Approved |
valganciclovir | Severe Aplastic Anaemia, CMV | Approved |
valine | Maple syrup urine disease | Approved |
vancomycin | cataract surgery, corneal endothelial dystrophy, corneal grafting, infective crystalline keratopathy | Approved |
vancomycin | cataract surgery, corneal endothelial dystrophy, corneal grafting, infective crystalline keratopathy | Approved |
vancomycin | cataract surgery, corneal endothelial dystrophy, corneal grafting, infective crystalline keratopathy | Approved renewal |
vancomycin | cataract surgery, corneal endothelial dystrophy, corneal grafting, infective crystalline keratopathy | Approved renewal |
vancomycin | cataract surgery, corneal endothelial dystrophy, corneal grafting, infective crystalline keratopathy | Approved renewal |
vancomycin | corneal perforation, fungal keratitis | Approved |
varicella vaccine | disseminated varicella prevention, congenital bullous ichthyosiform erythroderma | Approved |
varicella vaccine | prevention of chickenpox, dystonia | Approved |
varicella vaccine | Very long chain acyl-CoA dehydrogenase (VLCAD) deficiency, prophylaxis for varicella | Approved |
vismodegib | nevoid basal cell carcinoma syndrome, gorlin syndrome | Approved renewal |
vitamin b12 | vitamin b12 deficiency, Autistic Spectrum Disorder | Approved |
vitamin b12 capsule (cyanocobalamin) | methylmalonic acidemia | Approved |
vitamin e | Vitamin E deficiency, biliary atresia | Approved |
vitamin e (alpha tocoferil acetate) | cholestatic liver disease | Approved |
voriconazole | Acute Lymphoblastic Leukaemia, allogeneic sibling stem cell transplant, CT proven chest infection, pulmonary embolism | Approved |
voriconazole | Acute Lymphoblastic Leukaemia, Aspergillosis Lung Disease, Invasive Aspergillosis | Approved |
voriconazole | Acute Lymphoblastic Leukaemia, aspergillus grown in sputum, Aspergilus lung infection in neutrophenic patient, intensive chemotherapy | Approved |
voriconazole | acute lymphoblastic leukaemia, MUD BMT, Pulmonary Aspergillosis | Approved |
voriconazole | Acute Lymphocytic leukaemia, Neutropenic sepsis of fungal origin suspected aspergillus | Approved |
voriconazole | Acute Myeloid Leukaemia AML, Invasive Pulmonary Aspergillosis, metastatic breast cancer | Approved |
voriconazole | Acute Myeloid Leukaemia, aspergillosis infection | Approved |
voriconazole | Allergic bronchopulmonary aspergillosis | Approved |
voriconazole | Allergic bronchopulmonary aspergillosis, Cystic fibrosis | Approved |
voriconazole | aspergilllus infection, aspergillus tereus, immunosuppressed secondary to chemotherapy, respiratory infection | Approved |
voriconazole | aspergilllus infection, bone marrow transplant | Approved |
voriconazole | aspergillosis infection | Approved |
voriconazole | aspergillosis infection, hypoxia, lymphoma, Neutropenic Sepsis, Severe hypoxia | Approved |
voriconazole | aspergillus bronchitis, BSLT | Approved |
voriconazole | aspergillus flavus | Approved |
voriconazole | Atrial fibrillation, Geotrichum lung infection, hypophosphataemia, malleolus fracture, multiple pulmonary nodules, parietal subdural haemorrhage, pulmonary embolism, vasculitis | Approved |
voriconazole | Atrial fibrillation, Invasive Pulmonary Aspergillosis | Approved |
voriconazole | Candida glabrata infection, cervical spine arteomyelitis, diabetes, end stage renal failure, hepatitis C, Hypernatraemia | Approved |
voriconazole | Candida glabrata infection, Fungal endophthalmitis, adenocarcinoma, Chorioretinitis, diverticulitis | Approved |
voriconazole | cerebral cryptoccoma, probable tuberculosis | Approved |
voriconazole | chronic cavitatory pulmonary aspergillus, Invasive Pulmonary Aspergillosis | Approved |
voriconazole | chronic Wangiella Dermatidis infection | Approved |
voriconazole | cryptococcaemia, HIV infection | Approved |
voriconazole | diffuse large b-cell lymphoma, Invasive Pulmonary Aspergillosis | Approved |
voriconazole | Endocarditis, pulmonary embolism, pulmonary infarction, tricuspid and aortic valve disease | Approved |
voriconazole | Ewings sarcoma, systemic yeast infection | Approved |
voriconazole | felty's syndrome, Chest infection, neutropaenia | Approved |
voriconazole | Fungal endophthalmitis, scedosporium infection | Approved |
voriconazole | fungal infection, chemotherapy, mantle cell lymphoma | Approved |
voriconazole | fungal keratitis | Approved |
voriconazole | Invasive Aspergillosis | Approved |
voriconazole | Invasive Aspergillus infection, malignant otitis externa | Approved |
voriconazole | Invasive biapical cavitary Aspergillosis | Approved |
voriconazole | invasive necrotising fungal pneumonia, hypertension, metastatic calcifications, osteopaenia, previous CMV infection, Renal Transplant | Approved |
voriconazole | Invasive Pulmonary Aspergillosis, T Cell ALL | Approved |
voriconazole | left upper lobe mycetoma, cystic lung disease, recurrent right pneumothorax | Approved |
voriconazole | multiple central line infections, Autoimmune Haemolysis, chronic graft versus host disease, Congenital Immune Deficiency, intestinal failure, thymic transplant | Approved |
voriconazole | paecilomyces Prosthectic Left Hip Joint Infection, asthma, bilateral THJR, metallic aortic valve replacement, MSSA infection of left prosthetic knee joint, recent bilateral peroprosthectic neck of femur fractures, Rheumatoid Arthritis | Approved |
voriconazole | presumed aspergillus chest infection, chronic lymphocytic leukaemia, hypogammaglobulinaemia | Approved |
voriconazole | Pulmonary Aspergillosis | Approved |
voriconazole | Pulmonary Aspergillosis | Approved |
voriconazole | Pulmonary Aspergillosis, Acute Myeloid Leukaemia | Approved |
voriconazole | Pulmonary Aspergillosis, Acute Myeloid Leukaemia | Approved |
voriconazole | Pulmonary Aspergillosis, AML, Stem Cell Transplant | Approved |
voriconazole | renal tract infection, candida albicans infection | Approved |
voriconazole | Rheumatic Heart Disease, candidal endocarditis | Approved |
voriconazole | risk of fungal infection, Acute megakaryoblastic leukaemia, Persistent Neutropenic Fever | Approved |
voriconazole | suspected fungal infection | Approved |
voriconazole eye drops | fungal keratitis, corneal perforation | Approved |
whole thyroid | Graves' disease, Post-Radio-Iodine Hypothyroidism | Approved renewal |
xlys low try maxamaid | glutaric aciduria type 1 | Approved |
zoledronic acid | sensory neuropathy, osteomyelitis | Approved |
zoledronic acid | Widespread bone metastases, atrial fibrillation, COPD, hormone refractory, metastatic prostate cancer, Rheumatoid Arthritis | Approved |
zonisamide | astro-ganglioglioma, symptomatic partial seizures secondary to tumor | Approved |
zonisamide | astro-ganglioglioma, symptomatic partial seizures secondary to tumor | Approved renewal |
zonisamide | epilepsy, focal seizures, infantile spasms, refractory to other treatments, epileptic encephalopathy, global development delay | Approved |
zonisamide | epilepsy, focal seizures, infantile spasms, refractory to other treatments, epileptic encephalopathy, global development delay | Approved renewal |
zonisamide | epilepsy, focal seizures, infantile spasms, refractory to other treatments, epileptic encephalopathy, global development delay | Approved renewal |
zonisamide | epileptic encephalopathy, medically refractory seizures, autism | Approved |
zonisamide | epileptic encephalopathy, refractory seizures | Approved |
zonisamide | idiopathic generalised epilepsy | Approved |
zonisamide | Intractable epilepsy | Approved |
zonisamide | Intractable epilepsy | Approved renewal |
zonisamide | Intractable Epilepsy, congenital heterotopia, cortical cysts, developmental delay, hemiplegia, Hydrocephalus, migraine, sensory seizures | Approved |
zonisamide | Intractable Epilepsy, congenital heterotopia, cortical cysts, developmental delay, hemiplegia, Hydrocephalus, migraine, sensory seizures | Approved renewal |
zonisamide | Intractable Epilepsy, congenital heterotopia, cortical cysts, developmental delay, hemiplegia, Hydrocephalus, migraine, sensory seizures | Approved renewal |
zonisamide | medically refractory seizures | Approved |
zonisamide | medically refractory seizures, refractory generalised epilepsy | Approved |
zonisamide | refractory epilepsy | Approved |
zonisamide | refractory epilepsy, complex partial seizures, grand mal seizures | Approved |